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Df\ VII) l)/\RRELL A.RRINCJTON. Calpain 10: Mitochondrial Localization. FLlnction~ 
and Suhstrates. (Lndcr the direction or RIC'K S(~HNELLMANN) 
Abstract 
The calpain tll1l1ily of cysteine protcases has undergone intense study since its 
discovery ill 1976. Although IHlll1erOliS functions and proteolytic substrates have been 
linked to this 14-nlcnlber Elnl1ly, little is knovv'n about the five atypical calpain isofornls. 
Over the past 25 years. investigators have identified 'calpain-like' acti\'ities in 
nlitochondrial fractions isolated fronl various tissues. The studies undertaken in this 
dissertation \~/erc designed to positively identify the nlitochondrial calpain present in 
renal corticallllitochondria (RCM) and to e111cidatc its function and proteolytic targets 
under both basal and C'a2-""-challenged conditions. 
We iticnti fled the RCrY1 calpain as calpain 10 by both inl111Ulloblot analysis and 
via confocal nlicroscopy. We also found that Ca2+ -induced lllitochondrial respiratory 
dysfunction \vas the result ofcalpain-nlcdiatcd proteolysis of the C0l11plex I electron 
transport chain subunits NDUFV2 and ND6. In addition, \ve delllonstrated that calpain 
I () plays ,\ role in the Cornultion of the 1l1enlbranc pcrnlcability transition (IVIPT) pore as 
cva1uatcd by confocal analysis and 111itochondrial svvelling assays. 
The infection ofprinlary renal proxinlal tubule cells (RPTC) using an adcnoviral 
cassette expressing calpain 1 O-specific shRT\A. produced a variety of phenotypes 
involving both 111itochondrial physiology and cell survival. Mitochondrial respiration and 
1l1CI11branc potential vvere unchanged in virally-treatcd cells \vhile ATP levels vvcrc 
increased 2-fold by day five post-infection. Increases in cellular A TP were associated 
\\i·ith decreased ATP synthase f) proteolysis and increased synthesis of the sanle protein. 
XII1 
In additiol1~ cell survival was signifIcantly decreased by day 5 post-infection and was a 
rcsu It 0 r caspasc-depcndent apoptosis. 
Calpain lOis the only gcnc that has been genetically linked to Type II diabetes~ 
and its role in this disease process is believcd to be associated \"lith calpain 1 (fs function 
as a 1l1cdiator oi'glucose 111ctabolisn1 and insulin handling. \Ve identified the Type II 
diabetes susceptibility gene ORP 150 as a putative calpain 10 substrate. ORP150 \vas 
found to be dually targeted to both the ER and 1l1itochondrial fractions of rat RPTC. 
C'haractcrization of this n10leculc dCI110nstratcd that its induction is 111cdiated by both 
global and nlitochondrial-spccific insults and that ORP150 is a proteolytic target for 
calpain 10, 
In SLl111111ary, these results den10l1stratc the il11portal1ce of ca1pain 10 under both 
physiologic(ll and pathological conditions. Our data also suggest that calpain ] 0 111ay 
serve to integrate Illultiplc signaling events. thereby regulating ccllular ATP levels and 
survival J11cchanisnls. These studies provide further insight into the biology of calpain 10 
and its role in Ca1+-induced n1itochondrial dysfllllction~ and 111ay provide biochenlical 
evidellce Sli nicicnt to define calpain 10 as a potential target for therapeutic intervention 
in discasc statcs Illcdiatcd by the dysregulatioll of cel1ular Ca2+ honlcostasis. 
XlV 
(:HAPTER 1 
RE\lIE\V OF AC=Ul'E RENAL FAILURE AND CALPAIN BIOLOGY 
Acute Renal Failure 
Acute renal failure CARF) is a signi ficant clinical flnding that can be precipitated 
by a host of f~lctors .. ARF affects approxinlately 5°~) of all hospital adnl1ssions and can 
carry a nlortality rate of 50(;;;) in the general population (1) and up to 9()(1~ in aged or 
critically i II patients (2). Clinically. ARF is oHcn a di fficult diagnosis to 111ake because 
there arc 110 accepted diagnostic criteria as in acute lung injury or sepsis (2). HO\NCVer~ 
i-\RF can generally be defined as an increase in nitrogenolls \vaste products such as blood 
urea nitrogen and serUlll creatinine found in conjunction \vith a decreased glo111crular 
1~ltratioll rate (CJFR) and urine output (3). In hospital-acquired ARF, up to 75(10 of all 
cases arc the result of acute tubular necrosis (ATN), although this llloniker is sOlne\vhat 
of a 1l1isnOnlcr because renal f~lillirc ill hUlllans is rarely due to frank cel1ular necrosis. 
/\pprox i1l1alcly 35-50(!~) of ATN can be linked to sepsis~ 20-25(Yo to hypovolell1ia during 
and after Inajor surgery, and 7(1~) to radiocontrast agents (3). 
/\RF can be subdivided into three categories including prerenal, intrarcnal, and 
postrenal etiologies (2,3) (Fig. 1-1). Prerenal causes of ARF include VOlU111e depletion 
fron1 surgery. traunla, or crush injuries and drug-induced ARF in patients \vith bilateral 
renal artery stenosis. Intrarcnal .ARF is 1110St often associated 'vvith ischenlia and 
nephrotoxin-induced acute tubular necrosis, followed by renal dysfunction associated 
\vith vascular danlagc~ glolllcruloncphritis, and drug-induced acute interstitial nephritis 
(3). Postrenal Cornls of ARF are generally caused by obstructive disorders including 
col1ccting tubule obstruction or blockage oCextrarenal structures such as ureters, valves, 
or the urethra in 111en with prostatic hypertrophy (2~ 3). 
Prerenal 
Sudden and severe drop in 
blood pressure (shock) or 
interruption of blood flow to 
the kidneys from severe injury 
or illness. 
Intrarenal 
Direct damage to the kidneys 
by inflammation, toxins, 
drugs, infection, or reduced 
blood supply. 
Postrenal 
Sudden obstruction of urine 
outflow due to enlarged 
prostate, kidney stones, 
bladder tumor, or injury. 
Adapted from: http://www.orthowomenshealth 
Ibladder/images/bladder _image1.jpg 
Figure 1-1. Schematic diagram of the three major types of acute renal failure 
(ARF). Acute renal failure can originate from numerous causes, but can be easily 
grouped into three categories including prerenal, intrarenal, and Postrenal ARF. The 
most common cause of hospital-acquired ARF is intrarenal ARF. 
3 
Since acute tubular necrosis is responsible ror n10st cases of ARF. the renlaindcr 
of this discllssion \vill focus on the pathophysiology and 1110lccular ll1cchanis1l1S oCthis 
Conn of renal daillagc. [)ccrcascs in GFR during ARF can be n1cchanistically divided 
into t\\'o categories: vascular and tubular. In established ARF, renal blood nOv\! is 
reduced to 30-50(!lo with a selective reduction to the outer 11ledulla. In the early phase of 
ARF, decreases in renal perfusion pressure initiate constriction of efferent arterioles. 
outer nlcdul1ary congestion, and activation of tubuloglo1l1erular feedback (3), The renal 
vasculature bcconles hypersensitive to vasoconstrictors SLich as cndothclin. adenosine, 
angiotensin] I. throlnboxanc /\2. Icukotriencs, and syn1pathetic nerve stin1ulation. 
Conversely, the vasculature hecol11es hyposensitive to vasodilators sLlch as nitric oxide, 
prostaglandin F2, acetylcholine. and bradykinin. Later stages of vascular danlage are 
hallnlarkcd by structural danlagc to endothelial cells~ leukocyte infi)tration~ and the 
release or inllanllllatory nlcciiators. Tubular danlagc to renal epithelial cells is the secolld 
111ajor COlllpOllcnt of the decreased GFR seen during ARF. This dan1age ll1anifests itself 
as tubular obstruction. interstitial inflanlnlation, and tubular backleak of filtrate (2-4). 
Histologically. ARF is typi fled by the loss of cellular polarity and 111icrovi]lar 
brush border n1CIllbranes in the proxinla] tubule cells, cellular vacuolatjon~ leukocyte 
illftltratioll~ desqua1l1ation of tile tubular epitheliunl, interstitial edenla, and dilatation of 





Figure 1-2. Histological comparison of normal and necrotic renal tubules. 
The above histological sections are H&E stained kidney slices demonstrating both 
normal renal epithelia and epithelia post-ischemia. Notice the thick appearance of the 
normal tubules versus the thin, desquamous epithelia from the necrotic tissue. The tubule 
lumen is also dilated and filled with red blood cells and cellular debris (cellular casts). 
5 
Interestingly, frank cellular necrosis in hunlan ARF is not a C0111111011 finding and 
is usually lin1itcd to the SJ segnlent of the proxin1al tubule and 111cdullary thick ascending 
lin1b or Henle"s loop (2-4). Ho\vevcr~ ill n10st anin1allllodels of ARF, necrosis is fairly 
\vicicsprccld. Investigators have suggested that this 111ay be an artifact of the n1ethods used 
to induce ARF in anin1al n10dels sllch as severe ischen1ia (renal artery occlusion) and 
high doses or con1n1011 nephrotoxic agents as listed in Table 1-1 (2). Recent evidence 
suggests that the nlajority oftuhular cell injury in hun1an ARF is sublethal cell injury and 
apoptosis (2. 4). 
Table 1-1. (~ommon A.RF-inducing drugs and xenohiotics 
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~ecrosis. During renal ischell1ia. necrosis is a C01111110n haI1n1ark of dan1agc and 
is seen prinlarily in the proxinlal tuhule (5). The severe ATP depletion seen during 
ischc111ic insult leads to llun1crous dOw11strcalll effects including in1pairnlent of 
lipogenesis~ protein synthesis, lllenlbrane transport (5.6), and the disruption of the 
plaS111(1 n1e111hranc Na' /I( t ATPase (6, 7). Inlpairn1ent of the Na +/K+ ATPase leads to 
increased cytosolic calciu111 levels via a plasnla lllell1brane Na+;Ca++ exchanger (8). This 
i11crease in cytosolic {l'ce calciunl activates nUIl1erous cellular proteases and 
phospholipascs \vhich extend cytoskeletal dalllage and u1tin1ately in1pair 11litochondrial 
viabi lity plunging the cel1s into an even lllorc severe A TP deficit (5, 7). Recently, Dong 
e/ 0/ have also sho\vn that prolonged ischclllia and ATP depiction can create porous 
defects in the plasn1a 1l1cIllbrane ofnladinc darby canine kidney cells which can be 
inhibited in the presence of glycine and decreased pH (9, 10). In vivo~ during kidney 
repcrfusion, cytoprotective tissue glycine is washed out and pH values return to nornlal 
exacerbating already dinlinishcd ATP stores (11 ). 
The rcpcrfusion of ischclllic tissue Vvould seen1 beneficial to the oxygen-deprived 
cells orthc cortical nephron. Ho\vcver, reperfusion injury after tissue hypoxia is perhaps 
as deleterious as the ischenlia itsel r due to the generation of reactive oxygen species 
(RC)S) ( 12). Cell u lar ROS are generated in part by C0l11plexes I and I I I of the 
nlitochondrial electron transport chain~ lipoxygenases, cyclooxygenases, plasllla 
1l1elllbrane NADPH oxidase, the xanthine oxidase systenl, and by 11lixed-function 
oxidases found ill the cndoplaslllic reticu1utll (5, 7.13,14). The inhibition ofROS 
generali on by agents such as dcsfcroxanline ( 15), allopurinol (16). catalase ( 1 7); and 
ostcopontin (5, 18) or the scavenging or free radicals by glutathione, vitanlin E~ quercetin 
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(19). curclllllin (20) or superoxidc disll1utasc to nanle a few have a11 been sho\vn to 
protect against ischcnlia/rcpcrfusion injury in various anin1al 1110dels. Repcrfusion injury 
is also enhanced by the fornlation ofperoxynitritc and reactive nitrogen species fr0l11 the 
reaction bct\veen supcroxidcs and nitric oxide (NO), a Inoleculc sho\vn to be uprcgulated 
during ischenlia/rcpcrfusion injury (14,21-25). Increases in cellular ROS lead to the 
peroxidation of lipid 1l1enlbrancs, protein denaturation, carbohydrate danlagc, and DNA 
strand breaks (5, 26, 27). These alterations in cellular constituents can then lead to 
sublethal dysfullction, necrosis, apoptosis, or to signals for cell survival path\vays (7). 
()xidative danlagc to proteins during ischenlia/repcrfusion injury is beyond the 
scope oCthis discllssion, but plays a significant role in renal cell necrosis. Hovvevcr~ the 
r)NA strand breaks induced by cellular ROS lead to a very specific response v.;hich 
severely exacerbates the energy depiction already present during ischenlic injury. The 
cleavage of double stranded DNA leads to the activation of the nuclear enzynlc poly 
(ADP-ribosc) polYlllerase (PARP). Pi\RP catalyzes the transfer of ADP-ribosc fl'01l1 
nicotinanlidc adenine dinucleotide (NAO) to nuclear protein species. During periods of 
high ROS generation., PARP beC01l1eS overactivated leading to a severe depletion of total 
cellular NAl) and further ATP depletion (5~ 27,28). 
Oxidative danlage to lipids during ischenlia/reperfusion injury is quite deleterious 
to cell survival and can lead to leaky llle1l1brancs and inlpaired function of iOll pUlllpS and 
other CIl:lYllHltic processes (5). Cellular lipid profiles also change during 
ischenlia/rcpcrfusion injury ,via the activation of phospholipase A2• Previous studies have 
shown thaC in J11any injury 1l10dcls, the activation of phospholipase A2 correlates to the 
degree of f~ttty acid release and the extent of tubular cell injury (29-31). Not only are free 
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fatty acids and lysophospholipids directly toxic to cells~ but the 1110st C01111110n sn-2 f~ltty 
acid, arachidonic acid, is a kno\vn potentiator of oxidative dan1agc (5) and source of 
vasoconstrictive cicosanoids (12,32). 
Apoptosis. Renal cell apoptosis is a COn1111011 feature in expcrin1cntalnl0dcis of 
acute ischclllic and toxicant-induced rcnal injury (33-36). It is difficult~ ho\vever, to 
quanti fy the contributions Illude by necrosis and apoptosis in ARF in vivo. t\1uch of this 
StCIl1S fronl the f~lCl that £1poptosis occurs early-on (1-3 hours) after ischenlic injury, \vhilc 
it lllay take days for the histological evidence of necrosis to be detern1ined (33, 37) . 
. A.poptosis is the preferred and controlled nlethod of cell death and is essential for 
111allY processes sLIch as orgallogenesis, nornlal cellular turnover, and the deletion of 
potentially neoplastic cells (38). Apoptosis is initiated after llun1crouS cellular insults and 
nlay proceed via an intrinsic (1l1itochondrial) or extrinsic (death reccptor-nlcdiatcd) 
path\vay. l\poptosis is often the 1110re prevalent 1'orn1 of cell death seen in less severe 
cases of ARF (36) and occurs nl0stly in the distal tubular cells. Apoptosls is 1l10rC 
frequently seen in the distal tubule cells due to their substantial reliance on glycolysis for 
A TP production (7 ~ ]9-41 ), thereby n1aking thCll1 1l10re resistant to necrotic ce11 death. 
The stress-activated protein kinase (SAPK) p54 c-Jun N-tcrlllinal kinase has heen 
illlplicated in cell injury after renal ischenlia as wcll and is activated after injury in both 
proxinlal and distal tubule cells. The extracellular signal-related kinase (ERK) is 
activated only ill the distal cells and nlay also help explain 'why the distal epithelia is 
nlorc sensitive to apoptotic cell death (5, 42, 43). 
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The 111cchanis1l1S involved in the induction of renal cell apoptosis arc not 
conlplctcly understood and arc I110St likely ll1ultifactorial, but n1ay include the loss of 
cel1-1l1atrix and cell-cell adhesions and a reduction in extracellular survival signals (5,33. 
44) slIch as IGF-l, EGF~ HB-EGF, and HGF (45, 46). Studies by Dagher and colleagues 
have also sl1o\\/n that renal epithelial cells are quite sensitive to GTP levels. Techniques 
developed in their laboratory to selectively deplete GTP have cicnlonstratcd enhanced 
renal apoptosis (]], 47) as opposed to the necrotic phenotype seen after severe A. TP 
depletion (J5). 
Regardless orthe signal for apoptosis, this fornl of cell death has been shown to 
proceed by 1\vo l11cchanisl11S in renal epithelia after ischclllic injury; the intrinsic and 
extrinsic apoptotic pathways. Extrinsic apoptosis is initiated through ligand binding to 
one of a variety of death receptors. TNF and FasL-induced apoptosis have been 
thoroughly evaluated in renal cells, and in fact, both cytokines arc produced by renal 
epithelia and by infiltrating leukocytes (45, 46). Nearly all renal cell types express 
receptors for both TNF and FasL, but vary in their sensitivity to these cytokines (33, 4(), 
48-52). Ligand binding ofthcsc lethal signaling 1l1olecules induces death receptor 
oligoillcrization, the recruitnlent of adaptor nlolecuies, forn1at10n of the death-inducing 
signaling conlplcx (DISC), activation ofcaspasc-8, and the downstreanl activation of 
en-ector caspases (45~ 53). Type I cells arc quite sensitive to death receptor activation 
\vhilc Type II cells lllLlst Sil1111ltancollsly engage and activate Bid and the intrinsic 
apoptotic path\vay (53). 
;\ctivation oCthe intrinsic apoptotic patln"ray involves the recruitnlent of 
procaspascs, and it is clear that procaspases are activated by both cytotoxic and ischenlic 
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injury to renal epithelia in cell culture (Lau, Edelstein, Hortclano) and ill vivo (34, 
54)(DacI11Cn 200 I ~ Shi 2000, Sana). Initiation of the ll1itochondria-nlediatcd apoptotic 
progral11 begins \'vith the release of cytochrOtllC c, \vhich 1l1ay be enhanced or inhibited by 
lllel11bers orthe 8c1-2 f~llllily of proteins (Sax, Bak, Bid, Bcl-2, Bel-xL) (45). 
CytochrOlllc c then recruits other adaptor proteins including APAF-l and caspasc 9_ 
thereby fonlling \\'11at is known as the apoptosoille (45). This cell death cOlllplex goes on 
to activate the effector caspasc. caspasc 3 (33). Quite noteworthy is the fact that 
expression levels of caspascs and the pro-apoptotic Bcl-2 fanlily 1l1enlbers (Bax, Bak, and 
Bad) all increase in renal epithelia after ischcnlic injury (55-58). Pancaspase inhibitors 
have been used and sho\vn to be renoprotective against ischenlia/reperfusion injury in 
aninlai 1l1odcls, hOvvcvcf, the lack of inhibitor selectivity has slo\\'ed efforts in 
deciphering \\'l1ich effector caspascs are actually involved (34). Efforts to generate 
caspase knockout nlicc have nlet \vith linlited success as \\fell. For eXaJllplc~ Melnikov 
and colleagues de1l10nstrated that caspasc 1 -/- 11l1Ce \vere less susceptible to 
ischcnlia/repcrCusion injury. but sho\\'cd no decrease in cellular apoptosis (33_ 59). 
Hopefully', the generation ofnlorc specific and less toxic caspase inhibitors \vill allo\v for 
the inhibition of apoptosis and subsequent I/R injury, providing a llluch needed therapy 
for A.RF. 
l\,lechanisms of Renal C:ell Repair and Regeneration After ARF. As a result 
ofacLltc renal ischclllia or toxicant-induced injury, renal epithelial dysfullction is 
typically charactcri7cd by the loss of cellular apical/basal polarity, cytoskelctal 
redistribution, severe ;\ TP dcpletion~ Illitochondrial dysfunctioll, inlpaircd solute 
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transport. and decreased ion pUll1P activity including the Nat/K+ ATPase (2. 60-()4). 
After the initial dan1age to the renal epitheliull1, cells either die via necrosis or apoptosis. 
The renlaining tubular cells subsist in a sublethally injured state, poised to undergo the 
conlplcx process or regenerating the destroyed renal parenchynla (1,33, (5). The 
prevailing dognla concerning renal cell regeneration is that sublethally injured tubular 
cells restore cellular function, de-difTerentlate via the epithelial-to-nlcsenchynlal (EMT) 
transition. proliferate, nligratc, and finally re-differentiate to restore nlorphologic and 
physiologic function to the danlagcd nephron (Fig. 1-3) (2, 6()-70). Recent data also 
suggests the involvenlent of stenl cells in the regenerative process. Investigators have 
identi fied the presence 0 r both endogenous renal steIll cells and those originating fro111 
the bone 1l1aITO\V in aninlalll10dcls of acute renal failure (71-77). Ho\vever. the 
signilicancc of these findings are still unclear. 
13 
Figu re t -3. Proposed mechanism of renal cell repair and regeneration 
t) Renal epithelia begin as differentiated and quiescent COlU111nar epithelia. 2) After 
ischenlic injury, nUlllerous renal cells die via necrosis and apoptosis depending on the 
local level or insult in thcir area of hypoxia. 3) Sonlc cells are suhlethally injured and do 
not die. 'fhese cells lose their polarity and 1l1any of their physiological function. and can 
either initiate the repair process inl111ediately or dedifferentiate into nlescnchynlal-like 
eells \vhieh express vinlcntin. 4) Sublethally injured epithelial cells begin to Inigratc and 
proliferate to fill in denuded regions of the tubular IU111en. 5) The epithelial cells finally 






There is a signiflcant increase in cellular proliferation by surviving proxinlal 
tubular cells alter ischclllia/rcperfusion injury in both anilllal 1l10dcls (()5, 78) and hUlllClll 
cases of acute tubular necrosis (65~ 79) as nlcasured by peNA staining and incorporation 
of [J H1 thynlidine into nuclear DNA. Proli ferating cells take 011 a new nl0rphologic 
appearance and rcselllblc nlcscnchynlal cells with 1lattened cell bodics~ loss ofa brush 
border, and the dc-eli rrerentiatcd expression of enlbryonic proteins such as vinlcntin and 
NC Arv1 (hS, 70, 78, 80). In nlany \Nays~ dedifferentiated rena] epithelial cells recapitulate 
the cellular ontogeny 0 f renal organogenesis. 
During the proliferative phase of renal cell regeneration, it is heconling quite 
evident that nUlllerOUS gro\vth factors, of an autocrine and paracrinc nature, are necessary 
to support and stinlulatc renal cell gro\vth. This idea is supported hy observations that 
exogenously adlllinistcred gro\vth factors such as epidcnl1al gro\vth f~lctor (EGF), insulin-
like gro\vth f~lclor 1 (lCiF~ I ), hepatocyte gro\vth factor (HGF), fibroblast gro\vth nlctor 
(FCiF). heparin-binding EGF (HB-EGF), bone 1l1orphogcnic protcin-7 (BMP-7), and 
transi'ornling gro\vth 1'actor-0 (TGF-P) pr01110te cellular proliferation ill vitro and enhance 
renal recovery after ischenlia/repcrfusion injury (81-88). While quite effective in 3ninlal 
1l1odcls, only onc of these growth factors has been evaluated in hUl11anS (lGF-I). In this 
clinical trial, it \vas found that trcatnlcnt of patients \vith rcconlhinant JGF- I did not 
inlprovc renal function in subjects \vith conlorbidities (45,89). It should be noted, 
ho\vcvcr, that gro\vth f~lctor reginlens for llLlIllan trials \vould havc to be adnlinistcrcd on 
all acute rather than chronic basis to avolcf potential adverse effects caused by grcnvth 
factor-Illcdiatcd overproduction of cells or by the stinlulation of occult neoplastic cells. 
The nligration of renal proxinlal tubule cells to denuded areas of the tubular 
IUl11Cn is crucial for the structural and functional recovery of the nephron. C0111n1011 
1l1odcls used to study renal ccllllligration after injury utilize the nlcchanical scrape 
technique ( I, 70, t)O, 91) as vv'cll as the usc of lllodel nephrotoxicants sllch as 
dichlorovinylcysteinc (DCYC) (90). Interestingly~ incubation of renal tubular cells vvith 
nrowth factors has varyin u effects on n1i u ration vvith EGF(70 90) and HGF (92) b b b' ~ . 
stinlltlating and TCiF-{) (90) inhibiting this process, respectively. 
A,ncr the sLlcccssfulnligration and proliferation orrenal tubular cells fol1o\ving 
ischeI11ia/reperfusion injury, the restoration of epithelial function begins. Functional 
repair ofproxinlal tubule cells prinlarily includes the restoration ofnlenlbrane transport 
and nlctabolic functions (1). Key to the repair process is the reattachnlent of cells to the 
bascnlcnt 1l1cnlbranc, a process nlediated by collagen I\! and intcgrin binding (93.94). 
Follo\Ning bascnlcnt 1l1Cnlbrane reattachlllent nletabolic and transport processes such as 
Na')K+ ATPase activity, Na+~coupled glucose transport~ and ll1itochondrial function 
return to norn1al thereby restoring nephron physiology. The lllolecular nlcchanisnls 
driv'ing this return of function arc not cOl11pletely understood at the present, and a deeper 
understanding orthc signaling path\vays responsible for renal repair is needed before \ve 
can begin to develop inlprovcd therapies for patients in thc setting ofpost-ischcnlic rcnal 
1 nJ ury. 
TherHpeutic StrHtegies. NU111erOLlS studies in aninlal 1110dels have shown the 
efficacy of a variety of therapeutic agcnts in prcventing ischclllia/repcrfusion injury in the 
k idncy. These agents provide renal protection through various 111echanis111s ranging frolll 
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the inhibition of oxidative danlage to the stinlulatioll of pro-survival signaling path\\fays, 
and include the list of 1l101ecules in Table 1-2, including gro\vth factors, antioxidants, 
vasodilators and lllodulators of vascular tone, poly (ADP-ribose) synthetase (PARS) 
inhibitors, protease inhibitors, Na+/Ca~+ exchanger and calciu111 channel antagonists, 
iNC)S inhibitors, tyrosine kinase inhibitors, anti-illflanl111atory agents, diuretics, PP.AR-y 
agonists, and adenosine receptor agonists. 
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Table 1-2. Preventative therapies for ARF 
~~~~~~-iative Therapi~s for ARF in Anima-I-M~Od~I-S--=-~ 
I 
Antioxidants 
Vasodilators and Modulators 
of Vascular Tone 
I PARS Inhibitors 
I 
L ________ ~_ 













































































Ca 2+ Channel Inhibitors Verapamil (129,130) 
Nifedipine ( 130) 




SEA0400 ( 135) 
iNOS Inhibitors 1400W (136) 
GW274150 ( 137) 
Tyrosine Kinase Inhibitors Tyrphostin AG 126 (138) 
Anti-inflammatory Agents Docosahexaenoic acid (139) 
Sevoflurane (140) 
Olprinone (141 ) 
Indomethacin (142) 
Rofecoxib (142) 
Minocycline (143 ) 




1 nterleu kin-1 0 (148) 
Alpha-Melanocyte 
Stimulating Hormone (149) 
Diuretics Furosemide (150) 
Piretanide (151 ) 
PPAR Agonists L-165041 (152) 
I Rosiglitazone (153) 
I 
I Adenosine Receptor Agonists I CGS-21680 (154 ) 
I ~_._ .. __ . __ I ATL-146e ( 155) 
---~~--
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\Vhile it is clear that anin1al 1110dcls ofrcna) ischcI11ia/repcrfusion injury arc 
valuable tools for studying the protective effects of rcnoacti vc COll1pouncis, the translation 
of this research to 11LlllUlll beings is lacking, Many COll1poLlnds that have been evaluated 
in hUlllLln trials have f~lile(L posing nUll1erous questions concerning efficacy and variation 
between hUll1all and £1llin1al 1110dcls. One ll1ajor issue concerning hUll1an therapy in acute 
renal failure is related to the tinlc of drug adnlinistration. ARF in hunlans is rather 
insidious and is often goes undiagnosed in its early phase rendering 111any possible drug 
therapies ineffective, and since 1110st a11i111al studies initiate drug adnlinistration before the 
onset ofischclllia, it 1l1ay be too latc in 111any cases ofhulllatl ARF to intervene before the 
ll1ajority of dalllagc has occurred. \\lith this in nlind~ it lllay prove beneficial to elucidate 
ll1echanis1l1S of enhancing post-ischenlic repair as opposed to inhibiting the initial cellular 
dan1age itse) r 
lVlitochondrial dysfunction during renal ischemia/reperfusion injury. 
Mitochondrial dysfullction is a n1ajor hal1n1ark ofischenlia/reperfusion injury in 
nU1l1erOUS ccllnlodcls (156, 157). l\1itochondria arc the 111ajor source of cellular ATP 
generation in 1110St tissues. Consequently, cell types vvith high ATP den1ands, slIch as 
proxilnal tubule cel1s, arc quite sensitive to ischcI11ic injury. Alterations in 1l1itochondrial 
111orphology and function after ischcnlia/reperfusion injury are nUlllerous and include 
swelling and rupture orthe outer n1cn1brane (158-162), generation oCreactivc oxygen and 
nitrogen species (24, 1 ()3, 1(4). inlpaired respiratory function (130, 165-171.). increases 
in intranlitochondrial calciunl (172), and the release of apoptogenic proteins due to the 
opening of ll1Clllbranc pcrl11eability transition (\1 PT) pores or gross rupture of the outer 
21 
1l1CI11brallC ( 173-1 75). Variolls 1l1echanisI11S have been proposed to account for the 
lllitochondrial changes seen during ischc1l1ia/reperfusion injury (Fig. 1-4). 
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Figure 1-4. Schematic diagram of Ca2+ -induced mitochondrial dysfunction 
Mitochondrial Ca2+ overload is a common finding in many tissues during 
ischemiaireperfusion injury. Briefly, Ca2+ is taken up into the cell and subsequently into 
the mitochondria via a ruthenium red-sensitive Ca2+ uniporter. This increase in 
mitochondrial Ca2+ induces phospholipase activity, but decreases mitochondrial 
membrane potential, adenine nucleotide translocator activity, and total adenine nucleotide 
levels. If the cells do not proceed to necrotic cell death as a result of severe energy 
depletion, their mitochondria may progress towards a more swollen phenotype in which 
they have decreased electron transport chain activities, increased ROS and RNS species, 
and can ultimately signal apoptosis if they swell and rupture. 
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These nlechanisnls range fronl nlitochondrial calciunl accunlulation (172). loss of inner 
111enlbrane potential (L1'I'I11) (168, 176), adenine nucleotide depletion (177, 178), inlpaired 
adenine nucleotide translocator (ANT) activity (168. 176, 177), stinlulation of 
1l1itochol1drial phospholipases (29, 167, 168, 176, 179-182), or 1110St likely a conlbination 
ofn1ore than one of these events. !Viany of these changes in nlitochondrial viability 
ultinlatcly lead to cell death via necrosis or apoptosis. 
A.lthollgh there are nlany injurious stinlllli to the nlitochondrion during 
ischenli,v'rcpcrfusioll. 111any of these insults converge onto respiratory dysfunction, l'viPT 
and the release of cytochronle c resulting in necrosis and/or apoptosis. The renlainder 
of this discussion \vill focus prinHtrily on the role ofcalciulll-induced 1l1itochondrial 
dysfullction \vith particular attention paid to calciunl-1l1cdiatcd deficiencies ill the 
fUllction of' the electron transport chain. 
Cellular calciulll levels arc regulated by llU111erOUS nlechanisllls. the 1110St 
inlportant oC\vhich include receptor and voltage-nlediated channels, Na+-/Ca
2t 
exchangers. and ('a 2+ A TPases (183). Equally inlportant during ischenlia/rcperfusion 
injury arc plasnla 1l1CI11hrallC Na+!K+ ATPases \vhich falter during ischenlia-induccd ATP 
depletion. This ion pUll1P failure drives Nat extrusion through the Na+/Ca
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exchanger 
resulting in elevated cytosolic free calciull1 concentrations. NOr111al cytosolic free 
calciulll cOllcentrations have been deternlined in cultured renal epithelial cells (LLC-PK 1 
and IRPTC) and hover at approxinlatlely 100 11M (175, 184). During ischenlia, 
intracellular calciulll concentrations can rise to over 300 11M as denlonstraled by Tanaka 
cl (// in a nlodcl of renal chenlical hypoxia (Antinlycin A treatnlcnt) (175) and to levels in 
excess of 1 () ~lf\1 ill isolated kidney proxinlal tubules (Antinlycin A treatll1cnt) (185). 
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]'vlitochondrial calciu111 uptake is functionally linked to oxidative phosphorylation 
via its dependence on an intact nlel11brane potential across the inner ll1ell1brane (181). 
Moderate anlollnts of calcillnl uptake actllally stinlulate oxidative phosphorylation (176~ 
181, 18(), 187). Ho\vevcr, higher concentrations of Ca2+11l lead to inner 111enlbralle 
depolari/,ation. resulting in a large efflux of Ca2+111 (172. 181, 188), an inability to 
cfTcctively buffer cytosolic Ca21 , and reperfusion-phasc elevations in cytosolic and 
nlitochondrial free Call (172), One well-studied effect of ischenlia-induced elevations in 
Ca 2 I III is the i nei llct io 11 0 f the M PT pore ( 1 89- 1 (2), a p henonlenoll \vell doc Ulllen ted in 
renal ischenlia/rcperfusioin 1l1odels (175, 185, 193-198). 
In generaL fornlation orthe i\1PT pore requires the rutheniulll red~sensitive (199, 
2(0) accunlulation ofCa2+ in the Initochondrial nlatrix (201). The all10unt ofCa1; 
necessary for pore fornlation varies between species (1 77 ~ 202) and the organ SystClll 
Crolll \vhich the 1l1itochondria \vere isolated (203-205). Mitochondria1 Ca1 j acculludatioll 
is singularly sufficient to induce MPT in nU111erOUS tissues including liver (206), heart 
(18(»), adrenal cortex (187), and kidney (207, 2(8), but can be induced by a host of other 
!~lctors such as phosphate, oxidizing agents, sulfllydryl reagents, adenine nucleotide 
translocator (J\NT) ligands, pyrophosphates. uncoupling agents, fatty acids, and 
increased pH (201). MPT pore inhibitors include. hut arc not linlited to, respiratory 
substrates, adenine l1uclcotidcs, di~ and trivalent cations, conlpctitors ofcalciulll binding, 
free radical scavengers, oligonlycin, protons, polyanlincs. sulfhydryl reducing agents, 
BSA, and cyclosporin A (201). The MPT pore itself is believed to be COll1posed 
prilllarily of tile outer 111enlbrane voltage-dependent anion channel (VDAC) (209) and the 
inner 1l1Cnlbrane adenine nucleotide tran510cator (ANT) (177), with the fornlcr acting as 
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the pore channel and the latter functioning as a regulatory protein (201). Growing 
evidence is novv suggesting that the pore nlay actually be a protein supercolnplex knO\\/1l 
as the lllitochondrial tllcgachanncl (MMC) Illade up of a VDAC dinlcr in close contact 
with the inner Illclllbranc ANT (210), The f\1PT pore dianleter is cstinlated at 2-3 nl11 and 
allo\\/s the 1110VClllent of 1l101eculcs < 1500 Oa into and out orthe nlitochondria(20()~ 211 ~ 
212), Sustained Ca2i -induccd opening orthe MPT pore can lead to 1l1atrix s\velling~ 
rllpture ortlle outer ll1itochondrial111clllbrane, and the release ofproapoptotic proteins 
such as cytochronlc c and S111ac/Diablo(213). These progenitors orthe intrinsic apoptotic 
path\vay proceed to induce progranlnled cell death by activation of dOVv'l1streanl effector 
caspascs. It should also be Iloted that nl0dulators oCapoptosis fronl the Bcl-2 f(:unily of 
proteins are kno\vll to interact v.:ith \'DAC and to nlodulate the open or closed state of the 
pore (2 13 -2 1 5), 
l'v1itochondrial calciuIl1 accun1Ltlation plays a 1l1ajor role in 111itochondrial 
nlcn1branc function and in perpetuating ischcn1ic injury (181). Mitochondria act as 
intracellular calciuI11 sinks (21 ()), \\'ith a Ca1-t uptake Km of ~5-1 0 ~ll\1 (217). /\rnold cf uf 
have previollsly nlcasurcd renal n1itochondrial Ca2 + (Ca1+ 11l ) levels before and after 
rcperfusion in a rat kidney 1l10dcl of ischclnia/reperfusion injury (172). In this study, 
ll1itochondria \vcrc isolated in the presence ofrutheniul11 red to block calciu1l1 uptake 
induced bY;/1 ,';fro isolatioll lllCthods. The investigators found sinlilar levels ofCa2+m in 
both shanl-opcratcd and ischcll1ic kidneys inl111ediately prior to reperfusion (-,15-16 nn101 
Ca>/111g 111itochondrial protein), that these levels rcn1ained constant in shanl unin1als and 
increased to ()() nn101 ('a2+-/nlg protein after 24 hours ofrcperfusion in the ischenlic 
kidneys( 172). This rise in Ca~+ 111 ",vas directly linked to respiratory dysfunction and 
decreases ill acceptor-control ratios indicating a role for Ca2 ~ in ischenlia-induccd 
111itochondrial dysfunction. Mohaupt cl a/ have sho\vn sinlilar increases ill 11litochondrial 









Figure 1-5. Mitochondrial Ca2+ increases while ATP synthesis decreases during 
ischemia. 
The above ex perinlent conducted by Mohaupt e/ ol den10nstrates the significant increases 
seen in nlitochondrial Ca2 levels after renal ischenlia which can be blocked in the 
presence of the Ca2 channel blocker verapan1il. Likewise~ verapan1il can also preserve 
cellular ATP leve ls after an ischel11ic event. These data den10nstrate an in1portant 
pathological role played by Ca2+ during ischenl1a/reperfusion injury. Note: Figure taken 
fronl (218). 
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It is clear that renal ischcnlia/reperfusion injury significantly increases 
111itochondrial calciulll concentrations (171 ~ 172,218-220). Longstanding evidence f)'onl 
studies exanlining ischcnlia/reperfusion injury in IlU111erOUS organ systenls provide 
supportive data linking ischenlic injury to deficits in 111itochondrial respiration (171-173, 
108,218.221,222) and nlore specifically to defects in COlllplex I activity (167, 198,223-
226). These observations suggest the involvcnlcnt of a speci fic calci ulll-nlcdiated target 
necessary for the function OfC01l1plex I. Tvv'o attractive nlcchanis1l1S of calciunl-
dependent 1l1itochondrial respiratory dysfunction include the activation ofnlitochondrial 
phospholipases (227-229) and of endogenous 111itochondrial calpains (230-233). 
('alpain activation and renal failure. Renal ischenliairepcrfusion injury is 
1l1ediated in large part by increases in total cellular calciulll. This increase in cytosolic 
free Ca~· sets the stage for calciull1-induced danlagc nlcdiated by the activation of 
proteases~ phospholipases., nitric oxide synthase, and protein kinases to nanlC a fcvv. ()f 
these calciul11-scnsitive enzynles~ calpains represent an interesting class of proteins \vhich 
nlay be involved in the progression of ARF due to their diversity and subccl1ular 
distrihution. CaJpains, a class ofcalciunl~sensitive cysteine proteases, are inlplicatcd in a 
variety of hUI11al1 disease states in which there is a dysregulation of cellular calciulll 
hon1cos1asi s. 
1V1any cellular calpain substrates have been identified to date including a nUI11bcr 
orcytoskclctal proteins (paxillin. talin, vinculin., ct!l-spectrin) (234, 235). Recent studies 
hy Liu e/ 01 suggest that calpain-lllediated degradation of these cytoskeletal proteins leads 
to the progressive loss ofplasnla nlcnlbranc pernleability to ions, subsequent loss of 
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nlenlbrane integrity, and renal cell oncos1s (235). Nunlerous in vitro studies have also 
shovvn thc protective effects of dissinlilar calpain inhibitors on cell death induced by 
antinlycin /\ (236-240), hypoxia/reoxygenation (238,239), tetratluroethyl-L-cysteine 
(nephrotoxic halocarbon), bronlohydroquinone (nephro-toxic quinone), t-
butylhydroperoxidc (nlodcl oxidant), and ionon1ycin (Ca2+ ionophore) (241,242). In 
addition, calpain inhibitors have been shown to protect nlitochondrial function in ce11 
culture 1110dels as denlollstrated by Harrinlan et al (236). 
Recent \\/ork by Chattcljee and colleagues have shown the ill vi\Jo protection 
afforded by calpain inhibitor 1 (Cal 1-1) against renal ischen1ia/repcrfusion injury in the 
rat (122). Pretreatn1ent with Cal 1-1 in this study preserved renal histology, decreased 
SerLlnl urea, creatinine, ganlnla GT, AST, NAG, and FE(Na) and significantly inlproved 
creatinine clearance as cOlllpared to controls. Cal 1-1 also significantly reduced kidney 
MPO activity and MDl\ levels. Interestingly, decreases in iNOS and COX-2 levels \vcrc 
also observed, suggesting the involvenlent of nuclear factor-kappa B (NF-K B) (122). 
Taken together these data suggest a role for calpain isoforn1s in the progression of acute 
renal failure through actions on structural proteins of the cytoskeleton, through regulation 
of gene expression, and on n1itochondrial viability. More work, however, is llccessary to 
evaluate the diverse roles played by calpain in the pathogenesis of acute renal failurc. 
(~alpains 
The Calpain-Calpastatin System. The calpains are a superfanlily of cysteine 
protcases first descrihed and purified by Dayton et al in 1976 (243, 244). The calpains 
arc \vcll conserved anlong eukaryotes with various calpain genes expressed in fungi. (', 
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c!cga!l.\'~ I)r()s()phi!a~ and n1an1n1als (245). Within the vertebrate fanlily, there are 14 
large subunit ca1pain isoforn1s and a 28 kDa sn1a11 calpain subunit (245)~ son1C of\vhich 
are ubiquitously expressed (246) and S0111e that display a nlore tissue-specific distribution 
(247-240). The seenlingly ubiquitous calpain fanlily nlenlbers consist of calpains 1,2, 
4,5,7,9, and 10 (245,250-254). The nlore tissue-specific isofornls have nlRNAs 
expressed in the testes (calpain 11 ~ (255, 256)), skeletal nluscle (calpain 3a~ (257))~ 
sn100th nlllscle (calpain 8a, 8b; (247)), the testes and lung (calpain 13~ (255)), the 
placenta (calpain 6~ (258)), and in the skin up to 16 days after birth (calpain 12~ (259)). 
The calpain fanlily can be further subdivided into what are ternled ~vpical and atypical 
calpains (Fig. 1-6) (245). The typical calpains consist of those isofornls containing a 
pcnta-EF hand calciunl binding nl0tifin Donlian IV and are c0111prlsed of cal pains 1,2,3, 
8, (), 1 1, 12~ 13, and 14. The atypical ca1pains lack a penta-EF hand d01l1ain, contain a 
highly divergent C -tern1inal don1ain, and consist of ca1pains 5, 6,7, 10, and 15 (SC)LH) 
(260-262). 
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Figure 1-6. Schematic diagram of the known mammalian calpain isoforms 
This cartoon illustrates the known mammalian calpain isoforms. The gene and protein 
names are illustrated along with the overall domain structure for each species. This 
representation also points out the differences in domain structures betweeen the typical 
and atypical calpains. *Note - For calpain 6, the green dot above domain IIa denotes a 
change in the active site cysteine to a valine. 
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The typical calpains contain four n1ajor protein dOll1ains froll1 the N to C-·tern1inus 
(I-IV) (Fig. 1-7). 001nain I is located at the N-tern1inus and is an autolytic don1ain often 
cleaved after calpain activation and displays 72-86?/o h01l1010gy an10ng different species 
(hU1l1an, chicken~ rae pig, and rabbit) (245). 00n1ain II is con1prised of two subdonlains 
(lla and lIh) and contains the active site of the enzyn1e. Three key an1ino acids \vithin 
00111ain I I n1akc up a catalytic triad including a cysteine residue in 00n1ain IIa and both 
an asparagine and histidine residue in 00n1ain lIb (263). Recently, X-ray 
crystallographic studies have den10nstrated the abi lity of both 00n1ains I1a and lIb to 
cach hind one at0l11 of Ca2+ ~ thereby aligning the active site cleft and allowing subseqllent 
activation orthe enzyn1e (264). 00n1ain III links the two calciun1-sensitive don1ains and 
contains two potential EF-hand n10tifs, one at the 00n1ain II/III border and another at the 
00n1ain III/IV boundary, respectively (245). 00n1ain III is thought to playa role in 
phospholipid binding via the presence of a C2-like don1ain (265), Lipid binding to 
[)olnain III has been shown to enhance calciun1-binding to the calpains and n1ay help 
lo\\'er the ill \'l\'{) calciun1 requiren1cnts for full enzyn1e activation (2()5). 00n1ain III is 
a Iso thought to help regulate the enzyn1e' s activity via its participation in critical 
clectrostatic interactions (266, 267). 00n1ain IV of the typical calpains is highly 
hon10logous to that of 00n1ain VI of its 28 kOa sn1all subunit binding partner (245). This 
d0l11ain contains five calciun1-binding EF-hand 1110tifs and is thought to be the n1ajor 
player in regulating calpain sensitivity to cellular calciun1 (248). 
The atypical ll1c111bers of the calpain f~lnlily contain highly divergent all1ino acid 
sequcnces ill [)on1ain IV. Thc functions of the atypical calpains arc not clear at this 
point. Ho\vcvcr, the absence of a typical 00111ain IV suggests that these isofor111s 111ay 
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not he c0l11plctely regulated by calciuI11-binding, that they 111ay not din1erize \\'it11 the 
sn1al1 28 kDa calpain subunit (calpain 4), and that they n1ay have con1plctely novel 
functions, substrate affinities, and/or activation/inhibition nlcchanisnls. 
The sn1all calpain subunit (calpain 4) is the norn1al binding partner for both 
calpains 1 and 2 (245). This subunit consists of two don1ains (V and VI) (Fig. 1-7). 
00n1ain V is con1posed of a glycine-rich region with 110 known function other than its 
ability to heterodin1erize with the C-te1111inal region ofOon1ian IV of the typical calpains 
(\vitl1 the exception of calpain 3) (268). 00n1ain VI is a recapitulation of 00n1ail1 IV 
found in the typical calpains and contains a calciu1l1-binding penta-EF-hand 1110tif(269). 
Interestingly, a novel calpain sn1all subunit (css2) has been identified and can fonn 
functional hctcrodin1ers with nl-calpain (270), however, css2 is not fully redundant for 
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Figure 1-7. Schematic representation of the typical calpain domain structure along 
with its heterodimer (the calpain small subunit). 
The protein depicted above is typical of the EF -hand containing calpain isoforms. Each 
red asterisk represents a novel Ca2+ -binding site while each black asterisk represents an 
area of reported phosphorylation clustering. Protein domains; dl represents the autolytic 
domain, dlla and dllb represent the active site of the enzyme, dIll contains a C2-like 
phospholipid element, dlV contains a penta-EF hand Ca2+-binding domain, dV is the 
autolytic domain of the small calpain subunit, and dVI is a recapitulation of the penta-EF 
hand motif seen in the large calpain subunit. 
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Calpastatin is the only known specific and endogenous prolein inhibitor of the 
calpain fanlily. Ho\vever, both H- and L-kininogen and a2-nlacroglobulin arc protein 
species vvhich can also inhibit the calpains in addition to their o\vn endogenous substrates 
(272). Studies on calpastatin have been historically very difficult because its llligration 
011 SI)S-PAGE analysis is variable (245). In addition to its anon1alous n1igration 
characteristics, calpastatin is highly resistant to denaturation by heat (273)~ SDS. urea. 
and trichloroacetic acid treatn1ent (274, 275). Adding to the problen1 are the existence or 
8 calpastatin splice variants (18.7-85 kDa) (274, 276. 277) (278), n10st ofvv'hich do not 
rUIl truc to thcir 11101ecular weights upon SDS-PAGE analysis (279~ 280). The largest 
calpastatin isoforl11 (85 kDa) contains six donlains~ XL, L, L II, III, and 1\1 (Gol)). 
Donlain XL contains three PKA phosphorylation sites (281), don1ain L has no kll0\\ 11 
functiolL and [)onlains I-IV are n1arginally hon1010gous inhibitory dOll1aills contaillin~] 
three subdonlains, A, B. and C, critical for n1axin1un1 inhibitory activity (245). Each or 
the separate don1ains I-IV den10nstrate inhibitory activity against both calpains 1 and .2 
'Nith varying degrees of efficacy~ donlain I> donlain IV > d0111ain III > donldin fL fiT)lll 
the nlnst to least effective (282). Subdol11ain B (12 an1ino acids) is required Ic)r 
calpastatin's inhibitory activity~ but possesses no activity 011 its o\vn (282,283), 
Hcnvcvcr. a larger version of subdonlain B (27 an1ino acids) does posses inhibitor)' 
activity \vith an Ie:=;() of ~25 nM (calpain 2) to 800 nM (calpain 1) (283), but is not as 
elTcctivc as the conlplete calpastatin 11101ecule. The binding of calpastatin requires (~a~j 
(2S4. 285) and involves the association of subdonlains A, B. and C with calpain donlains 
1\'. II, and \t'1 (sn1all subunit), respectively (286-288). Taken together, these observations 
denlonstrate that calpastatin binds to the typical calpains in association with the sn1al1 
36 
calpain subunit. This would suggest that calpastatin n1ay be incapable of inhibiting the 
atypical calpai ns or those typical calpains that do 110t heterodin1erize with the sn1all 
calpain subunit (calpain 3). 
(:alpain Inhibition. Calpain inhibitors are quite diverse and vary considerably. 
A l1u111bcr of representative calpain inhibitors fr0l11 varioLls inhibitor classes are listed in 
Table 1-3. 
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Representative Calpain Inhibitors 
Molecule Inhibition Reference 
Protein Inhibitors 
Calpastatin pM range (245) 
Kininogen 36 nM (289) 
u2-macroglobulin 500 nM (289) 
Natural Products 
Leupeptin 140 nM (290) 
Phevalin 1.3 uM (291 ) 
E64 6.2-8.8 ~lM (292) 
Penicillide 7.1 pM (293) 
Peptidyl Aldehydes 
Calpeptin 40 nM (294) 
MDL-28170 1 ~lM (295) 
SJA-6017 7.5 nM (296) 
ALLN 190-220 nM (297) 
ALLM 120-230 nM (297) 
Non-peptide Inhibitors 
PD150606 210-370 nM (298) 
PD151746 260 nM - 5.3 ~lM (298) 
Peptide Biphenyls 87 pM (299, 300) 
Table 1-3. Representative caJpain inhibitors 
Listed above are calpain inhibitors frolll various inhibitor classes including protein 
inhibitors~ inhibitors derived fron1 natural products, peptidyl aldehydes, and non-peptide 
inhibitors. IC_~(l values are listed for each individual calpain inhibitor. 
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Protein inhibitors include calpastatin, kininogen, and a2-111acroglobulin (245, 
272), and inhibit via disruption of the calpain active site. Reversible calpain inhibitors 
such as C'alpain inhibitor I or calpeptin are generally sn1a11 peptidic n10lecules that act as 
high affinity ca1pain substrates thereby blocking the active site fron1 other protein targets. 
Conversely, the irreversible inhibitors consist of acetylating agents, epoxides, and 
dia/onlethylketones \vhieh all pern1anently n10dify the active site cysteine residue of 
presull1ahly all the calpain large subunit isofornls (excluding calpain 6 which lacks an 
active sitc cysteine). 
The search for calpain inhibitors has been ongoing since the discovery of calpain 
over 30 years ago. The first generation of inhibitors lacked potency and selectivity and 
included a variety of rather dissinlilar lllolecules such as EDTA and EGTA (ea2-
chclators), iodoacetic acid, 5,5'-dithiobis(2-nitrobenzoic acid), N-ethyln1aleinlidc. 
1l1crsalyL iSocoulllarin, and diisopropyl phosphorofluoridate (301). 
A second generation of conlpounds, natural calpain inhibitors, \vere disc()\'crcd 
and isolated fronl the Strepto171yces sp. and include peptidyl aldehyde, diketopiperazine, 
and pyrazinonc derivatives. Exanlples of this generation of inhibitors include IClIpcptin, 
(l\c-Leu-Leu-Arg-H) (302), antipain ([(S)-1-carboxy-2-phenylethyl]-carbanloyl-L-V'al-
Arg-H) (303), strepill P-1 (N-i-valeryl-Tyr-Val-Arg-H) (301) and the pentapeptides 
staccopin P-l and P-2 (Val-Val-Val-Val-Phe-H and Val-Val-Val-Val-Tyr-H, 
respectively) (JOl). However, these peptide aldehydes lacked cell pernleability and 
selectivity for the calpains over other protease systenls. Subsequently, investigators 
began vv'orking '.\lith the peptidyl aldehydes, consequently inlproving inhibitor potency 
through structure-activity relationship analysis and cell pernleability and stability by the 
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addition of hydrophobic N-tern1inal capping groups (301). The inhibitor derivatives froll1 
these efforts include calpeptin (304), MOL 28170 (295)~ and calpain inhibitors I and II 
(Ac-Lcu-Lcu-Nlc-H and Ac-Leu-Leu-Met-H) (297). Other, n10re recent, calpain 
inhibitors f)'on1 the Streptolllyces sp. include 3-benzyl-6-isopropyl disubstitutcd 2( 1)-
prazinonc (Pheval in) (291), diketopiperazine~ and tetrapeptide (305). 
Other naturally occurring calpain inhibitors include dan1nacanthal fron1 the root of 
I\I/orillc/(/ citrij'o/io (306), penicillide fron1 the culture broth of the Pcnicil/illlJl species 
F607()O (293), and tralls-epoxysuccinyl-Lleucylan1ido-4-guanidino-butane (E-()4) 
isolated fi'on1 the fungus AspergillllsjapolliclfS TPR-64 (307). Of these three inhibitors, 
E-()4 has been the n10st intensely studied. E-64 and its cell-pern1eable derivative E-64d 
are irreversible inhibitors orthe calpains and exert their inhibitory effects via covalent 
binding of the active site thiolate (301). These epoxysuccinyl peptides are highly 
selective for the cysteine proteases, but are unfortunately not selective for calpains (308). 
Follo\ving the successful isolation and characterization of natural calpain 
inhibitors, an eft(]rt to lise the inforn1ation gained fron1 these studies to develop 11101'(' 
speci flc sn1all 11loiecuic inhibitors was initiated. These efforts can be seen as the 
developn1ent of the third generation of calpain inhibitors. Atten1pts at sl11a11 1110lccule 
devcloplllcnt and synthesis have been bolstered recently by the availability of crystal 
structures of calpain 2 and of the core catalytic regions of both calpains 1 and 2 alk)\ving 
for enhanced inhibitor design (263, 309-312). Most investigators have endeavored to 
design pcptide ll1inlctics containing chell1ical 'warheads' that replace the scissile all1idc 
bond \vith an electron deficient center that can either bind reversibly or irreversibly with 
the thiolate n10icty of the active site cysteine (301). Electrophilic carbonyl-containing 
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functional groups that have been used as chen1ical 'warheads' include (X-diketoncs (313). 
ex-kcto phosphorous con1poullds (314), aldehydes (294. 295, 297, 304. 315, 31 ()), and (x-
keto carbonyl con1pounds such as ex-ketoacids, cx-ketoanlides, and cx-ketoestcrs (313, 
J 17-310). It \vas later discovered that irreversible inhibitors could be produced by 
replacing the scissile bond of calpain substrates with ll1cthylsul foniun1 salts (320-322), 
disulfide linkages (323), epoxysuccinates and their derivatives, vinyl sulfoncs (324), and 
ketorncthylenes (322, 325-329), Of note, a nunlber of "non-warhead' peptide biphenyl 
hybrid con1pounds have been synthesized, the 1110St potent of\vhich exhibits an IC)() of87 
pM (299. 3(0). 
The fourth. and perhaps n10st exciting generation of calpain inhibitors are the 
non-peptide COll1pounds (301,330). These con1pounds include the natural products 
danlnacanthal (30(»), Phevalin (291), diketopiperazine, and tctrapeptide (305) as 
n1entioned earlier. but also include the novel <x-nlercaptoacrylates (301) as first described 
by \;\!ang cf af in 1996 (298). The n10st potent cx-n1ercaptoacrylates, PO 150606 and 
r[) 15174(), \vere not only cell pern1eable, but were 600-fold nlore selective for calpain 
over cathepsin B (298). This selectivity is thought to be derived fronl the novel binding 
site ortlle u-tllcrcaptoacry1ates as cOlnpared to active-site calpain inhibitors. Indeed, 
recent x-ray crystallographic data have shown that P0150606 hinds to don1ain \lI orthe 
sJ11a11 calpain subunit (calpain 4) and n1ay function in a sinlilar fashion as subdolllain C of 
the calpastatin inhibitory donlain (331,332). It is also possible that the (1-
1l1crcaptoacrylatcs n1ay exert their effects through inhibition of the calpain donlain IV EF-
hands sillce this dOlnain is highly conserved with don1ain VI of calpain 4. If this is true, 
it \vould suggest that this class of COlllpounds nlay only be useful for inhibiting the 
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typical calpains. as the atypicals lack the penta-EF-hand don1ain and prcsun1ably do not 
heterodin1crize \V1th calpain 4. Two other non-peptide inhibitors of the calpains include 
aurintricarboxylic acid CA. T A) (333) and the quinolinecarboxyan1ides (334), ho\vever. the 
exact nlcchanislll of inhibition for these con1pounds is not fully understood and 111ay 
rcsult Crolll binding to an allosteric sitc other than the calpain activc site. 
The design of calpain inhibitors has enjoyed a long and circuitous route. We have 
gOlle It"0111 the identification of potent natural inhibitors lacking selectivity and cell 
perJncahility to both peptidyl and non-peptidyl inhibitors exhibiting excellent potency. 
SerLlnl stability, and cell pern1eability. However, we have not yet been able to produce 
inhibitors sufficiently selective for calpains over other cysteine proteases, nan1ely the 
cathcpsi I1S. 111 fact, the n10st selective calpain inhibitor to date is t-80c-Lcu-Phe( 0 L)-
CH~F \vhich is 450-fold and 680-fold nlore selective for calpain lover cathepsins Band 
L, respectively (326). followed closely by the a-n1ercaptoacrylates (298). This is not 
surprising since the proteolytic n1echanisnl for all of the cysteine protease fanlily 
1l1cIl1bcrs is virtually the saIne. At present, n10st inhibitor design has centered on using 
structure activity relationships to design peptide n1in1etic inhibitors. These efforts have 
also focused on the unprinled side of the scissile bond and have left the prinled side 
virtually unexplored. Future efforts for drug discovery in this area would be best served 
by designing inhibitors that span the P-S-P' bond in the active site cleft or by searching 
for secondary allosteric sites capable of regulating calpain activity. In fact~ the latter 
suggestion could create specific calpain inhibitors for the diverse group of atypical 
calpains. of\vhich 111allY are involved in hU11lan disease processes. 
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Mechanisms of calpain activation. Calpains are described as Ca2+-dependent 
cysteinc protcases. This 1l1eanS that therc is an absolute Ca2+ requirenlcnt for full 
activation orat least the typical calpain isofol111S. However~ it has been clear for quite 
SOlllC till1C that the ill vitro (~a2+ concentrations necessary for activation of both calpains 1 
and 2 \\'crc substantially higher than the 50-30n nM Ca2+ concentrations found in living 
cclls (335). [n f~lCL ill an ill vitro setting LLsing purified bovine calpains 1 and 2, the Ca~+ 
concentrations nccessary for their full activation were 6-1 00 ~lM and 0.8-1.6 111M, 
respectively (336). Consequently~ investigators have cndeavored to identi fy Illechanisllls 
for rcducing the Ca~t- rcquiren1ents for the ubiquitous calpains under physiological 
conditions. In the litcrature~ nun1crous nlcchanisn1s have been identified, but have 
produced fe\\:' conclusive answers (Fig. 1-8). These n1echanisll1s include autolysis (337-
339); dissociation fron1 the sn1all calpain subunit (340), phospholipid binding (341-346). 
translocation (347-349), phosphorylation (245, 350), and interactions \vith various 
'activator' nlo\ccu\es (351-355). 
NUIl1crous investigators have posited the idea that calpains are proenzynlcs and 
1l1USt undergo autolysis to bcconlC active. It has been shown that both calpains 1 and 2 
undergo N~tcnninal autolysis \vhen incubated with Ca2+ (337-339), producing 76 and 78 
k[)a proteins, respectively (356). Autolysis of the calpain n101ecules has been shown to 
reduce the Ca~ i concentration required for half-n1axinlal proteolytic activity of calpain 1 
fronl 3-50 to 0.5-2 pM and that of calpain 2 froll1 400-800 to 50-150 ~lM (357). 
Ho\vcvcr. the reduction ofCa~+ required for half-n1axinlal activation is a 11100t point since 
the Ca2i concentration needed for autolysis itselfis roughly equal to that required for 
cnzynlc activation (337, 358, 359). Interestingly, it has been shown that both 
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unautolyzcd calpains 1 and:2 retain proteolytic activity (336,337,360), while others have 
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Depicted above are the known mechanisms of typical calpain activation. These 
mechanisms include direct Ca2+ activation, autolysis, dissociation of the large and small 
subunits, degradation of the endogenous inhibitor calpastatin, membrane translocation, 
phospholipid binding, phosphorylation, and interaction with various 'activator' 
molecules. 
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v\lhi Ie it is clear that autolysis is not necessary for enzyn1e activation~ it has been 
shown that autolysis does occur under ill vivo conditions (336~ 364) and n1ay playas yet 
undiscovered roles for calpain function. One exciting role for this autolysis lnay be to 
generate active polypeptides, S01l1e of\vhich have been shown to exhibit chcnlotactic 
activities tovv'ards in1n1unocytes (365) and neutrophils (365. 366). 
The 28-kDa sn1all calpain subunit is known as the endogenous calpain regulatory 
subunit hctcrodin1crizes with the large calpain subunit, and has been reported to contain 
chaperone activity necessary for proper folding orthe large subunit (3()7). Reports in the 
carly 1 ()8()s suggested that calpain activation was dependent upon dissociation of the 
large and sn1all subunits after exposure to Ca2+ and appropriate substrates (34U, 3(8). 
Years later, Yoshizawa e/ 01 den10nstrated that the large and s111a11 calpain subuni1s could 
dissociate after treatnlent \\/ith Ca2+ and that the large subunit retained proteolytic activity 
and reduced Ca2 ' requirenlents under these conditions. One physiological prnbk'ili \\ith 
this echoes observations nlade on calpain autolysis; the an10unts of Ca2-+ necessary to 
induce subunlt dissociation are orders ofnlagnitude higher than that seen in living cells. 
Conversely, calpains and their sn1all subunit heterodinlers have been sho\vn to be 
assoclatccl follo\\'ing activation \vith Ca2+ in living cells (369). While a nUlllber ofstuciies 
havc s}lO\Vn associated snlall subunit labi lity and calpain activation (3 70~ 371 ) and the 
ability of the core catalytic region to proteolyze tluorogenic substrates (264. 372). it is 
nlore likelv that these observations are artifactual in nature and that the in \'h'o activatiol1 
ofcalpain (typical calpains) is regulated to S0l11C degree by S111a11 subunit interactions. 
A third n1cchanisn1 proposed for decreasing the Ca2+ require111ents necessary for 
calpain activation involves the binding of phospholipid species. The typical calpains 
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have been shown to be activated by a nun1ber of lipids including phosphatidylinositol 
(343), phosphatidylinositoI4,5-bisphosphate (PIP2) (345,346), gangliosidcs (342,373), 
and Illixturcs of various lipids (341,342,344), of which PIP2 is the n10st effective. The 
intcraction bct\vcen the calpains and phospholipids is an attractive n1echanisn1 of 
activation due to the presence of a C2-like phospholipid binding n10tif found in donlain 
III orthe typical cal pains (265). This n1echanisn1 would also unify the concept of cal pain 
activation aftcr translocation to the plasn1a nlen1brane (347-349) where the calpains 
would be in a position to encounter phospholipids, transient Ca2+ influxes, and 
endogenous substrates. Unfortunatel y, it is sti 11 di fficult to explain calpain activation 
\vith th is theory si nce extrenlely high nlolar ratios of lipid to calpai n (375-4100: 1 ) are 
necessary to decrease the an10unt ofCa2+ necessary for enzynle activation (337, 345, 
34()). It is unlikely that endogenous calpains would encounter lipid concentrations this 
high ill \'i1'o, and \vould suggest that phospholipid regulation of calpain activity is not the 
"holy grail"' of calpain regulation that has been sought for so long. Of note, it has been 
also sho\\'11 that the individual conlponents of phospholipids (fatty acids and 
Iysophospholipids) can n10dulate calpain activity through activationlinhibition orthe 
enzynlc (374, and unpublished data by Arrington). 
The post-translational nlodification ofprotcins by phosphorylation plays a 
substantial role in regulating lllany enzynle and signal-transduction path\vays, and the 
calpains arc no exception. The phosphorylation status of calpains 1 and 2 has been 
elucidated by· using antibodies specific for phospho-Ser~ phospho-Tyr~ and phospho-Thr 
and by iv1ALDI-TOF lnass spectronletry. These analyses denlonstrated 9 and 8 
phosphorylation sites on calpains 1 and 2, respectively (375) These phosphorylation sites 
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arc located in clusters on both calpains 1 and 2 and can be found near the don1ain IIII 
junction and at the N-ternlinal region of donlain lIb (245). Analysis of the an1ino acid 
sequcnces surrounding these clusters predict two PKA (calpain 1) and one PKC site 
(calpai n 2)~ one PKCi site, one casein kinase I site, and two calnlodulin kinase II sites 
(245), 11\11 of the sites are not phosphorylated on each calpain isoforll1 at all tinles, and it 
appears that there are 2-4 phosphates/nlolecule on average (245). Studies directed at 
dcphosphorylating the calpains has deternlined that the phosphates cannot be rell10ved in 
thc presence or phosphatases unless exposed to Ca~-+ concentrations in excess of 500 ,uNL 
and that rcnloval of all phospho-Ser and phospho-Thr residues reduces calpain activity to 
<15(Yc) (245). More recent data suggest that calpain 2 can be activated by the EC.F 
reccptor via activation of the ERK/MAPK pathway (376). This activation occurs through 
phosphorylation of Scr-50 \\/hich is not found in calpain 1, and results in full activation of 
the cllzyrnc (350). This \vork is validated by findings that MEKK I-deficient fibroblasts 
losc calpain activity, show reduced cleavage of cytoskeletal proteins (377), and that MEK 
inhibitors inhibit EGF-induced calpain activation (376). It is clear that calpain 
phosphorylation can playa signiflcant role in n1ediating protease activity. Moreover~ it is 
conceivable that phosphorylation of key residues n1ay activate calpains in the absence of 
Ca2 ' and playa pivotal role in the activation/inhibition of the atypical calpains \v11ich lack 
a Ca~'--sensitivc dornain IV. 
;\ final 1l1cchanisnl reported for the activation of calpains involves their 
interaction \\/ith so-called 'activator' nlolecules. The flrst of these n10lecules is 
isovalerylcarnitine which has been shown to reduce the Ca2+ requirenlent necessary for 
hal f-n1axilllal activation of calpain 2 but not of calpain I (353,354). Again, ho\vcver. the 
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1110lar ratio of isovalerylcarnitine to calpain (20,000: 1) necessary for this effect is n10rc 
than likely not attainable ill vivo. A nun1ber ofproteinatious calpain activator nlolecules 
have also been described. The first of these protein activators, a heat-stable 40-45 kDa 
protein, reduces the half-ll1axin1al Ca2+ concentration necessary for calpain 2 activation to 
less than 20 ~lM, and has been isolated fron1 both hun1an neutrophils (352) and rat 
skeletal ll1uscle (378). A sin1ilar 40 kDa protein purified fron1 erythrocytes \vas sho\\/n to 
reduce the Ca2t concentration required to activate calpain 1 fron1 50 to 0.2 ~lM (355). 
Another activator nlolecule, a 15 kDa protein, functions as a h0l110dill1er and reduces the 
Ca2 ! requirenlent necessary for calpain 1 proteolytic activity to 0.4-0.5 pM (351 ). 
Sequence analysis has shown that this protein is virtually identical to a goat liver protein, 
UK 114. This particular calpaill 'activator' protein is active at 1: 1 UK 114 to calpain 
ratios (J51). Subsequently, a 10 kDa protein that functions as a 20 kDa hon10dinlcr \vas 
identified as acyl-eoA binding protein and reduces the Ca2+ requirenlent of calpain 2 to 
()- 7 ~lM. This protei n activator functioned in a 1: 1 n101ar ratio with calpain 2 but not 
calpain 1 (379). Other, less potent, protein activators of the calpains have been descrlbcd 
and increase the catalytic activity of the calpains by 2, (380), 10 (381), and 25-fold (382). 
A lthough there have been nun1erous reports of conditions and rlloleculcs that 
See1l1 to reduce the absolute Ca~-i requiren1ent necessary for calpain activation, nlany of 
these reports arc confined to ill vitro experin1ents or to those in which there is no 
evidence 0 r activation under ill vivo conditions. Therefore, it is likely that such 
1l10lecules do exist but that their relevance in nortnal physiological or pathological 
conditions renlain to be verified. 
49 
Physiological Roles for the Calpains. The physiological roles orthe calpains 
have been under investigation since their discovery over 30 years ago, and are in large 
part still unclear. C'alpains are different than 1110St proteolytic syste111s in that they cleave 
peptidcs at a lil11itcd l1unlber of sites and leave large, often fully active protein fragn1cnts. 
slloocstin u that they 111ay playa critical role in reu-ulatory or siunalin u l)athwavs. bb b b b b "" 
Calpains 111ay also posses regulatory functions outside of their ability to cleave peptide 
honds since sonle n1enlbers and splice variants of the calpain fan1ily lack active sites 
(calpain ] 0) (383) or specific residues of the catalytic triad necessary for proteolytic 
activity (caipain 6) (258). While still largely a n1ystery, the known functional roles for 
the calpains can be broken do\vn into several categories including cell cycle progression 
(384), apoptosis (385), signal transduction (386), regulation of gene expression (330), 
platelet function (364. 387), and cellular n1igration (388) 
Sequential progression through G 1, S, G2, and the M phases of the cell cycle is 
absolutely required for n1itosis and cellular proliferation. Calpain activity has been 
inlplieatcd in the proll10tioll of the G I-S phase transition point, a key step ll1ediated by 
eye lin-dependent kinases (cdk2, cdk4, and cdk6) and their heterodinler partners cyclin [) 
or eyelin E. Nunlerous studies have den10nstrated the ability of the ealpains to cleave 
in1portant regulators of the Gl-S transition including cyclin D (384), cyclin E (389), 
p27 ki l'l (a cdk inhibitor) (390), and the upstrea111 l11odulators of the G 1 checkpoint p53 
(3<) 1 ~ 3(2) and pI 07 (393). These observations would suggest an inlportant regulatory 
role for the calpains in norn1al cellular turnover and en1bryonic devc10plllcnt. and \vhose 
ovcractivation could contribute to tun10rigenesis as proposed by Carragher el a/ (394). 
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Progranl1l1Cd cell death~ or apoptosis, is the conlnlon and preferred 1110dc of cell 
death in nurnerous cell types. Various roles for calpains in this process have been 
reported and in S0111e cases suggest conflicting nlechanisnls and nlodes of regulation. 
Calpain has been sho\vn to pronlote apoptosis via activation of caspase 3 (395), caspase 
12 (396), Bax (397-399), Bid (400), p53 (401), and by the conversion of Bel-xl fronl an 
antiapoptotic protein illtO a proapoptotic nl01ecule (396). Sinlilarly, calpains have been 
sho\vn to participate in llun1crous n10dels of apoptosis under varying stinluli (402-406). 
ReceIlt evidence also sho\\ied that the calpains have a role in the induction of caspasc-
independent cell death (407, 408), including the release of apoptosis inducing factor 
(AIF) fron1 the Il1itochondria (408). Conversely, calpains have been denlo11strated to 
inhibit apoptosis via the inactivation of p53 (409) and caspases 7 and 9 (410). Whi Ie it is 
clear that calpains participate in the series of events leading to apoptosis, the role of 
calpains in this process is quite varied and differs with respect to cell type and thc nature 
or thc apoptotic sti nl u 1 us. 
Signal transduction events are critical ll1ediators of nUll1erous cellular processes, 
including cell survivaL apoptosis~ and induction of gene expression. For exan1plc, 
calpain-nlcdiated cleavage of PKC results in the generation of a constitutively active 
enzyn1e which presun1ably regulates downstreanl signaling events (411). More recent 
evidence has also inlplicated calpain in the degradation of PKC a (412-414) and (') and 
subsequent hypoxia-induced neuronal cell death (413). Calpains can also inactivate 
proteins such as focal adhesion kinase (FAK). Calpain-nlediated F AK cleavage 
generates a 30 kDa cytosol1c fl-agnlent which acts as a donlinant negative kinase (415. 
41 () and also prevents integrin-n1ediated signals froll1 reaching the PI3-kinase and 
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ERK/MAPK signaling pathway (417). Calpain-n1ediated cleavage of Src (418) and the 
EGF-rcccptor (419) has also been shown to inhibit their signaling functions. 
Calpain can also directly cleave nun1erous transcription factors including c-fos, c-
.lun (420), and pS3 (391) and can regulate transcription indirectly via cleavage orthe 
transcription factor repressor IKB-a, thereby facilitating NF-KB translocation to the 
nucleus (421,422). The transcription factor con1plex TCF/LEF-1 is indirectly regulated 
by calpain through the cleavage of the ~-catenins (423). Calpains also indirectly 
influence transcription through cleavage of the signal transducers and activators of 
transcription proteins, STAT 3 and STAT 5 (424). Thus, calpains can cleave a large set 
of proteins, n1any of which contain signaling and transcriptional functions. 
A large class of calpain substrates includes a nun1ber of cytoskeletal proteins: 
all-spectrin, u-fodrin, paxillin, vinculin, vin1entin, desnlin, ezrin, talin, FAK, cortactin, 
and actin (415,416,425-433). Many of these cytoskeletal proteins are cleaved after 
either calcl unl or integrin-n1ediated platelet activation (434). The calpain-n1ediated 
rcn10dcling of cytoskeletal proteins plays a pivotal role not only in platelet adhesion and 
aggregation but also in post-clotting events such as clot retraction (434) and pron10tion of 
the shedding of pro-coagulant containing nlicrovesicles fron1 the plasnla n1en1brane of 
aggregated platelets (435). The dependence of platelets on norn1al calpain function has 
also been den10nstrated by the use of a calpain 1 knockout nl0use in which the authors 
sho\ved abberant platelet function (436). 
Many of the cytoskeletal conlponents listed above are not only involved in norn1al 
platelet function but also in the signaling nlachinery necessary for cellular 111igration .. A. 
subset of these cytoskeletal proteins for111 large n1ultiprotein c0111plexes that are in close 
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association \vith cellular integrins (330). These associations link the extracellular n1atrix 
to the cytoskeleton and provide signals that regulate cellular n1igration and other cellular 
functions (437). The norn1al assen1bly and disassen1bly of focal adhesions can be altered 
by calpain activation and the subsequent cleavage ofFAK, talin, and paxillin (415). 
These cleavage events are thought to be necessary for the detachn1ent of cells fron1 the 
ECM prior to 111igration, while inhibition of these events with calpain inhibitors 
suppresses cell n10tility (394). FU11her studies utilizing calpain 4 deficient fibroblasts 
denlonstrated the inability of these cells to n1igrate due to their failure to turnover focal 
adhesions necessary for nligration (438, 439). However, calpains seen1 to be dispensable 
for other cytoskeletal-nlediated events such as cytokinesis (438). Future work, ho\vever, 
needs to be done in order to evaluate the role of calpains in 111igratory 'dysfunction' such 
as that observed in n1etastatic cell lines. 
Pathological Roles for the Calpains. Although calpain activity is required for 
l1orn1al cellular function, it has becon1e quite clear over the last 20 years that their 
activation or lack of activity is linked to a nUl11ber of disorders and disease states. 
Calpain-associated pathologies can be grouped into three categories including cancer, 
disorders coupled to the dysregulation of Ca2+ hon1eostasis,! and those linked to genetic 
111utations in calpain isofor111s (Table 1-4). 
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Table 1-4. Disease states linked to calpain isoforms 
- Calpain Isoform+
l 
Disease Pathology -- .--~.~. __ ~~ 
Muscular Dystrophy, Stroke, Traumatic Brain Injury, Spinal Cord Injury, I 
Calpain 1 I Alzheimer's Disease, Neurodegenerative Disorders, Cataracts, Cancer, I + Atherosclerosis I 
f-------------·----Muscular Dystrophy, Stroke, Traumatic Brain Injury, Spinal Cord InjUry,-' 
Calpain 2 Alzheimer's Disease, Parkinson's Disease, Neurodegenerative 
Disorders, Cataracts, Cancer, Atherosclerosis 
~-----"--------~"------
Calpain 3 Cataracts, Limb-Girdle Muscular Dystrophy type 2A 
Calpain 9 Gastric Carcinoma 
_"~C~a ~e_a i_n _.1_0 ____ -'---T-L-y'L--pe __ 2_D_i_a_b_et_e_s _________________________________ . _____ "_ 
Many recent studies have begun to inlplicate calpains in the progression or 
suppression of tUll10r fornlation. For exanlple, elevated calpain levels have been dctcctcd 
in breast canccr tissues and is highest in estrogen receptor positive tUll10rs (440). 
Sinli larly, calpain overcxpression has been shown in hunlan renal cell carcinon1a (441 ). 
basal cell carcillon1a, squan10us cell carcinoll1a (442), and in chronic lynlphocytic 
leukell1ia (B-CLL) cells (443). In addition, calpain-ll1ediated degradation of the tUll10r 
supprcssor protein neurofibroll1atosis type 2 (NF2) has been shovvn in neuronal 
scl1\VannOll1as and n1eningion1as (444). Striking results froll1 the work of Man10une e! (II 
have denlonstrated a role for calpain 2 in the invasive potential of prostate carcinon1a 
cells (01.) 145 cells) (445). In contrast, at least one of the calpain isoforll1s, calpain 9, 
\vas observed to bc do\vnregulated in gastric cancer tissues and cell1ines (252,446), 
suggesting its role as a tunl0r suppressor gene. 
Ischcn1ic tissue dan1age n10st conln10nly results froll1 the insufficient supply of 
blood to an organ systen1, but nlay also stenl frolll exogenous toxicants. In n10st 
circunlstanccs, tissue ischen1ia results in the elevation of cytosolic free Ca2+ and leads to 
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the downstreanl activation of Ca2 + sensitive enzynles such as phospho1ipases~ kinascs~ 
and proteolytic systcnls. Calpain activation has been inlplicated in a variety of ischenlic 
IT10dcls both in vitro and ill vivo and have been shown to induce cell death in neuronal 
(447), cardiac (448), hepatic (449), intestinal (450), and renal ischenlia (122). These 
observations suggest a clear role for the calpains in ischenlia/reperfusion injury and 
highlight a secnlingly universalnlechanisnl for ischenlia-induced cell death in organs 
susceptible to oxygen deprivation. 
Neurodegenerative disorders are conlnlonly associated with increased calpain 
activation, and arc thought to be linked to the dysregulation of cellular Ca2+ honleostasis 
round in nlany of these pathologies (451). In the case of neural ischenlia, or stroke, 
cellular ('a2-+ levels increase due to the overstinlulation of the NMDA, AMPA, and 
kaillite glutanlate receptors. This excitotoxicity activates intracellular cal pains, 
ultinlatcly leading to neuronal cell death (452). Neuronal calpain activation during both 
ischcJl1ic and other neurodcgenerative processes can often be assessed by the calpain-
nlediated production of all-spectrin breakdown products (453). Increased calpain 
activity has also been denl0nstrated to contribute to excitotoxicity-nlediated 
neurodegcneration in Huntington's disease (454, 455), anlyotrophic lateral sclerosis, 
Alzheinlcr's disease (456, 457), and Parkinson's disease (458, 459). In addition to the 
cxcitotoxic roles played by the calpains in neurodegeneration, calpains have also been 
linked to the etiologies of both Alzheinler's disease and 111ultiple sclerosis through 
cleavage ofp35 to p25 (a cdk 5 activator inlplicated in the forn1at10n of tau 
neurofibrillary tangles) (120, 460, 461) and ofnlyelin and nlyelin basic protein (462), 
respectively. The enhanced calpain activity seen in ischenlia and nlodels of 
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nCLlrodcgeneration suggest a pivotal role for cal pains in various forll1s of neuronal cell 
death. \Vc 11lay be able to exploit this knowledge therapeutically by using calpain 
inhibitors to block acute neuronal cell death during ischen1ia or to prevent disease 
progression in n10re chronic disorders such as Alzhein1er's or Parkinson;s disease. 
I n addition to neurogenerative disorders; calpain activation has also been 
observed ancr traun1atic spinal cord injuries (463). The cell death observed after acute 
spinal cord traun1a is linked to local increases in intracellular free Ca1+ concentrations 
subsequent to the disruption of local vascular supply (463). Calpain protein levels have 
been shown to be increased in the sites surrounding spinal cord injuries (464) and 
inhibition of calpain activity using cell-penl1eable inhibitors can provide signi ficant 
neuroprotcction in anin1al n10dels of traun1atic spinal cord injury (465, 4(6). 
Atherosclerosis is a vaso-occlusive disorder halln1arked by the infiltration and 
proliferation of vascular sn100th n1uscle cells (vSMC) into the intin1allayer of the 
arteries. I)alllage to the arterial endotheliun1 induces vSMC proliferation; n10nocytc and 
T lyn1phocytc infiltration, platelet aggregation, and the deposition of lipids and 
cxtracell ular n1atri x proteins (467). These events lead to the forn1ation of a vascular 
plaquc~ an occlusion of the arterial lU111en, and increased risk of vascular events including 
stroke and n1yocardial infarction. Calpains have been in1plicated in the progression of 
atherosclerosis via their effects on vSMC n1igration (468) and proliferation (469). 
FurthcrnlolT, calpain inhibition has been shown to inhibit post-angioplasty restenosis in a 
rabbit nlodcl of fcnloral artery atherosclerosis (470). These studies suggest the 
involvcnlcnt oCcalpain isofornls in the pathogenesis of atherosclerosis and highlight a 
potential therapy using calpain inhibitors in patients undergoing angioplasty. 
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Cataract fOrJnation is a disease of the eye lens and is characterized by 
opacification of the lens proper. There are nunlerous environnlental and hereditary 
stinlllli \vhich initiate the fornlation of cataracts~ but all conlnlonly lead to the disruption 
ofplasnla nlenlbrane integrity and an increase in free cellular Ca2+ concentrations (471). 
Increases in cellular free Ca2+ activate cytosolic calpain 2, thereby inducing the cleavage 
and precipitation of lens crystallin proteins a and ~ (472). The protein aggregates 
produced by calpain 2 activation induce light scattering in the lens, severe lens 
opacification, and ultinlate blindness unless treated surgically (472). Inhibition of cal pain 
activity in aninlalnl0dels of cataract fornlation has been shown to reduce light scattering 
and cataract progression (473) and nlay prove to be a viable alternative to surgery in 
cataract patients identified in the early stages of the disease. 
To date, virtually all known calpain-associated pathologies are believed to evolve 
frolll the dysrcglllation of calciunl honleostasis. However, genetic defects in two calpain 
isofornls have been identified and linked to hunlan disease states. The first of these 
disease states is nluscu1ar dystrophy. In both Duchenne and Beckers nluscular dystrophy, 
disruption orthe dystrophin gene leads to plasnla nlenlbrane pernleability. cellular Ca2 1-
influx, calpain activation, and cleavage ofnlyofibrillar and cytoskeletal proteins vv'hich 
produce the characteristic nlllscle wasting observed in nluscular dystrophy (474,475). In 
the nlid-1990s, Richard et {II discovered that the autoso1l1al recessive condition of linlb-
girdle nluscular dystrophy (Type 2A) lllapped to the nluscle-specific calpain 3 gene found 
on chronlosonle 15 (476). Decreases in calpain 3 activity lead to increased levels of IkB-
ex, decreased nuclear translocation ofNF-kB, and decreased expression of cell survival 
genes resulting in enhanced ll1yocyte apoptosis (477, 478). In fact, calpain 3 knockout 
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lllice veri fy that this is the likely nlechanisnl of nluscle cell death seen in linlb-girdle 
nluscular dystrophy (478). 
A second hUlllan disease state associated with a genetic defect in a calpain 
iSOrOrlll is Type II diabetes. In 2000~ a genonle-wide scan for Type II diabetes 
susceptibility genes deternlined that calpain 10 was associated with hereditary Type II 
diabetes ill select populations including Mexican An1ericans and a Finnish subpopulation 
(383). Decreases in calpain 10 activity have been linked to decreased insulin-nlediated 
glucose turnover (479). decreased glucose-induced insulin secretion (480)~ and 
illlpairnlent in glucose production (479). Taken together, these data \vould suggest a 
signi ficant role for calpain lOin regulating glucose nletabolisn1. Recently. a calpain 10 
knockout nlouse \vas generated in1plicating calpain 10 as a n1ediator of ryanodine-
induced apoptosis in pancreatic beta cells (481). Unfortunately, this n10use has not been 
fully characterized and the glucose status of these anin1als renlains to be deternlincd. 
Identification orthe physiological targets of calpain 10 and its role in glucose utilization 
and diabetes nlay provide novel therapeutic strategies for the treatn1ent of Type I I 
diabetes. 
The atypical calpains. The atypical calpains are those enzynles \vhich lack a 
penta-EF hand Ca~j binding n10tifin don1ain IV and instead contain an 'atypical' donlain. 
The atypical calpains consist of calpains 5, 6,7, 10, and 15 (260-262). In contrast to the 
typical calpains the renlaining n1an1n1alian calpain isoforn1s do not appear to interact \vith 
the regulatory calpain 4 sl11a11 subunit, and it is equally unclear as to whether or not the 
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atypical calpains require Ca~+ for activation. Unfortunately~ very little is known about 
the physiological or pathological roles of these enzyn1es with the exception of calpain 10. 
C'aIpain 5 was first identified as a hon1010gue to the C'. elegalls sex detenllination 
gene, 11'0-3 (254, 258,482). Subsequently, it was discovered that a second sex 
deternlination protein TRA-2A was the endogenous 1,.([-3 substrate (483). However. it is 
still unclear as to vvhether or not a hun1an h01l1010gue to TRA-2A exists. The calpa1n 5 
gene product is constitutively expressed in n1an1n1alian systen1s and contains a highly 
divergent T-dotnain in place of the typical calpain don1ain IV (482). Calpain 6 is also a 
novel atypical calpain that denlonstrates a 47% identity to calpain 5 (258). Sequence 
analysis has detern1ined that calpain 6 lacks an active site cysteine residue and is n10st 
likely devoid of proteolytic activity (258). Despite an apparent lack of proteolytic 
activity, calpain 6 is found on the X chron10son1e and n1ay playa role in sex 
deternlination in vertebrates (254). Calpain 7 is perhaps the n10st divergent orthe 
atypical calpains and retains hon1010gy to the other calpains through its possession of a 
proteolytic don1ain (484). Calpain 7 is flanked by an atypical N-ternlinal dOlnain and an 
atypical C'·-ternlinal donlain (PBH don1ain) (248) that displays hon1010gy to the Pal8 
protease fron1 the fungus Aspergillus nidulalls reported to be in1portant in alkaline 
anlbient pH adaptation (484). The latest calpain fan1ily n1en1ber (calpaill 15) was 
identi fled through genon1ic scans for calpain active site d01l1ains and was fOllnd to be 
highly honlologolls to the ])rosophila protein SOL~ s1l1all optic lobes protein (260). The 
calpain 15 gene encodes a protein containing zinc finger-like repeats and a calpaill-likc 
protease don1ain (260). Proposed functions for this gene product include proteolysis, 
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transcription factor activity, RNA binding, and protein-protein interactions during visual 
systen1 dcvelopn1cnt (260). 
Perhaps the n10st well-studied 111enlber of the atypical calpains is calpain 10. 
Calpain 10 \vas first described in 1999 by Braun and colleagues (original nonlenclature 
tCrJllcd this isofonn as eAPN 8), and is located on chrolllosonle 2 (485). The prinlary 
calpain 10 transcript encodes the largest calpain 10 isofonll (CAPN lOa) and produces 
another 7 splice variants of varying nlolecular weights (383). Calpain 10 is conlpriscd of 
rOLlr donlains including don1ains I, II, and III which denlonstrate nlodcratcly high levels 
of hOlllology to the typical calpains. The fourth donlain, donlain III', is the n10st atypical 
and inlparts as yet undetellllined functions to this calpain isofornl. Calpain lOis 
conlplctcly devoid of Ca2+ sensitive EF-hands, but has been reported to function in a 
Ca~ f- -sensitive nlallner (253, 486). It is thought that Ca2+ may regulate calpain 10 through 
binding to donlains I I and III which has been den10nstrated for calpains 1 and 2 (264). 
Caution nlust be used when interpreting these data, however, as there have been no Calt _ 
binding studies perforn1ed using reconlbinant calpain 10. The initial studies on calpain 
10 exanlined the constitutive expression of both nlRNA and protein in nunlerous tissues 
and denlonstrated an age-dependent decrease in protein levels fron1 hun1an lens sanlples 
(253). Subsequently, the authors den10nstrated the Ca2+ -sensitive nature of cytoplasnlic 
calpain 10 \vhcn they observed the cytoplasnlic to nuclear translocation of calpain 10 
after iononlycin treatnlent in alpha TNF4-1 cells (253). 
Calpain 10 has been the first gene to be directly linked to the developnlent of 
Type II (non-insulin dependent) diabetes nlellitus (383). Positional cloning studies 
revealed a Type II diabetes susceptibility gene in a Mexican Anlcrican popUlation vvhich 
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\vas subscqucntly cloned and found to be calpain 10(383). Since this finding in 2()OO~ 
1l11111erOllS investigators have evaluated the calpain 10 gene with respect to insulin 
resistance and relative risk for Type II diabetes in various populations and have found an 
association in Mexican Anlericans (383~ 487)~ a subset of the Finnish population (383), 
i\1l1erican Caucasians (488), British Northern Europeans (489), African Anlericans (490), 
a subset of the Chinese population (491)~ a subset of the Polish population (492), a South 
Indian population (493), nlenlbers of the Swedish population (494), the Japanese (495), 
and Koreans (496). Un fortunately, other studies have shown no association bet'vveen 
calpain I () and diabetes (497-499) which n1ay be due to statistical bias fron1 factors sllch 
as underlying popUlation stratification. However, ani111al models of Type II diabetes have 
greatly contributed to the understanding of the role played by calpai11 lOin this disease 
state. For exanlple, investigators have den10nstrated decreased calpain 10 n1RNA in the 
\vhite blood cel1s of spontaneously diabetic obese rats (500), and in the Otsuka Long-
Evans Tokushin1a Fatty (OLEFT) polygenic type 2 diabetic rat, calpain 10 was one of 14 
quantitative trait loci identified. 
To date, three critical single nucleotide polynlorphisll1S have been identified for 
the calpain 10 gene and include SNP-43, -19, and -63 (383). Con1binations of these 
SNPs have been shown to create n10re 'at-risk' haplotypes and are designated as 
haplotype 112 (SNP-43 allele 1, SNP-19 al1ele 1 and SNP-63 allele 2) and 121 (SNP-43 
allele 1, SNP-19 al1elc 2 and SNP-63 allele 1) (383). Other SNPs identified in the calpain 
10 gene include SNP-44 and SNP-l1 0 (a n1issense nlutation in the coding region of ex on 
10 (T504A)) (501). 
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Figure 1-9. Calpain 10 splice variants 
I 
"~ .~. m m' 
........ m m' 
~ ~. m m' 
. ....... ~ m m' 57.8 
49.1 
, m m' 29.4 
" mm' 15.5 
15.2 
The above schematic describes each variation in calpain 10 transcript splicing, the 
predicted protein domain structure, and the predicted molecular weights of the translated 
gene products. Data on each splice variant was compiled from the NCBI protein 
database and calpain 10 gene record. 
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The calpain 10 gene is cOlnposed of 15 exons with the prin1ary transcript 
undergoing differential splicing to produce a fan1ily of8 calpain 10 isofonns (calpain 
lOa-I Oh) (Figure 1-()) (J83). Although little evidence exists to verify the protein 
expression of all 8 isoforn1s, a nunlber of calpain 10 protein isoforn1s have been 
identified in both rat ocular cells (253) and pancreatic ~-cells (486). In1nluno]ocalization 
and functional studies have placed calpain 10 in association with the cytosol (253)~ 
nucleus (253), secretory granules (486), and endoson1al vesicles (502) under varying 
stinll11i. Hovvever, it is still unclear if all 8 calpain 10 transcripts are translated ill vivo 
and vvhether or not these proteins have individual localizations and functions. 
The rev.';" known physiological functions for calpain 10 have all been elucidated 
fronl the correlative data linking calpai11 10 to Type II diabetes. Currently, the kno\vn 
rnolecular targets for calpain 10 are linlited to pathways involving glucose nlctabolisnl 
(502) and insulin secretion (486). Insulin resistance and ilnpaired glucose uptake into 
skeletal 1l1uscle and adipose tissue are nlajor features of Type II diabetes (50J). A critical 
rate-linliting step in insulin secretion is the insulin-n1ediated transport of glucose by the 
GLUT-4 transporter (504). Previous studies den10nstrated a role for calpains in the 
transport of GLUT -4 vesicles after insulin stimulation (505-507) and n10re recent 
evidence has identified calpain 10 as the calpain isoforn1 responsible for this vesicle 
translocation (502). In addition, calpain 10 polyn10rphisnls are associated 'Nith defects in 
insulin secretion (489) and glucose tolerance (508). Subsequent studies provided 
evidence that long ternl calpain inhibition in pancreatic ~-cells inhibited glucose 
nlctabolisnl, downstreanl Ca2+ -n1ediated responses, nlitochondrial A. TP production, and 
insulin secretion (480). Interestingly, a 54 kDa isofornl of calpain 10 binds the 
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nlenlbrane fusion tSNARE proteins syntaxin and SNAP-25. Overexpression of calpain 
lOin this systenl not only increased insulin secretion and proteolysis of SNAP-25~ but 
calpain inhibition blocked the insulin secretion in this 1110del (486). 
Calpain 10 has also been associated with apoptosis in nun1erous cell types. 
Johnson and colleagues were the first to describe a role for calpain 10 in apoptosis and 
did so by denlonstrating the inhibition ofryanodine-induced apoptosis in pancreatic f)-
cells llsing calpain 10 knockout n1ice (481). More recently, Lu ct al uncovered a 
correlation bet\veen par-4 antisense treatn1ent of PC 12 cells and a reduction in glutalllate-
Illcdiated apoptosis (403). While this study provided little direct evidence for calpain 10-
Illediated apoptosis, it did denlonstrate decreases in intracellular calciunl and of calpain 
10 nlRNA levels, suggesting an interaction bet'W'een par-4 and induction of calpain 1 () 
(403). Subsequently, Wu cf aI, using calpain 10 antisense, den10nstrated a proapoptotic 
role for calpain lOin rat renal interstitial fibroblasts (509). The authors described 
enhanced calpain 10 expression and caspase-3 activity leading to increased levels of 
apoptosis after treatn1cnt of these fibroblasts with lipoxin A4 (509). However, the 
Illolecular targets involved in this forn1 ofapoptosis were not identified in this study. 
It is clear that calpain 10 is an 1n1portant n10lecule regulating diverse cellular 
events including glucose nletabolisn1, insulin secretion, and apoptos1S. However, nluch 
\\'ork is needed to elucidate the exact 1l1echanisIl1s by which calpain 10 1l1ediates these 
events. Future vv'ork nlust also be cOll1pleted in order to understand the true nature of 
calpain 10 activation. For exall1ple, calpain 10 lacks the EF-hand dOll1ain structure found 
in the typical calpain isoforn1s, suggesting that its activity 1l1ay be nlore sensitive to as yet 
undiscovered regulatory nlolecules than it is to Ca2+. In addition, post-translational 
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n10difications such as phosphorylation nlay playa key role in activating calpain 1 () as has 
been sho\vn Cor calpain 2. It is equally ten1pting to hypothesize the existence of a calpain 
1 O-speci fie endogenous inhibitor since it is unlikely that calpastatin interacts with this 
calpain isoforn1 as it lacks a typical donlain IV and does not heterodinlerize vvith the 
S111all calpain subunit. Furthernlore~ a concerted effort to elucidate the roles for all 8 
calpail1 I () isofornls should be initiated as their in vivo substrates are likely as diverse as 
those identi fled for the largest nlenlber of the calpain 10 fanlily. 
IVlitochondrial Calpains. One of the first nlitochondrial proteases to be purified 
and \vell-eharacterizcd \vas described over 25 years ago by Mori et (1/ who denlonstratcd 
a n1atrix-associatcd proteolytic activity capable of cleaving pre-ornithine 
transcarban1ylase to its nlature fornl in isolated liver nlitochondria (510). The protease 
involved in this cleavage was found to be sensitive to both EDTA and leupeptin. hut not 
to serine protease inhibitors~ suggesting the presence of a Ca2 + -sensitive cysteine protease 
(510). This finding is the fIrst report of a "calpain-like" protease residing in the 
nlitochondria~ although the authors did not link this activity to the calpains since calpa111 
biology was itself still in its infancy at the tinle. 
The first identification of a calciunl-dependent nlitochondrial protease \vas Inade 
in 1982 by Beer ct a/. The authors denlonstrated the presence of both Ca2-+ -dependent 
and Ca2+ -independent proteolytic activities in extracts of sonicated rat liver nlitochondria. 
There \vcrc two ('a2 + -dependent proteolytic activities which were described to be half 
n1(1xinud at 25 pM and 750 pM Ca2-+, respectively (231). The calciunl-dependcnt 
activities ohserved in this study were sensitive to EGT A, N-ethylnlaleinlide, lcupeptin, 
65 
cytosolic extracts, and Ca2+-dependent protease inhibitor partially purified fronl 1l1011SC 
lung (231), suggesting that the protease in question nlay have been one of the newly 
described neutral cysteine proteases (calpains). Interest in these findings \vaned for 
Ilearlya decade and \vas finally reevaluated by Tavares et al in 1991. Tavares and 
colleagues used COIUlllll chronlatography to separate three distinct calpain activities n'on1 
isolated rat liver lllitochondria. In this senlinal report of a nlitochondrial calpain, the 
authors described the presence of three independent calpain activities in puri fled 
lllitochondrial nlatrix and two in the inten11en1brane space (233). These activities \vcrc 
found to be nlaxinlal at a neutral pH and at Ca2+ concentrations previously reported for 
both calpains 1 and 2 (30 pM and 2 nlM), although the third activity described had an 
internlediate Ca2 + requirnlent (200 ~lM) (233). Further experinlents denlonstrated the 
inhibitory activity of ICllpeptin and the thiol blocking reagents N-ethylnlalein1ide and 
PCMB on all three of the described calpain activities (233). The two reports detailed 
above were, however, only descriptive and did not attenlpt to identify the calpain isoforn1 
, responsible for the observed activity or the physiological role played by the calpains 
found in the 111itochondria. 
'Years later, Gores et al identified a nlitochondrial calpain-like activity n10stly 
confined to the intern1enlbrane space of purified rat liver nlitochondria. The activity 
denlonstrated in this study \vas calciun1-inducible and was inhibited by cysteine protease 
inhibitors (230). Furthernl0re, the authors found that they were able to inhibit Ca2 "-
induced MPT fo1'l11ation via pretreatnlent with calpain inhibitors. This \vas the first study 
linking 111itochondrial calpain activity to a n1easurable function, be it physiological or 
pathological. In 1999, Endo e/ (1/ denlonstrated that retinal nlitochondrial aspartate 
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al11inotransferase (nlAA T) lost its enzynlatic activity in a calpain-dependent nlanner after 
90 1l1inutcs of retinal ischenlia (511). The authors were able to den10nstrate an increase 
in lllitochondrial calpain activity and were able to in1nlu11oprecipitate calpain activity 
fron1 isolated n1itochondria using n10noclonal antibodies to calpain 2. However. an 
interesting point concerning these studies lies in the fact that the authors never 
dcnlonstrated any in1n1unoblot data confin11ing that calpain 2 was indeed responsible for 
the degradation of n1AA T (511 ). 
'- ' 
Further evidence of a nlitochondrial calpain and its role in n1itochondrial 
physiology has been published by Casas et ([/ who described the presence of an 
interlllen1brane space calpain found in isolated rat liver n1itochondria capable of cleaving 
the nuclear RXRa protein into a truncated nlitocho11drial RXRa that induced the 
transcription of n1itochondrial genes (512). The authors provided evidence that a 
1l1itochondrial calpaill localized to the internlenlbrane space cleaved RXRa into a 44 kDa 
n1itochondrial RXRa (512). The calpain-like activity observed in this study was 
inhibited by Icupeptin, antipain, and ALLN, but not by the Ca2+ chelators EDT A or 
EGT A, suggesting a Ca2+ -independent calpain isoforn1 s1111ilar to that described by Beer 
el (fl. 
To this point in the discussion, only Hcalpain-like" activities have been described, 
leaving the actual identity of the n1itochondrial calpain in question. Considering that 
there arc 14 large calpain isoforn1 subunits and that n1any of the typical calpains arc 
kno\vn to translocate to n1en1brane fractions after activation, it is conceivable that 
lllltltiple nlclllbrane-bound or intra-organellaI' calpain isofornls exist. To this end, t\VO 
recent reports have been subn1itted which suggest the association of calpain 1 to the 
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lllitochondrial fraction (232,408). Polster ct 01 have recently dell10nstrated the calpain-
dependent release of the apoptosis inducing factor (AIF) froll1 11litochondria after Ca2 ' 
overload (408). The authors de1110nstrated that isolated rat liver 111 itochondria release 
AIF after incubation \vith both reconlbinant Bid and calpain 1. They \vere also able to 
s!10\V that Ca~' -induced MPT [orn1ation and subsequent release of AIF was both 
eye losporine A and calpeptin-sensitive, suggesting that an endogenous n1itochondrial 
ealpain could also stin1ulate A.IF release (408). Analysis of these data \vould suggest that 
AIF release fron1 liver n1itochondria is regulated by both an unidcntifid cndogenous 
1l1itochondrial calpain and by calpain 1 which presun1ably translocates to the 
internlcnlbrane space given the proper stin1ulus. Subsequent to these findings, Garcia 
and colleagues dell10nstrated the localization of calpain 1 to the n1itoehondria of rat 
cerebral cortex and to those of the SH-SY5Y neuroblastonla cell line (232). Ho\vcver, 
the data presented in this study do not eonfirll1 the sub-organellar distribution of cal pain 1 
and it is likely that the calpain 1 is n1erely associated with the outcr nlitochondrial 
111enlbrane. 
The n1itochondrion is a highly conserved organelle and is esscntial for various 
biochenlical pathways involved in cellular 111etabolisll1 and prograll1n1ed cell death. 
Cii ven this, it is feasible to suggest that lllitochondrial proteins are those that have been 
selected for over tinle and should be represented in son1e fonn in 1l10re prinlitive life. 
Indeed, \vhcn one observes the lower eukaryotes such as the protozoan parasites, 
dranlatic sinli larities between 11litochondrial proteins and processes can be seen \vhen 
c0111pared to 1110re conlplex eukaryotes such as C'acnorhahditis e/eRolls, Drosophilio 
nic/ullogastcr, and the vertebrates. Recently, Arnoult ct al have identi fied the release of a 
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prinlitivc cysteine protease fronl the internlenlbrane space of the giant 111itochondrion of 
the parasite Leis/znulIli{l 1l1qjor (513). The authors identified a calpain-like sequence in 
the kinctoplastid database and were also able to denlonstrate the cleavage of a kno\\/n 
calpain substratc, P ARP (involved in DNA repair). These observations fronl lower 
cukaryotes suggest thc evolutionary conservation of calpain-like proteins in the 
nlitochondrion and underscore the inlportance of these proteases in physiological and/or 
pathological processes. 
Project Rationale. As described above~ acute renal failure (ARF) is a devastating 
disease resulting in nlortality rates of 50% or greater. Years of research have linked the 
pathology of ARF to nunlerous nlechanisnls, of which Ca2+ overload, calpain activation, 
and nlitochondrial dysfunction appear to be key players. The downstreanl events 
follo\ving renal ischenlia have nunlerous features, of which nlany can be tied to the 
activation of intracellular calpains. Renal ischenlia leads to increased cytocolic calciunl 
\vhich not only activates cytosolic calpains resulting in nlenlbrane disruption, but also 
results in increascd nlitochondrial calciunl levels. Ischenlia-induced nlitochondrial 
dysfunction can be due to a nunlber of factors including oxidative stress and 
phospholipase activation, however, the increase of intranlitochondrial calciunl levels are 
pcrhaps thc nlost destructive due to disruption of electron transport, induction of the 
1l1clllbrallc pernleabi 1 ity trallsition~ and release 0 f proapoptotic proteins into the cytosol. 
Nunlcrous lines of evidence have placed the nlitochondrion at the center of both 
the necrotic and apoptotic cell death pathways. In forn1ation concerning the roles of the 
calpain isofornlS in cell death has also been forthconling in the last 20 years. Calpain 
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activation has been sho\vn to induce both necrosis and apoptosis under various conditions 
and blockade of its activity is cytoprotective in lllany experinlental nlodels. Since the 
early 1980s, nloul1ting evidence has supported the idea that the nlitochondrion possesses 
an endogenous calpain isofornl and nlay also be the target of calpain translocation after 
injury. The presence of a Ca2+-inducible nlitochondrial ca1pain would provide great 
insight into the nlechanisnls ofCa2+-induced nlitochondrial dysfunction during ischen1ic 
renal injury and n1ight also provide a novel patll'vVay for therapeutic intervention in ARF. 
In this study I sought to unequivocally identify an endogenous Illitochondrial 
calpain isolated fron1 renal proxinlal tubule lllitochondria and to identify its role during 
ca1ciull1 overload, an event known to occur during renal ischenlia/reperfusion injury. 
also proposed to identify nlitochondrial substrates for this calpain and to evaluate the 
effects of decreased protein expression of the isoforn1 discovered. Future laboratory 
endeavors \vil1 be designed to develop an inhibitor specific for the nlitochondrial calpain 
in efforts to selectively block n1itochonclrial dysfunction during renal 
ischen1ia/repcrfusioll inj ury. 
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CHAPTER 2 
C,i\LPAIN 10: A MITOCHONDRIAL CALPAIN AND ITS ROLE IN (~A2+_ 
INDUCED MITOCHONDRIAL DYSFUNCTION 
ABS'TR.t\(~T 
Calpains~ Ca2t -activated cysteine proteases~ are cytosolic cnzynlcs inlplicatcd in 
nLinlerOLiS cellular functions and pathologies. We identified a nlitochondrial Ca2 '-
inducible protease that hydrolyzed a calpain substrate (SLL VY -AMC) and was inhibited 
by active site-directed calpain inhibitors as calpain 1 O~ an atypical calpain lacking dOlllain 
IV. Inlnlunoblot analysis and activity assays revealed calpain lOin the nlitochondrial 
outer nletnbrane~ internlenlbrane space, inner nlenlbrane~ and 111atrix fractions. 
Mitochondrial staining \vas observed when C-tern1inal GFP-tagged calpain 10 \vas over-
expressed in NIH-3T3 cells and the n1itochondrial targeting sequence \vas localized to the 
N-tcrnlinal 15 an1ino acids. Over-expression oftnitochondrial calpain 10 resulted in 
nlilochondrial swelling and autophagy that was blocked by the n1itochondrial 
pCrlllcabilily transition (MPT) inhibitor cyclosporine A. Using isolated lllitochondria, 
C'a~' -induced M PT \vas partially decreased by calpain inhibitors. More Inlportantly. 
C'a2- -induced inhibition of Conlplex I of the electron transport chain was blocked by 
calpain inhibitors and two Conlplex I proteins were identified as targets of nlitochondrial 
calpain 10, NDUFV2 and ND6. In conclusion, calpain lOis the first reported 
1l1itochondrially-targeted calpain and is a n1ediator of 11litochondrial dysfunction through 
the cleavage of C'olllplex I subunits and activation of MPT. 
INTRODUCTION 
Calpains. Ca2-1- activated cysteine proteases. are involved in a nun1ber of 
physiological and disease processes: calpains are linked to the pathogenesis of 
Alzheilller's disease, cataracts, linlb-girdle n1uscular dystrophy, gastric carcinonla, and 
Type II diabetcs (245). Calpains cleave diverse protein species including receptors (419), 
ion channels (514,515), cytoskeletal conlponents (235, 516-518), proteases (410,519, 
520). oncogenic proteins (521), and cell signaling n10lecules (386,522). Calpains also 
are thought to participate in the induction of cellular necrosis in variolls cell types (54, 
523-525) and in thc regulation of apoptosis through interactions with p53, Bid, and 
caspase 3 ( 10, 519, 521). Unfortunately, in nlany cases the specific calpain responsible 
for these cellular actions and disease processes has not been identified. 
Whi Ic calpains are a 14-n1cn1ber fan1ily, only a few calpain isoforn1s have been 
studied extensively. Calpains 1 and 2 are ubiquitously expressed cytosolic cnzyn1cs that 
dilllcrizc vv'ith a sn1all calpain subunit (calpain 4). Calpains 1 and 2 are approxin1ately 80 
kDa and consist of four don1ains (I-IV). 00111ain I is an autolytic don1ain often cleaved 
during calpain activation. 00n1ain II contains the catalytic active site where histidine, 
cysteine, and asparagine residues critical for proteolysis are located. 00n1a1n I I I has a 
C2-like phospholipid-binding don1ain, and 00n1ain IV contains a Ca2 + -binding penta-EF-
hand n10ti r COn11l10n to 1l1any Ca2 +--binding proteins. Calpains arc conln1on Iy separated 
into tvv'O groups, typical and atypical, based on the presence or absence of Donlain IV' 
(245). The absence of a typical don1ain IV n1ay in1part novel functions~ substrate 
affinities, and activation/inhibition Inechanisn1s to the n10re understudied atypical 
calpains (258). 
\\1hjJe caJpajns are generaJJy thought to be cytoso)jc proteins. Hood e/ {II has 
suggested that calpain 1, previously thought to be solely cytosolic, also localizes to golgi 
and ER n1en1branes (526). Moreover, there are nun1erous reports of a n1itochondrial 
calpain-like activity (230~ 231,233,408,512,513,527). However, cytosolic 
contan1ination of the n1itochondrial preparations has been a concern, and investigators 
have inconsistently described the sub-nlitochondrial location of this calpain-like activity 
(nlatrix fraction versus internlen1brane space). At this tiIne, a specific n1itochondrial 
calpain has not heen identi fled. 
The function of a putative n1itochondrial calpain has not been elucidated. 
Ho\vever Ca2-t -sensitive proteolytic activities in n1itochondria have been associated \vith 
the cleavage of RXR-a (512), pre-ornithine transcarbanlylase processing (510), cleavage 
of nuclear PARP and aspartate an1inotransferase (511), and induction ofMPT (408,527). 
Further, n1itochondria are dynan1ic organelles participating in cellular Ca2+ regulation and 
are capable of buffering large al1l0unts of cytosolic Ca2+ (528). Mitochondrial Ca21 
uptake is known to induce the 1l1itochondrial pernleability transition (MPT) and 
nlitochondrial dysfunction (529, 530). In the present study, we have taken a nlolecular 
approach to identity the n1itochondrial calpain and have evaluated its role in 
nlitochondrial dysfunction. 
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MATERL4LS AND METHODS 
lVIitochond rial I solation and Fractionation. 
Kidney n1itochondria were isolated froll1 n1ale Sprague Dawley rats (C'harlcs 
River Laboratories~ Wiln1ington~ MA) (250 g) and fen1ale New Zealand white rabbits 
(Myrtlc~s Rabbitry, Thon1pson Station, TN) (2 kg) as previously described (162~ 531). 
Briefly, kidney cortex \vas n1inced and hOll10gellized in ice-cold Buffer A (0.27 M 
sucrose, 5 n1M Tris-HCI, 1 n1M EGTA, pH 7.4). Nuclei and cellular debris \vere pelleted 
by centri fugation at 600 x g for 5 n1in. The supernatant was centrifuged at 7700 x g for 5 
n1in resulting in a crude n1itochondrial pellet. The pellet was washed once in ice-cold 
0.27 M Sllcrose and resuspended in Buffer B (130 n1M KCl, 9 n1M Tris-P04, 4 111M Tris-
Hel, 1 111M EGT A, pH 7.4). Crude n1itochondria were then layered onto a 
sucrose/Percoll gradient and centrifuged at 20,000 x g for 20 n1in. 
Puri fled renal cortical n1itochondria (RCM) were subfractionated as described 
previously (532). Outer n1en1brane rupture was achieved by hypotonic lysis in icc-cold 
BulTcr (' (10 111M KH 1P04, pH 7.4) for 20 n1ill at O°C. Mitoplasts were separated fron1 
the supernatant by centri fugation at 7 ~ 700 x g for 5 ll1in. The outer ll1cll1brane fraction 
was obtained by centrifugation of the supernatant at 54,000 x g for 30 n11n. The resulting 
pellet \vas resuspended in ice-cold Buffer D (300 111M sucrose, 1 111M EGT A, 20 n1M 
MOPS, pH 7.4) and sonicated five tin1Cs ill 30 s bursts. Inner n1en1brane and n1atrix 
fractions were then separated by centri fLIgation at 54,000 x g for 30 n1in. Outer and inner 
nlen1branc fractions were resuspended in Buffer D. Fraction purity was assayed via 
nlarkcr cnzynlc analysis (outer n1enlbrane ~-- 1110noanline oxidase, intern1cn1branc space ~ 
adcnylate kinase, inner nlen1brane-- cytochron1e oxidase, Inatrix fUI11arasc). The 
activities ofl11onoanlinc oxidase (533), adenylate kinase (534), cytochron1c oxidase 
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(535)~ and funlarase (536) \verc deternlined by standard 111ethods. Fractions \vere frozen 
at -70°C for subsequent inlnlunoblot analysis. 
Calpain Activity. 
Calpain activity vv'as assayed spectrophoton1ctrically using the calpain-spcci fic 
substrate SLLVY -AMC (Bachen1), as previously described (292). Whole, energized 
1l1itochondria (200 pg) were diluted in Buffer B and incubated with various 
cOllcentrations ofCaCb in the presence of 50 ~lM SLLVY-AMC. Activity was nleasurcd 
under linear conditions as a function of AMC hydrolysis using excitation and cnlission 
\vavelengths of 355 and 444 nn1, respectively. RCM incubated in the absence of 
substrate exhibited the san1e fluorescence as Buffer B alone. 
Respiratory Conlplex Activity. 
Conlplex I enzyn1e activity was n1easured as previously described (537). The 
assay n1ediull1 was COll1posed ofantinlycin l\ (2 ~lg/n11), ubiquinone (65 pM). NADH 
(130 ~lM L KC'N (2 n1M) in a phosphate buffer (25 111M potassiull1 phosphate, 5 lnM 
MgCI 2, 2.5 nlg/nll BSA, pH 7.2). ReM (20-50 ~lg) were then added and NADH 
ox idation was nleaSllred spectrophoton1etrical1y at 340 nn1 for 3-5 l11in before the addition 
of rotenone (2 ~lg/n11). Absorbance changes were n1easured for another 3 n1in. and 
Conlplcx I activity reported as the rotenone-sensitive NADH:ubiquinone oxidoreductase 
acti vity. 
Conlplex II enzyn1e activity was n1easured as previously described (537). Briefly, 
RCM (20-50 pg) \vere preincubated in assay n1edia (25 n1M potassiun1 phosphate, 5 111M 
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MgCb~ pH 7.2) and 20 n1M succinate for 10 n1in at 30o e. Anti111ycin A (2 ~lg/n11)~ KCN 
(2 n1M), rotenone (2 ~lg/n11), and 2,6-dichlorophenalindophenal (50 ~lM) \vere added, and 
absorbance at 600 nn1 recorded for 3 n1in. The reaction was then initiated with 
ubiquinone (65 pM)~ and absorbance n10nitored far 3-5 n1in. 
COl11plex III activity was n1easured as previously described (537). Briefly, 
cytochron1c c (III) (15 ~lM), rotenone (2 ~lg/n11), dodecyl-b-D-111altoside (0.6 111M), and 
llbiqllinol-.2 (35 ~lM) \vere added to assay ll1edia (25 111M potassiun1 phosphate, 5 111M 
MgCI~, 2.5 111g/1111 BSA (fraction V), 2 111M KCN, pH - 7.2) and the nonenzyn1atic rate or 
reduction of cytochron1e c ll1easured for 1 111in at 550 n111. To initiate the reaction, ReM 
(5-.20 ~Lg) \vere added, and the initial increase in absorbance was 111easured for.2 n1in. 
Measurenlent of ReM Oxygen Consumption (Q02). 
Oxygen consu1l1ption \vas 1110nitored as previously described (531) using a six-
chanlbered oxyn1cter and con1puter interface (Strathkelvin, 1110del 928~ Glasgo\v. lJK). 
RCM were suspended at approxin1ately 1.3 nlg protein/n11 in n1itochondrial incubation 
butTer \vith pyruvatc/n1alate (5/5 111M) as the respiratory substrates. In son1e eXperil11cnts, 
succinate (10 n1M) or ascorbic acid/TMPD (5/0.5 111M) were added in the presence of 100 
pM rotenone (a C'ol11plcx I inhibitor) or 2.5 ~lM antin1ycin A (a Con1plex III inhibitor), 
rcspectively. ReM were gassed (5% C02/95 % O2) for 5 111in prior to treatn1cnts and 
111eaSUren1ent ofrcspiration. The respiratio11 chall1ber was ll1aintained at 37°(, and stirred 
n1agnetically .. After the basal rate (state 4) of O2 consun1ption was deternlined, ADP 
(final concentration=1 n1M) \vas injected to obtain state 3 respiration. Only nlitochondria 
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with respiratory control ratios (RCRs- state 3/state 4) 2: 4 were used for cxperinlcnts to 
ensure that test nlitochondria \vere tightly coupled. 
In son1e experin1ents, respiration n1easuren1ents were perforn1ed in the presence 
or absence of 1 ~LM Ca2+ over various tin1e courses. For inhibition experin1ents, calpain 
inhibitors were added 30 n1in prior to the addition of 1 pM Ca2+ and respiration nlcasured 
after 5 n1in. Ca2+ 'Nas added to Buffer B in all experinlents such that Ca2+ concentrations 
vvcre n1aintained at 1 ~lM. 
[\11 itoehn nd rial S,velli ng. 
RC~M swelling was assessed spectrophoton1etrically as previously describcd 
(230). Briefly, RCM \vere suspended at a final concentration of 1 n1g/n1l of 
nlitochondrial protein in Buffer B supplen1ented with pyruvate/n1alate (SIS n1M) and 
absorbance n1caSlired for 10 n1in at 540 nM. After basal n1eaSllren1ents were taken, Ca2+ 
was added (1 ~lM final sustained Ca2+ concentration) and absorbance was n10nitored for 
an additional 5 n1in and swelling rates (~A/n1in) detern1ined. 
Zynlography. 
Zyn10graphy was perforn1ed as previously described (538) \vith n1inor 
1110di fications. Zynlogran1 gels were cast inlll1ediately prior to electrophoresis and 
consisted of a 10°1<) non-denaturing acrylanlide resolving gel and an 8% stacking gel. 
Resolving gels \vcre copolyn1erized with the calpain substrates FITC-casein (10 nlg/n11) 
or SLLVY-AMC (50 ~lM). RCM protein sanlples (200 ~lg) and purified porcine calpains 
1 and 2 (2 ~Lg) (Calbiochcll1) \vere loaded and subjected to electrophoresis in a non-
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denaturing funning buffer (125 n1M Tris-base, 625 111M glycine, 5 111M EGTi\, pH 8.0) at 
120 \/ for 2 hours at 4°C. Gels were subsequently bathed in Ca2+ incubation buffer (50 
111M Tris-HCL 5 111M CaCb, 10 n1M 2-n1ercaptoethanol, pH 7.0) overnight at 4°C and 
in1aged on an Alpha Innotech in1aging station fitted with a FITC filter. 
I 1l11l1U noblotti ng. 
Isolated RCM fractions were sUbjected to SOS/PAGE (4-12 % acrylan1idc) and 
transferred to nitrocellulose n1elllbranes. Men1brancs were incubated with prin1ary 
antibodies to n1-calpain, ~l-calpain, calpain 10, NOUFV2, OAP 13, and N06. The 
prin1ary antibodies used were n1011oclo11al rabbit a11ti-hun1an n1-calpain (Affinity 
Bioreagents -- 1 : 10(0), rabbit anti-hun1an n1-calpain (doll1ain IV) (Calbiochen1 -- 1: 10(0), 
rabbit anti-hun1an ~l-calpain (don1ain III-IV) (Abcan1 - 1: 10(0), rabbit anti-rat calpain 10 
(dolllain II) (generously provided by Ton1 Shearer, Oregon Health a11d Science 
University, Portland, OR -- 1 :2(0), rabbit anti-hun1an calpain 10 (don1ain IIr) (Abcan1 -
I: I DOO), rabbit anti-rat calpain 10 (don1ain II) (Biogenesis -- 1: 1000), rabbit anti-
NDUFV2 (generously provided by Dr. Yan1aguchi, The Scripps Research Institute, La 
Jolla, C A 1 :200), n10noclonal n10use anti-hun1an DAP 13 (Genway Biotech, Inc ... 
pglJl1L). and 1110noclonal n10USC anti-hun1an NOC) (Molecular Probes -- 1 ~lg/n1L). 
Antibody incubation was followed by a horseradish peroxidase-conjugated goat anti-
rabbit secondary antibody (Santa Cruz - 1 : 1 0(0). Inln1unoreactive protein \vas visualized 




cDNA ft)r hU111an calpain lOa (8C004260) \vas obtained fron1 ATCC in the 
pOTS7 shuttle vector. Full length calpain 10 was anlplified by PCR (Sense: 5"-
TGGGAGCCCGCGGAGCCGAG-3'" Antisense: 5'-
TeATC' ACTGCCA TGACGGAGACCTC-3 ') and subcloned into pcDNA3.1-TOP()-
TA-C'T-GFP (pcDNA3.1-C APN 1 O-GFP) (Invitrogen) producing a calpain 1 O-GFP fusion 
product (C-ternlinal GFP). GFP control plasnlids coding for cytosolic GFP and 
ll1itochondrially targeted GFP (cytochroll1e oxidase IV signal sequence) \vere generous 
gifts fron1 Dr. Douglas Sweet (Medical University of South Carolina, Charleston, SC). 
('oI11pleI11cl1tary DNA sequences coding for the N-tern1inal 15 an11no acids of 
calpain 10 were generated, annealed, and ligated into pcDNA3.1-TOPO-T A-CT -GFP 
(pcDNA3.1-TS-GFP) to assess N-tenninal sufficiency for 111itochondrial targeting. The 
negative control for this experin1ent \\I'as obtained via ligation of the above sequence into 
pcDNA3.1- TOPO-T A-CT -GFP (pcDNA3.1-TSINV -GFP) in the reverse orientation. 
Cell culture and Transfection. 
NIH-3T3 fibroblasts were n1aintaincd in Dulbecco's Modified Essential Mediun1 
(DMEf\1) containing 10°i<) fetal bovine serun1 until confluent. Cells were split and plated 
onto 35-111n1 confocal dishes (MatTek) at a density of250,000 cells/plate. At 70% 
conflucnce, cclls \verc transiently transfected with 1 ~Lg pcDNA3.1-CAPN 1 O-GFP, 
pc[)N A3.1-TS-GFP, or pcDNA.3.1-TSINV -GFP plasn1id constructs using Lipofectan1inc 
2000 (Invitrogen). Selected plates were treated with 6 ~LM cyclosporine A, 5 n1M 3-
n1cthyladeninc (3-MA), or vehicle (DMSO) 4 hr after transfection. Cells were incubated 
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for 24 hr and, vv'he11 indicated, exposed to 50 nM MitoTracker Red (Molecular Probes) 
and/or 100 nM LysoTracker Red (Molecular Probes) for 20 n1i11 prior to confocal 
nlicroscopy inlaging. Cells were in1aged using a Zeiss LSM 5 confocal l11icroscope using 
l11ultiplc tracks to elinlinate fluorescent crosstalk. 
Statistical Analysis. 
RCM isolated fron1 one rabbit represent one experinlent (11= 1). The appropriate 
ANOV A \vas pcrforn1cd for each data set by using Sign1aStat statistical soft\varc. 
Individual n1eans were con1pared with Fisher's protected least significant difference test 
with PS;O.05 being considered a statistically significant difference betw'een nlcan values. 
Means \Nith different lettered subscripts within groups are significantly different fronl 
cach other, PS;O.05. Linear regression w'as also perfornled by using Signla Stat statistical 
sof1\varc. 
RESUL1'S 
Calpaill Activity in Isolated \1itochondria and Submitochondrial Fractions. 
To detenlline the presence of calpain activity, rabbit RCM were incubated \\'ith 
increasing concentrations of Ca~-t- in the presence of the calpain substrate SLL VY -Ai\vlC. 
ReM cleavage of SLLVY -AMC occurred in the absence of added Ca2+, was linear over 
tinlC (data not shown), and increased in the presence of increasing Ca2+ concentrations 
(Fig. 2-1 A) to a nlaxinlunl of 120(~} of control at 10 pM Ca2+. The addition of increasing 
concentrations of the Ca2+ chelator EGT A to RCM pern1eabilized with O.5(Yo digitonin, in 
the presence of 1 ~LM Ca2+, produced a nlaxinlal 50°1t) decrease in SLLVY -AMC 
hydrolysis (Fig. 2-1 B). Blockade of the Ca2+ uniporter with rllthenillll1 red also inhibited 
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Ca~j-induccd hydrolysis of SLLV'{ -AMC in RCM (Fig. 2-1 C). Ca~+-activatcd SLLC'.!-
AMC hydrolysis \vas inhibited in a concentration-dependent nlanner by the calpain 
inhibitors calpeptin and E-64, but not by the calpain inhibitor PD150606 (Fig. 2-1 D). 
These data reveal that RCM exhibit basal calpain activity, that exogenous Ca~+ increases 
calpain activity in a rutheniunl red-sensitive nlanner, that calpain activity exists in the 
absence 0 r Ca:2+, and that the calpain inhibitors calpeptin and E-64, but not PD 150606, 
blocked the calpain activity. Because rutheniunl red blocks Ca2+ uptake across the 
111itochondrial inner nlenlbrane and the increase in calpain activity produced by 
exogenous Ca2f \vas rutheniunl red-sensitive, \ve suggest that the calpain activity is 
located in the nlitochondrial ll1atrix. Because the calpain activity \vas insensitive to 
PO 150()06 which binds to don1ain IV of typical calpains (298), we suggest that the ReM 
calpain lacks the penta-EF-hand don1ain and is a nlenlber of the atypical calpain fan1ily. 
To detern1ine which sub-nlitochondrial fraction(s) contain calpain activity, RCM 
\VeIT fractionated into outer nlen1brane, internlen1brane space, inner nlen1brane, and 
nlatrix ft'actions. Marker enzynles (lTIOnOanline oxidase - outer n1en1brane, adenylatc 
cyclase -- intern1en1brane space, ctyochron1e oxidase -- inner n1en1brane, fun1arase -
1l1atrix) \vcre used to assess n1itochondrial fraction purity (Table 2-1). Ca2-r-activatcd 
hydrolysis of SLL VY -AMC was observed in each fraction with the outer 111Cnlbrane 
having the highest activity and the n1atrix the least on a per nlg protein basis. Maxitnal 
activity 'Nas observed at 2 111M Ca2-+- in the outer 111en1bralle and at 10 111M for the 
rCI11aining three fractions (Fig. 2-1 E). These results reveal that calpain activity is present 
in nlultiple n1itochondriallocations. 
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Figure 2-1. n.CM calpain activity. 
(A) Coupled RC'M (200 pg) were incubated vvith the calpain suhstrate SLLVY-AMC (50 
pM) and increasing concentrations ofCaCb. and fluorescence 111casured for 6 n1il1 at 25 
°e. (B) ReM calpain activity vvas 111casured in 0.50/0 digitol1in-pern1eabilizcd 
n1itochondria in the presence of 1 pM CaCl~ and increasing concentrations ECiT/\, (C) 
ReM calpain activity \vas nleasured in whole nlitochondria in the presence of 1 ~LM 
CaCI~ and increasing concentrations of rutheniun1 red. (0) RCM \vere pretreated f()r 20 
n1il1 on ice \vith increasing concentrations of calpeptin (closed circle). E-64 (open 
triangle). and PI) 150606 (open dianl0nd). and subsequently assayed for 1 pM C~a~-j­
induced hydrolysis of SLL VY -AMC. (E) Purified nlitochondrial fractions (open circle ~ 
n1atrix. closed circle - outer n1enlbrane. open triangle - internlen1branc space. closed 
triangle - inner n1en1brane) \vere assayed for SLLVY-AMC hydrolysis in the presence or 
increasing (;a~+ concentrations (0-10 111M). Data are expressed as 111eans ± SEM (N=3). 
Means \vith different lettered subscripts \\1ithin each group are significantly different fron1 
each other. /)<0.05. 
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FITC-cascin zyn10graphy is a technique con1n10nly used to evaluate calpain 
activity in cell lysates. We cll1ployed this technique to evaluate calpain activity in rabbit 
ReM fractions and in the cytosol fron1 renal cortical cells. Equal anlounts of total protein 
(200 ~Lg) rrOn1 cytosolic, n1itochondrial, and subn1itochondrial fractions were loaded into 
individual 7yn10gran1 gels. Two bands of activity were observed in the cytosol 
corresponding to calpains 1 and 2 (Fig. 2-2A), both known to exist in the cytosol of renal 
proxinlal tubule cells (235). However, no bands were detected in the san1ple lanes for 
\vhole nlitochondria or n1itochondrial subfractions, suggesting that the nlitochondria 
harbored no endogenous calpain 1 or 2, that the ll1itochondrial preparation \vas fi-ce of 
cytosolic contan1ination, and that n1itochondrial calpain exhibits a substrate speci ficity 
different fronl that of the typical calpains. 
We n10dified this assay to evaluate ll1itochondrial calpain activity by replacing 
FITC-casein \vith SLLVY-AMC (a known ll1itochondrial calpain substrate ill l'ilro) as the 
calpain substrate. AMC is liberated by proteolytic activity to generate fluorescent bands 
in the gel. Purified calpains 1 and 2 were used as controls and fluorescent bands \vere 
identified in the presence ofCa2+ (Fig. 2-28). No fluorescent bands vvere observed in the 
outer n1enlbranc and intern1cn1brane space fractions in the presence of Ca2+. In contrast. 
one strongly fluorescent band and two weaker bands were observed in the nlatrix 
fraction. One weaker fluorescent band of activity was identified in the inner nlen1branc 
that co-nligrated \vith the bands in the n1atrix fraction and n10st likely represents fraction 
in1purity (Table 2-1). These results reveal three distinct calpain activities in the n1atrix 
fraction that arc Ca2+-inducihle and are different than calpains 1 or 2. No activity \vas 
observed in the outer n1en1brane and intern1en1brane space fractions. 
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Table 2-1. Specific activity of marker enzymes in mitochondrial subfractions 
Table 2-1. Relative specific activity of marker enzymes in mitochondrial subfractions 
Monoamine Adenylate Cytochrome 
Fumarase 
Fraction oxidase kinase oxidase 
Outer membrane 100 9±2 3±1 9±2 
Intermembrane Space 20±1 100 5±2 1S±4 
Inner Membrane 11 ±2 21±5 100 17±3 
Matrix 1±1 19±3 2±1 100 
Enzyme activites were determined in the mitochondrial subfractions as described in the Materials and Methods. 
The highest specific activity was normalized to 100% for each marker enzyme tested. Data represent the 
Mean ± S.D., (n=5). 
85 
A 
C1 C2 Cyt Mit OM IS 1M Mat 
B 
C1 C2 OM IS 1M Mat C2 C1 
Figure 2-2. Zymographic analysis of ReM calpain activity 
R M sub-fract ions were assayed for Ca2+ -induced calpain activity using (A) FITC -casein 
and (8) SLLVY -AMC zynlography. Reco111binant porcine calpain 1 and :2 (2 ~lg). 
cytoso lic. nd RCM fractions (200 ~lg) were loaded and subjected to non-denaturing 
PAGE. Gels were ubnlerged in a 10 n1M Ca2+ bath for 10 n1in at 4°C and inlaged using 
an Alpha Innotech i111aging station. Results are representative of five individual 
xp rinl nts. (Ahhrc1 ialions: C l-calpain 1 C2-calpain 2, Cyt-CytosoL Mit-
Mitoch ndria. OM-outer nlenlbrane, IS-internlenlbrane space, 1M-inner nlenlbrane. Mat-
nlatri x) 
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Identification of ('alpain lOin ReM Subfractions. 
The protein localization algorithnl MITOP2 (http://ihg.gsf.de/n1itop2/starLjsp) 
\vas used to dctenl1ine which of the 15 calpain isoforn1s would be predicted to localize to 
nlitochondria. While a negative score using this algorithnl does not exclude the 
possibility ofnlitochondriallocalization~ this algorithnl only returned a positive score far 
c<1lpain 10. Cytosol ic and ReM fractions fron1 rabbit and rat kidney cortex \vcre probed 
far calpain 10 with three separate antibodies directed against different calpain 10 donlains 
using i111111unoblot analysis. The presence of calpains 1 and 2 also were cxanlined. A 75 
kDa band \vas identified in all rabbit and rat ReM fractions using all three calpain 1 () 
antibodies~ albeit at different levels (Fig. 2-3A). An inlnlunoreactive band also v/as 
identi fied in the cytosol using an antibody against calpain 10. Inlnlunoblots probed \vith 
antibodies against calpains 1 and 2 revealed inlnlunoreactive proteins against thcir 
respective purified proteins and cytosol but not in any of the ReM fractions (Fig. 2-3A). 
These results reveal that calpain 10 also resides in the n1itochondria in at least two 
species (rabbit and rat), and is present in all ReM fractions. Further, the bands of 
illllllullorcactivity are consistent with the largest calpain 10 isoforn1 (Calpain lOa - 75 
kOa) (539), indicating the absence ofnlitochondrial inlport signal cleavage. 
The strong fluorescent band identified in the nlatrix san1ple following 
zYlll0graphy \vas eluted and subjected to SDS/PAGE and inlnlunoblot analysis using an 
anti-calpain 10 antibody (Fig. 2-38). These results reveal that the nlitochondrial nlatrix 
calpain activity observed during zYll10graphy is calpain 10. 
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Figure 2-3. C:alpain 10 is expressed in multiple mitochondrial subfractions. 
(A) Rat and rahhit RC'M suh-fractions (50 ~lg). cytosolic fractions (50 pg). and 
ITC0l11hinant porcine calpains 1 and 2 (I ~lg) \vere subjected to SDS/PACj I: and then 
in1111Ullohlotted 'vvith allti- calpain 10 (dIIA). anti-calpain 10 (dIIB). anti-calpain 10 (T-
d0I11uin). anti-calpain 1. and anti-calpain 2 antihodies. as indicated. (8) Follo\ving 
cal pai n zynlography. protein fronl the active enzynlatic band indicated abovc \,vas 
extracted and subjected to SI)S/PAGE and inlll1unoblotted with the anti-calpain 10 (dIIB) 
antibody. Results are representative of three independent experilllcnts. eA hhreriu{ ions: 
C l-calpain 1. (12-calpain 2. ()M-outer nlenlbrane. IS-internlell1brane space. 1M-inner 
nlcn1branc. Mat-nlatrix. Cyt-C'ytosol) 
A 
Rat 
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Calpain lOis Targeted to Mitochondria via an N-terminal Targeting Peptide. 
Hun1an calpain lOa was subcloned into a TOPO-TA-CT-GFP vector (Invitrogen) 
to produce a calpain 1 O-GFP fusion protein containing an intact N-tern1inlls and a C-
tcrn1inal GFP n10iety. This construct was chosen to avoid n10dification of the N-tenninus 
which could result in the loss of putative n1itochondriallocalization n10tifs. 
NIH-3T3 cells were transfected with the pcDNA3.1-CAPNI0-GFP construct 
exposed to MitoTracker and/or LysoTracker Red, and in1aged via confocal 11licroscopy. 
Cells also \vere transfected using GFP constructs specific for cytosol (data not sho\vn) or 
lllitochondria (Fig. 2-4A) to serve as positive GFP controls for these con1partn1ents. 
During initial experin1ents, we observed two distinct popUlations of cells after 
transicction \vith the CAPN 1 O-GFP construct. All transfected cells den10nstratcd GFP 
expression that \vas localized to intracellular conlpartn1ents with S0l11C being punctuate ill 
nature and others cxhibiting larger globular patterns of GFP expression. The latter of 
these t\VO groups of cells exhibited altered cellular n10rphology, decreased plate 3dhesion~ 
and the fornlation of autophagocytic vesicles as shown by costaining with LysoTrackcr 
Red (Fig. 2-48). The fornler of these two groups of cells exhibited norn131 cellular 
Illorphology but contained swollen n1itochondria (Fig. 2-4C) conlpared to 
1l1itochondrially-targetcd GFP controls (Fig. 2-4A). These data reveal the targeting of 
calpain 10 to the nlitochondria and suggest that calpain 10 nlay playa role in 
nlitochondrial dysfunction and/or s\velling as evidenced by the changcs seell in 
Illitochondrial 1110rphology. 
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Figure 2--'" C:alpain 1 () translocates to mitochondria and induces mitochondrial 
s\vclling. 
NIH-3T3 fibroblasts \vere used for all transfections because of their distinct elongated 
1l1itochondrial n10rphology. (A) Cells were transfected with a control 111itochondrially-
targeted green fluorescent protein (Mito-GFP) construct and subsequently stained w'ith 
MitoTracker Red. (8) Cells were transfected w'ith pcDNA3.1-CAPN lO-GFP. and 
subsequently stained ~:ith LysoTracker Red. This panel depicts cells den10nstrating 
glohular patterns of (JFP localization which colocalize with LysoTracker Red. (C) Cells 
were transfected with pcDNA3.1-CAPN 1 O-GFP. treated ~rith vehicle (DMSO) 4 hr later. 
and subsequently stained \vith MitoTracker Red. These cells represent the n1ajority of the 
cell population. show· n1itochondrial GFP staining. and retain their norn1al cellular 
1l10rphology in culture. (D) Cells were transfected with pcDNA3.1-CJ\PN I O-l'FP. 
treated 'vvith cyclosporin A (6 ~lM) 4 hr later. and subsequently stained with MitoTrackcr 
Red. (E) Cells \vere transfected with pcDNA3.1-CAPN 10-GFP. treated \vith 3-
1l1ethyladeninc (10 n1M) 4 hr later. and subsequently stained with MitoTracker Red. 
Results are representative of three independent experin1ents. The 'Alhite bar in panel A 
represents a distance of 20 pn1. 
Mito-GFP MitoTracker Red Overlay Enlargement 
Calpain 10-GFP LysoTracker Red Overlay 
Calpain 10-GFP MitoTracker Red Overlay 
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To test the hypothesis that the N-ter111inus of calpai11 lOis responsible for 
111itochondrial 10calizatio11~ oligonucleotides coding for the first 15 N-ternlinaI al11ino acid 
residues (Figure 2-58) were annealed and ligated into the TOPO-TA-CT-GFP vector. 
Negative controls included the san1e oligonucleotides inserted in the reverse orientation. 
NIH-3T3 cells transfected with these constructs displayed cytosolic targeting and 
111itochondrial targeting for the reverse and forward orientations~ respectively (Fig. 2-5/\.). 
These results reveal that the N-ternlinal 15 a111ino acids of calpain 10 are sufficient for 
111itochondrial targeting. We also analyzed the N-ternlinus of calpain lOusing the LaTeX 
soflvv'arc package TeXtopo designed to display peptide sequences in an alpha helix 
representation (Figure 2-58). The results revealed that the N-ternlinus of calpain 10 can 
fornl the classical n1itochondrial targeting 1110tif, the a111phipathic helix. 
,\'litochondrial S\velling Induced by Over-expression of (~alpain lOis Sensitive to 
Cyclosporine A and 3-lnethyladeninc. 
A.s discussed above, over-expression of ca1pain 10 resulted in the conversion of 
the llornlaI branched reticular 111itochondrial n10rphology of control cells (Fig. 2-41'\.) to 
that ofslnaller~ round and swollen organelles (Fig. 2-4C). Thus, we hypothesized that the 
calpain 1 O-induced nlitochondrial swelling n1ay be sensitive to cyclosporine 1~ (an 
inhibitor of 1'v1PT (540») or 3-nlethyladenine (an inhibitor of MPT and autophagocytosis 
(540)). C~ells were transfected with the calpain 1 O-GFP construct, treated vv'ith 
cyclosporine A or 3-nlcthyladenine, and the n1itochondria exa111incd by confc)cal 
111icroscopy. Cyclosporine A and 3-nlethyladenine preserved the nornlal branched 
111itochondrial n10rphology and integrity (Fig. 2-40 and 2-4E, respectively) as c0l11pared 
to cells expressing calpain 1 O-GFP alone, suggesting that calpain 10 l11ay n1ediatc 
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11litochondrial swel1ing, in part, through the forn1ation of the MPT pore. Hovv'cver. M PT 
fornlation \vas not exp1icitly exan1ined in these experill1ents and it is possible that the 
nlitochondrial fl-agnlentation observed in our studies could also result fronl Initochondrial 
depolarization. electron transport chain dysfunction, or changes in 11litochondrial fission 
or fusion proteins. 
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Figure 2-5. The N-terminus of calpain 10 is required for mitochondrial targeting. 
(A) NIH -3T3 fibroblasts were transfected with the pcDNA3 .1-TS-GFP and pcDNA3.1-
TSINV -GFP constructs. pcpNA3.1-TS-GFP-transfected cells were subsequently stained 
with MitoTracker Red. Results are representative of three independent experiments. (B) 
This helical wheel diagram shows a representation of the calpain 10 N -terminus as if it 
were a helix using the TexTopo LaTeX package. The putative helix is amphipathic in 
nature, containing hydrophobic and aliphatic residues on one half and positively-charged 
residues on the other. Adjacent to the helical wheel diagram is a schematic 
representation of calpain 10 and its N-terminal 15 amino acids used to engineer the 
calpain 10 targeting sequence-GFP construct (asterisks denote positively charged 
residues) . The white bars in panel A represent a distance of 10 f.lm. 
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To further exanline the possible role of calpain lOin MPT~ RC'M \vcrc treated 
v.lith 1 ~LM Ca~( in the presence and absence of cyclosporine A or calpeptin, and RCM 
s\vclling dctcrnlincd. The addition ofCa2+-induced RCM swell1ng which \vas blocked by 
cyclosporine A (Fig. 2-6A). Mitochondrial pretreatnlent \vith calpcptin blocked -~JO{~) of 
Ca~i -induced RCM s\velling, indicating a role for calpain 10 in the fornlation orthe l\1PT 
pore (Fig. 2-(8). 
Calpain 1 0 lVlcdiat(~s CaH-induced Mitochondrial Dysfunction. 
As sho\vn in Figure 48, calpain 10 over-expression resulted in fraglllcntcd 
nlitochondrial nlorphology. This type of organellar derangenlent is seen not only during 
MPT, but is also characteristic ofnlitochondria with danlaged or inlpaired C01l1pOncllts of 
the electron transport chain (ETC) (541). Thus~ calpain 10 nlay nlcdiate ETC 
dysfunction. To test this hypothesis, RCM \vere isolated and suspended in incubation 
buffer containing the 1l10del Conlplex I substrates pyruvate/nlalate (5/5 nlM). State 3 
respiration \vas nlcasured over tinle after treatnlent with 1 ~LM Ca2-+ in the presence of 1 
111[\/1 ADP. State 3 respiration was unchanged under nornloxic and hypoxic conditions ill 
the absence of C'a~ f (Fig. 2-7 A), and all future respiratory ll1easurenlents \verc pcrfornlcd 
under nornlOX ic conditions. The addition of 1 ~LM Ca~+ produced a tinle-dcpendent 
decrease ill ll1itochondrial state 3 respiration (Fig. 2-7B)~ and all subsequent experilllcnts 
\verc conducted follo'Ning the incubation of RCM with 1 ~lM Ca2+ for 5 nlinutes. 
Pretreatlllent (30 nlin) of RCM with increasing concentrations of the active-site calpain 
inhibitors calpcptin and E-64, but not the donlain IV calpain inhibitor PO 150606 
preserved lllitochondrial state 3 respiration (Fig. 2-7C). Higher concentrations of E-64 
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did not further preserve state 3 respiration. Sinlllltaneous nlcaSllrenlent of state 3 
inhibition and ReM calpain activity denlonstratcd a strong correlation bet\vccn these t\VO 
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Figure 2-6. Mitochondrial calpain mediates Ca2+-induced MPT. 
1. 
(A) Cyc losporine A pretreatn1ent inhibit 111itochondrial w iling induced b-, 1 pM Ca- . 
Basal n1itochondrial we lling wa n1onitored for 10 n1in after which Ca2 -induced 
. \vcl ling wa. n1onitor d for an additional S nlin. (8) R M \N r pretreated 'vvith 
calpcptin lor 30 n1in and 111itochondri al welling induced b treatnlent wi th 1 ~lM Ca-', 
Swelling 'vvas n1 eas llred a ' indicat d above. Data are expre sed a Ineans ± S -J M (N -=J), 
Means with different lettered sub cript within each group are ignificantl y differcnt rr0111 
each other. p<O.OS . 
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Figure 2-7. Mitochondrial calpain mediates Ca2+-induced respiratory dysfunction. 
State J 111itochondrial respiration was 111casured using isolated RCM (].J nlg/n11) in the 
presence and absence of' 1 ~lM Ca2+ and various calpain inhibitors. (A) State J 
Initochnndrial respiration \vas n1easured in the ahsence of Ca2 t- under conditions or 
norn10xia and hypoxia in the presence and absence of the COll1plex I substrates 
pyruvatc/n1alatc (SIS n1M). (B) State 3 11litochondrial dysfunction \vas n1easured as a 
function of tin1c in the presence of the Con1plex I substrates pyruvate/n1alatc (SIS Inrvl) 
and] pM CalT . (C) RCM \\"ere pretreated for 30 111in \vith a variety ofdissilnilar calpain 
inhibitors. ReM \vere then challenged with 1 pM Ca l + for 5 n1in and state J 
n1itochoncirial respiration nleasured. The calpain inhihitors calpeptin and E-64 protected 
against state 3 dysfunction while PO 150606 did not. The solid and dashed lines represent 
lnitochondrial state 3 respiration in the ahsence and presence of 1 ~lM Ca21 • respectively. 
(D) rv1 itochondrial state 3 dysfunction is positively correlated with increases in 
111itochondrial calpain activity (1'2=0.93). Data are expressed as nlcans ± SEM (N=J). 
Means with di fferent lettered subscripts within each group are significantly di fTerent 1'rOn1 
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To detennine the site of ETC dysfunction, isolated RCM were suspended in 
incubation buffer containing pyruvate/nlalate (Conlplex I substrates), succinate/rotenone 
(Conlplcx II substratc/Conlplex I inhibitor), or ascorbate-TMPD/antinlycin A (Conlpicx 
IV electron donor/C'onlplex III inhibitor). RCM state 3 respiration was then nleasured 
after trcatlllent with 1 ~lM Ca2+ for 5 n1in. Respiratory deficits were observed only in the 
lreatnlcnt group containing the Conlplex I substrates (Fig. 2-8A). To veri fy these 
findings, \VC pcrforllled specific COlllplex I, II. and III activity assays and detcrnlined that 
only C0111plcx I activity was significantly decreased after Ca2+ exposure (Fig. 2-88) and 
that this activity could be preserved by pretreatlllent with calpeptin. These findings sho\v 
that Ca21 -induced respiratory dysfunction is lilllited to Conlplex I under these conditions 
and that electron transport in C~onlplexes II-IV renlains intact. 
Calpain 1 () (~Ieaves [\1 itochondrial Contplex I Subunits. 
C-"olnplcx I of the ETC is con1posed of 46 individual subunits. We sought to 
dctcrn1inc the c01l1plex I protein substrate(s) of calpain 10. To do this, we analyzed each 
or the 4() COll1plcx I subunits for possible calpain cleavage n10tifs using the PEST-FIN [) 
algori thnl ( http://srs.nchc.org.tw/en1boss-bin/enlboss.pl? _ action=input& __ app=pestfind). 
The PEST-·FIND algorithnl is useful for the identification of possible calpain and 
protca:,,;clll1C substrates. but does not predict actual cleavage sites vvithin protein targcts. 
Subsequent to PEST analysis, four protein species were identified as potential calpain 
substrates; NDlJFV2, DAP13. NDUFS7. and ND6. Antibodies were available and 
obtaincd for NDlJFV2. DAPl3, and ND6. Aliqllots fron1 ReM were treated vvith 1 ~lM 
Ca~ i and subjected to in11l1unoblot analysis using antibodies against NDUFV2. DAP 13 
and the ND6 subunits of Con1plex I. NDUFV2 and ND6 underwent proteolysis in the 
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presence of C£1 2+ that was cotllpletely inhibited by the calpain inhibitors ALLN and 
caJpeptin but not the serine protease inhibitor bestatin (Fig. 2-8C). DAP 13 did not 
undergo hydrolysis (Fig. 2-8C). Pretreatnlent with rutheniunl red also blocked NDUFV2 
and ND6 degradation (Fig. 2-8C)~ suggesting that calpain 1 O-nlediated proteolysis of 
Conlplcx I subunits occurs in the ll1atrix. Our results denlonstrate Ca2+-induced calpain-
dependent proteolysis of the COll1plex I subunits NDUFV2 and ND6, but not of the 
DAP 13 subunit. 
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Figure 2-8. (:olnplcx I subunits NDlJFV2 and ND6 are proteolytic targets of the 
mitochondrial calpain. 
(A) I~(>lated RClV1 \vere treated vvith 1 ~lM Ca2 +- for 5 111in in the presence of Con1plc\: I 
suhstrates p)rUvate/ll1alate (SIS 111M). Con1plex II suhstrate and inhibitor 
slIccil1111cirotcl1nnc (10 111M/1 00 ~lM). or COll1plex IV electron donor and COlnplex III 
inhihitur ascnrhall' plus TIv1PJ)/antin1ycin A (5/0.5 n1M /2.5 ~lM) (8) Conlplex L II. and 
I I [ en;, 'Tne activities \\:"ere Ineasured in isolated ReM as outlined in the text. 
iVlitochol1dria \\ere pretreated \vith calpeptin (30 nM) or diluent for 30 n1in and 
suhsequently exposed to 1 ~ll'v1 Ca2+ for 5 n1in. Data are expressed as nleans ±: SEl'v1 
(NJ). fvleans \vith different subscripts \\:'ithin each group are significantly different fr0l11 
each othl'r. p<:O.05. (C~) Isolated ReM vvere pretreated vvith various inhibitorst~)r 30 l11in 
in the pl'l'Sl~l1Ce or Conlplex J substrates and then exposed to 1 ~lM Ca2+ for 5 111in. 
~i.tJllplL':-) \\l~rC then prepared for \\'Yestern blot analysis and \vere prohed \\ith antihodies 
;.t~(lil1st the ('rHllplex I suhunits NI)lJFV2. NI)6. and I)AP13. Results ar~ representative 
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Figure 2-9. Proposed mechanism of action for calpain lO-mediated ETC 
dysfunction. 
Depicted above is a schematic diagram of the proposed mechanism of calpain 10 action 
following Ca2+ -induced mitochondrial dysfunction. After injury, increases in cytosolic 
Ca2+ are translated to the mitochondria via the ruthenium red-sensitive calcium channel 
uniporter. Increases in matrix Ca2+ activate mitochondrial calpain 10, inducing cleavage 
of two critical subunits of Complex I, ND6 (*) and NDUFV2 (#), leading to subsequent 
respiratory deficits. Increases in mitochondrial calcium also contribute to the induction 
of MPT, possibly through proteolysis of membrane pore proteins. 
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DISC~USSION 
Calpains arc ubiquitously expressed throughout eukaryotic organisn1s and are 
involved in nunlcrous cellular functions (245). Within nlanln1als~ calpains L 2~ 4, 5~ 7, 
1 O~ 12, and 13 are ubiquitously expressed, \vhereas calpains 3, 6, 8, 9, and 11 have n10re 
tissue-specific distributions (539), in1plicating a diverse set of roles for calpain fan111y 
n1en1bcrs. Ho\vcver, the physiological and pathological roles of n10st calpain isoforn1s 
have not been exanlined. \Vhde calpains are thought to be cytosolic proteins, 
investigators have reported calpain-like activities in isolated n1itochondria (230,231,233. 
408,512,513,527). Using nll11tiple approaches, we identified a resident n1itochondrial 
calpain as calpain 10 and detern1ined that it plays a role in n1itochondrial dysfunction. 
Ma el uf first cloned calpain lOin 2001 and proposed that this calpain isoforn) 
vvas localizcd to the cytosol and translocated to the nucleus after increases in cellular Ca
21 
(253). ()ur data reveal that calpain lOis present in the cytosol and nlitochondria. \vitholll 
signi ficant nuclear staining under basal conditions (Fig. 2-4C). However, \ve have not 
evaluated the effects of Ca2~ overload on calpain 10 subcellular localization. We believe 
that ollr cloning strategy avoids the conlplications and cross-reactivity of antibodies lIsed 
fc)l' inlnlunohistochenlistry (lHC) and provides a clearer picture of the subcel1ular 
10cali/atiol1 or calpain 10. 
Many n1itochondrial nlatrix-targeted proteins contain either a N- or C-ternlinal 
signaling 1110tif(542, 543). This n10tif1110st C01111110nly takes the fonn of an N-tcrnlinal 
anlphipathic helix containing positively-charged residues on one half of the helix and 
hydrophobic residucs on the other (543). We deter111ined the presence of such a Inotifin 
calpail1 10 llsing the LaTeX software package TeXtopo (Fig. 2-58), designed to display 
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peptide sequences in a helical representation (544). We tested the hypothesis that the N-
tenninal 15 anlino acids of calpain 10 are responsible for n1itochondrial localization, and 
found that cells expressing GFP conjugated to the N-ternlinal 15 an1ino acids localized to 
the n1itochondria whereas cells expressing GFP conjugated to the sanlC nucleotides 
inserted in the reverse orientation ren1ained in the cytosol (Fig. 2-SA). 
Investigators have previously reported a Ca2+-inducible calpain-like activity in 
n1itochondria (230,231,233,408). Our data reveal that calpain activity is present in 
intact n1itochondria and is increased following Ca2+ addition. Because Ca
21 
is 
concentrated in the ll1itochondrial nlatrix, and rutheniu1l1 red blocked the Ca2 f--induced 
increase in calpain activity, we propose that the n1ajority of Ca2+-inducible calpain 10 
activity in nlitochondria is localized to the nlatrix. This idea is supported by the 
cxperinlcnt in which calpain 10 was identified in the nlatrix fraction follo\ving 
Iyrnography. Nevertheless, using isolated RCM fractions we observed calpain activity 
and calpain 10 protein in the outer nlenlhrane, internlenlbrane space. inner nlenlbrane, 
and Illatrix fractions. While these results support the work of others \vho have repo11cd 
calpain activity in n10re than one n1itochondrial fraction (233), calpain 10 nlay be inactive 
in the rcnlaining fractions and it is not clear what function calpain 10 has in these 
fl'actions. 
Using pernleabi lized nlitochondria and Ca2+ chelation, \ve observed that 
approxinlately 50o~) of the n1itochondrial calpain 10 activity was Ca2+-dependent. It is 
unclear \vhether the renlaining cysteine protease activity in the nlatrix was due to C'a2-~­
independent cal pain 10 activity or due to the activity of another cysteine protease. One 
explanation is that calpain lOis less Ca2 +--dependent than the typical calpains due to its 
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IllitochondriaI s\velling (529,545,546). Calpain 10 over-expression induced 
nlitochondrial fragnlentation and swelling, consistent with MPT (50), and this altered 
111itochondrial nl0rphology \vas blocked by two MPT inhibitors. In addition, calpain 10 
over-expression induced nlitochondrial autophagy, a process blocked by 3-1'v1A and 
thought to be stinlltlated by MPT induction (174, 546, 547). We denl0nstrated 30o~) 
inhibition of M PT by the calpain inhibitor calpeptin, denl0nstrating that the forn1a1iol1 of 
the MPT pore is nlediated by other Ca2+ -dependent processes. Gores el ([/ previously 
reported a liver n1itochondrial calpain-like activity that regulated MPT (230,527). It is 
conceivable that calpain 10 does not directly regulate MPT per SC, and the nlitochondrial 
fh:lgnlcntation seen in our studies nlay be regulated via other calpain 10-nlediated 
proteolytic events. Nevertheless, cyclosporine A and 3-nlethyladenine blocked the 
111itochondrial fragnlentation and swelling observed subsequent to calpain 10 
ovcrcxprcsslon. 
The nlitochondrial ETC provides a nlechanisnl for the generation of A TP through 
the oxidative phosphorylation of ADP. As previously reported (530), nlitochondrial Ca2~ 
overload results in decreased ETC activity. OUf results reveal that Conlplex I is the n105t 
sensitive conlplex to Ca2+ -induced nlitochondrial dysfunction and that calpain inhibition 
'vvith calpcptin protects against Conlplex I dysfunction. We sought to deternline potential 
COlllplex I protein substrate(s) of calpain lOusing the PEST-FIND algorithnl 
(http://srs.nchc.org). Four Conlplex I proteins were identi fled and three proteins were 
tested (NDLjFV2~ DAP}3, and ND6). Ca2+-induced inhibition ofETe \vas associated 
vv'ith hydrolysis ofNDUFV2 and ND6 but not DAPt3. Further, prctreatnlent with 
rutheniunl red also blocked NDlJFV2 and ND6 degradation, suggesting that Ca21 _ 
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induced calpain 1 O-n1cdiated proteolysis of NDUFV2 and ND6 subunits occurs in the 
n1itochondrial nlatrix. 
[)cf1cicncies or n1utations in various protein subunits ofCo111plexes I-IV have 
been idelltif~ed and linked to clinical syndronlcs (548). Con1plcx I subunit nlutations are 
perhaps the n10st con11110n and account for 330/0 of all respiratory chain disorders (549). 
In addition~ Ricci e! (II have shown that the proteolysis of Conlplex I subunits can also 
contribute to ETC dysfunction by de1110nstrating the caspase-n1ediated cleavage of the 75 
kDa NDUFS 1 subunit (550). In the current study, vve have identified t\VO Conlplex I 
subunits, NDlJFV2 and ND6. which undergo calpain-n1ediated hydrolysis. The 
NDUF\/2 subunit is a nuclear-encoded 24 kDa protein found in the ll1atrix ar111 of 
Conlplex I and is required for C'on1plex I activity (551,552). Defects in this protein have 
been identified previously and result in encephalopathies and bipolar disorder (553~ 554), 
The ND() subunit, a 20 kDa protein encoded by the n1itochondrial genon1e~ is a 
transnlenlbrane protein kno\\/n to assist in Conlplex I assenlbly, is required for Conlplex I 
acti\'ity. and \vhose n1utations are associated with Leber's Hereditary Optic Neuropathy 
(LHON) (555-558). Thus, sin1ilar to the n1itochondrial calpain-induced hydrolysis of 
ND6 and NDlJFV2 and the associated C0111plex I dysfunction, genetic alterations in these 
proteins result in inhibition ofC'onlpIex I. Interestingly, Koopn1an et al. has sho'A;'n that 
single subunit n1utations in COll1plex I not only reduce enzyn1e activity of the COll1plcx, 
but arc otten associated with alterations in n1itochondrial 111orphology (541); a 
phcnonlenon \VC observed with calpain 1 () over-expression. 
In sUll1111ary, VlC have identified the endogenous 111itochondrial calpain as calpain 
10 and that it plays a role in ll1itochondrial viability. While the physiological and 
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pathological functions of calpain 10 have not been studied extensively, it has been linked 
to ryanodinc-induced apoptosis, GLUT4 vcsicle translocation, pancreatic beta-cell 
exocytosis, cataractogenesis, hypertriglyceridenlia, and is genetically linked to Type: II 
diabetes. a disease associated with nlitochondrial dysfunction (253, 481, 486, 494, 502, 
559). l\1itochondria are increasingly being thought of as cell death checkpoints at \vhich 
signals for necrosis and apoptosis are sent for downstreanl processing. It will be exciting 
to elucidate the role of calpain lOin orchestrating these events and ho\v we nlay be able 
to lllanipulate this syste1l1 for therapeutic intervention in disease states donlinated by the 
dysregulation of cellular Ca2~ honlcostasis. 
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CHAPTER 3 
MITOCHONDRIAL CAL~PAIN 10 REGULATES ATP SYN1'HESIS /\'ND 
CELL CURVIVAL IN RENAL PROXIMAL TUBULE CELLS 
ABSTRACT 
Calpains~ Ca~ r--activated cysteine proteases, are a 14-nlelllber fanlily of cytosolic 
enzynlcs inlplicated in nUlllerous cellular functions and pathologies. Our laboratory 
recently dctenl1ined that calpain lOis also resident in 1l1itochondria, is active in the 
nlitochondrial nlatrix, and degrades two Conlplex I subunits of the electron transport 
chain. To deternlinc the physiological role ofnlitochondrial calpain 10, we developed an 
adenoviral-dclivered shRNA for calpain 10, infected renal proxinlal tubular cells (RPTC) 
and exall1ined nlitochondrial function and viability over tinle. Mitochondrial calpain 10 
expression decreased below detectable levels 3 days after infection vv'hile cytosolic 
calpain 10 levels rcnlained unchanged at day 3 and decreased to ~20% of control by day 
5. Exalllination of basal and uncoupled oxygen consunlption (Q02) and ll1itochondrial 
nlcillbrane potential revealed no differences anlong control, scranlble shRNA, and 
calpain 10 shRNA-infected cells. Hovv'ever, cellular A TP levels increased 2-fold on day 
4 and 5 in calpain 1 () shRNA-treated cells as cOlllpared to controls. Calpain 1 () 
knockdovv'n \vas correlated with increased expression of AMP-activated protein kinase 
(AM P]() and l!\TP synthase ~, suggesting that these proteins are proteolytic targets of 
calpain 10. Using isolated renal cortical nlitochondria (RCM)~ ATP synthase f) \vas 
cleavcd in a Ca2+-dcpendent 11lanner that was blocked by a calpain inhibitor. RPTC 
survival also was evaluated and found to be significantly decreased by day 4 of the virus 
treatll1ent. In sunlnlary, we have identified a role for calpain lOin the regulation of 
AMPK and A TP synthase ~ levels, that 111arkers of 111itochondrial viability renlain 
unchanged after calpain 10 shRNA treatnlent that calpain 10 can regulate cellular ATP 
levels, and that cytosolic calpain 10 n1ay playa pro-survival role for RPTC. 
INT'RODUCTION 
('alpains, Ca2-+--activated proteases, are n1en1bers of a larger class of cnzyn1es 
kno\vn as cysteine proteases and are linked to the pathogenesis ofnunlcrous disease 
states including Alzhein1er's disease, cataracts, lin1b-girdle ll1uscular dystrophy, gastric 
carcinonla, and Type II diabetes (245). Calpains are responsible for the linlitcd 
protcolysis ofnunlcrous protein targets including receptors (419), oncogenic proteins, 
(521) and cell signaling n10lecules (386, 522). Calpains also are thought to participate in 
the induction of cellular necrosis through interactions with the cytoskeleton in various 
cell types (54, 523-525) and in the regulation of apoptosis through interactions with r53~ 
/\IF, Bid, Bax, and caspase 3 (10,408,519,521, 560). Unfortunately, ll1any of the 
calpain targets identified have been revealed through the use of non-specifIc calpain 
inhibitors, calling into question which calpain isofor111 is responsible. In addition, little is 
knO'NIl about the Il10lecular n1echanisn1s and protein targets for the atypical calpains that 
lack [)olllian IV and whose C-tern1inal dOlnains are highly divergent as c01l1pared to their 
nl0rc \vell-studied typical counterparts. 
While calpains are a 14-n1enlber fa111i1y, only a few isoforn1s have been studied 
extensively, and little to no \\/ork has been conlpleted on the atypical class of calpain 
1110lcculcs, save for calpain 10 \vhich has been identified as a Type II diabetes 
susceptibility gene (559). Recent work on calpain 10 has provided increasing evidence 
that this nlolecule plays a key role in regulating glucose nletabolis111 and insulin secretion 
(486,502), all of\vhich are in1portant pathways with respect to diabetogenesis. 
QUI' laboratory has recently identified calpain 10 as a Ca::!+-inducible 
nlitochondrial calpain capable of cleaving electron transport chain proteins after 
ll1itochondrial Ca2-t overload. We have also de1110nstrated that 111itocondrial calpain 10 
regulates Ca2-+ -induced state 3 respiratory dysfu11ction and that it 111ay playa role in the 
fornlation oCthe nlitochondrial pernleability transitio11 (MPT) pore. 
('alpain 1 () has also been shown to be involved in the apoptotic process. Johnson 
and colleagues denlonstrated a decrease in apoptosis in pancreatic p-cells isolated fronl 
calpain 1 () knockout nlice conlpared to wild-type cells after treatn1ent with ryanodine, 
palnlitatc, or lo\v glucose (481). Wu et aI, using calpain 10 antisense 111ethodology, 
dCI110nstratcd a proapoptotic role for calpain 10 in rat renal interstitial fibroblasts (509). 
The authors denlonstrated induced calpain 10 expression and caspase-3 activity, leading 
to enhanced apoptosis after treatnlent of fibroblasts with Iipoxin A4 (509). 
UnrortLlllatcly~ the nlolccular targets of calpain 1 O-nlediated apoptosis have yet to he 
elucidated. 
To deternline the physiological role of nlitochondrial calpain 1 O~ we have 
developed an adenoviral-delivered shRNA for calpain 10, inoculated rena] proxinlal 
tubular cells (RPTC) and exanlined nlitochondrial function and viability over tinlc . 
.,I 
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Elucidation of the effects of calpain 10 action n1ay provide novel therapeutic targets for 
disease intervention. 
MA.l'ERIALS AND METHODS 
Isolation. CuIture~ and Infection of Renal Proximal Tubules. 
Isolation and culture of renal proxin1al tubules were pcrforn1cd as described 
previously (5() 1-563). Fenlale New Zealand White rabbits (1.5--2.5 kg) \\:ere purchased 
fron1 Myrtle's Rabbitry (Thon1pson Station, TN), RPTC were isolated using the iron 
oxide perfusion ll1ethod and grown in six-well tissue culture dishes under inlproved 
conditions. The culture nlediunl was a 1:1 ll1ixture ofDulbecco's n10dified Eagle's 
n1ediull1/ Hall1's F-12 ll1ediun1 (without glucose, phell01 red, or sodiunl pyruvate) 
supplenlcnted with 15 111M HEPES buffer, 2.5 n1M Lglutal11ine, 1 ~lM pyridoxine Hel, 15 
111M sodiulll bicarbonate, and 6 111M lactate. Hydrocortisone (50 pM), scleniun1 (5 ng/nl1), 
hUIlHln transferrin (5 pg/ll1l), bovine insulin (10 nM), and L-ascorbic acid-2-phosphatc 
(50 ~lM) were added daily to fresh culture ll1ediull1. Isolated tubules \\'ere plated at 1 111g 
ofprotein/\vell in 35 111111 dishes. On day 6, RPTC were infected with scranlble-shRNA 
virus (\/ector BioLabs- 5 x lOx PFU/n11) (Mal of 10), calpain 10-shRNA virus Uv1()! or 
10), or diluent. Sall1ples were isolated on days 1-5 post-infection for subsequent analysis. 
l\1itochondrial Isolation and Fractionation. 
Renal cortical ll1itochondria were isolated froll1 fell1ale New Zealand \\I"hite rabbits 
(2 kg) as previously described (162~ 531), Briefly, kidney cortex was nlinccd and 
hOlllogenized in ice-cold Buffer A (0.27 M sucrose~ 5 n1M Tris-HCI, 1 n1M EGT A, pH 
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7.4). Nuclei and cellular debris were pelleted by centrifugation at 600 x g for 5 111il1. The 
supernatant \vas centrifuged at 7700 x g for 5 n1in resulting in a crude nlitochondrial 
pcl1ct. The pellet \vas \vashed once in ice-cold 0.27 M sucrose and resuspended in Buffer 
B (130 n1M KCI~ 9 n1M Tris-PO.+, 4 n1M Tris-HCI, 1 n1M EGT A, pH 7.4). Crude 
ll1itochondria \vere then layered onto a sucrose/Percoll gradient and centrifuged at 20,000 
x g for 20 n1in. 
RPTC n1itochondria \vere isolated via differential centrifugation. Briefly. RPTC 
\vere lysed in hon10genization buffer (50 n1M Tris-HCl, 1 111M 0-n1ercaptocthanoL I 1111\11 
EDT A, 0.32 M sucrose, pH 8,f)) containing protease inhbitors with brief agitation and 
sonicated Cor 10 sec. The subsequent honlogenate was centrifuged at 900 x g for 5 n1in. 
The supernatant \vas centri fuged at 7700 x g for 5 n1in resulting in n1itochondrial and 
cytosolic fractions. Mitochondria were resuspended ill hon1ogenization buffer for 
in1n1unoblot analysis and in Buffer B for subsequent activity assays. 
Calpain ,'-\ctivity. 
Calpain activity was assayed spectrophotonletrically using the calpain-speci fic 
substrate SLLVY -AMC (Bachen1), as previously described (292). Whole. 111itochond1'ia 
(200 pg) \verc diluted in Buffer B and incubated with 10 n1M CaCl~ in the presence or so 
pM SLL VY -AMC'. Activity was n1easured under linear conditions as a function of Al\~C 
hydrolysis using excitation and en1ission wavelengths of355 and 444 nn1, respective1y. 
RCM incubated in the absence of substrate exhibited the sall1e fluorescence as ButTer B 
alone. 
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lVlcasurClncllt of ReM Oxygcn ('onsunlption (QOz). 
Q02 \vas nlonitored as previously described (562). Briefly, RPTC bathed in 37°C 
culture nlediunl were gently detached fron1 culture dishes with a rubber policenlan and 
transferred to a 37°C Q02 challlber. Basal RPTC~ Q02 was 11leasured polarographically 
llsing a Clark-type electrode. After the basal rate of Q02 was deternlined, FCCP (final 
concentration= 10 pM) was inj ected to obtain uncoupled Q02. 
ATP Synthase f3 Degradation. 
The sensitivity of A TP synthase ~ to calpain 1 O-lllediated cleavage was 
detern1incd using isolated rabbit RCM. Briefly, isolated rabbit RCM were incubated \vit11 
1 pM Ca2+ for 1 hr at roon1 tenlperature in the presence and absence of calpeptin (10 
pM). ATP synthase ~ degradation was subsequently evaluated by inlll1unoblot analysis. 
Ilnl11U noblotting. 
Isolated RCM and RPTC \vere subjected to SOS/PAGE (4-12 o~) acrylalllide) and 
transferred to nitrocellulose n1en1branes. Mell1branes were incubated \\/ith prill1ary 
antibodies to ealpain I, calpain 2. calpain 10, AMPK, ATP synthase r, Hsp60, caspasc J. 
and GAPDH. The prinlary antibodies used were n10noclonal rabbit anti-hunlan n1-
calpain (Affinity Bioreagents - 1: 1 0(0), rabbit anti-hunlan In-calpain (don1ain IV) 
(Calbioehcn1 1: 1 000), rabbit anti-hunlan p-ealpain (doll1ain III-IV) (Abean1 -- 1: 1000), 
rabbit anti-rat ealpain 10 (donlain II) (Biogenesis -- 1: 1 000), nl0noclonal nlouse anti-ATP 
synthase f) (Santa Cruz -- 1: 1 OOO)~ rabbit anti-hull1an AMPK (Cell Signaling -- 1: 10(0), 
111011se anti-hlll11an Hsp60 (Abeall1-- 1: 1 OOO)~ and rabbit anti-hull1an caspase 3 (Stress 
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Signaling- I: 1 0(0). Antibody incubation \vas followed by a horseradish pcroxidase-
conjugated goat anti-rabbit or goat anti-nlouse secondary antibody (Santa Cruz - 1: 10(0). 
[nlnlunorcactivc protein was visualized by enhanced chenlilunlinesence (A.nlcrshaln) and 
inlaged using an Alpha Innotech inlaging station. 
Adcnoviral (~onstruct. 
Three independent siRNA sequences were obtained (Anlbion) and evaluated for 
their ability to inhibit calpain 10 translation. Sequence #3 produced > 95~;() knockdo\vll 
of ealpain 10 expression after a 24 hour transfeetion in HEK-293 cells. Subsequently, 
oligonucleotides encoding this siRNA sequence (sense - 5'-TCGAG 
CCGAGTGAGGTGT AC A TTGTTCAAGAGACAA TGT ACACCTCACTC'GGTTA-3', 
and antisense - 5'-CTAGTAACCGAGTGAGGTGTACATTGTCTCTTGAA 
C AATGT ACACCTCACTCGG C-3') were annealed and ligated into Anlbion's pSilencer 
Adena 1.O-CMV shuttle vector. Following isolation of pure plasnlid, HEK-293 cells 
v/cre co-transfccted with the provided linearized adenoviral backbone DNA and the 
shuttle vector. Arter viral replication, HEK-293 ce111ysates were harvested. 
Reconlbinant adenovirus anlplification was conducted by the MUSC Viral Vector Core 
Faci lity \vllo provided us \vith puri tied and titered reconlbinant adenovirus (5 x 10 1 ~ 
partieles/lnl, 1 x 1 Ol() PFU/nll). 
lVleasureJl1cnt of ATP. 
A TP was nlcasured via luci ferase-nlediated biolul11inescence as previously 
described (564). Bricfly, RPTC were \vashed three tinles with ice-cold PBS and 
subsequently lysed on icc with 1 00 ~L1 triton/glycylglycine lysis buffer. Honlogenates 
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vvere inlnleciiately centrifuged at 14.000 x g for 5 n1in at 4°C. Supernatants \vere 
• _ '~ ••• '" ',' r 
collected and kept on ice. Each san1ple (50 ~Ll) was con1bined with an equal volunle of 
lucifcrasc reagent (ATP Biolun1inescence Assay Kit CLS II, Roche) and inlaged 
in1111cdiately using an Alpha Innotech ill1aging station fitted with a chen1ilull1inescent 
tllter. 
ASSCSSlllCllt of ~uclcar Morphology. 
Nuclear nlorphology was assessed as previously described (565). Briefly, RPTC 
\verc \vashcd t\vice \vith PBS, n1cdiunl was ren10ved, cells were fixed for 10 n1in using 
] ()(~/~) bufTered forn1alin/4 % fornlaldehyde and washed with PBS. After washing, RPTC 
\vere pernlabilized for 10 n1in in PBS/O.1 o/~) Tween-20. Pern1eabilized cells were washed 
thrce tin1cs with ice cold PBS and treated for 10 ll1ill with DAPI (16.6 pM final 
concentration) at roon1 ten1perature. Covered RPTC vv'ere washed three tinlcs with ice 
cold PBS. Visualization of DAPI staining \vas perforn1ed uSillg a Nikon TE300 Eclipse 
Fluorescence 111icroscope (Nikon, Melville, NY) with excitation and en1ission filters of 
350 and 486 nn1, respectively. Condensed nuclei froll1 10 high powered fields were 
counted for each trcatn1ent group. 
[VlcasurClllcnt of IVlitochondriall\1elnbrane Potential (A\fJm ). 
Qualitative assessn1ent of 1l1itochondrial nlen1brane potentia] was evaluated by 
JC-l (5,5' ,()/)' -tetrachloro-l, 1 ' ,3,3' -tetraethylbenzinlidazolcarbocyanine iodide) staining . 
.J(~-] 10ading into 111itocholldria is detected by a shiH in fluorescence frolll green~ \\"hich is 
characteristic of its 1l10non1eric forn1~ to red, which reflects its aggregation in 
1l1itochondria. Plated RPTC were incubated with 200 11M JC-l for 20 ll1i11 at 37°C. Cells 
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'were subsequently washed three tinles with 37°C culture 111edia and inll11ediately inlagcd 
using a 2()X objective on a confocal nlicroscope (Zeiss LSM 5) (excitatioll 488 11111: 
SilllltltlillCClUS green Cllllssions (5l 0-525 n111) and red ell1isslons (590 11111) ch::Ulncls using ~l 
dllLlI band-·pass filter). 
Statistical Analysis. 
RPTC and RCf'v1 isolated fron1 one rabbit represent one experinlellt (11-=1). The 
appropriate /\NO\/,t\ \vas perforn1ed for each data set by using SignlaStat statistical 
software. Individual n1cans \vere conlpared with Fisher's protected least significant 
eli fferellcc test \vith 1)~O.05 heing considered a statistically significant difference het\vccn 
1l1Can values. Means \vith different lettered subscripts within groups are significantly 
di ffcrent lI'on1 each other, P:-SO.05. Linear regression \vas also perfornled hy using SignlCl 
Stat statistical software. 
RESLJL'fS 
Adcnovirus-111cdiatcd Knockd(HYn of C~alpain 10 Expression. 
RPTC' \verc infected \vith either scranlble shRNA (scranlble) or calpain 10 
shRNA (virus) and incubated for a period of 5 days. Control RPT(~ are cells treated \vitl1 
diluent. Control, scran1ble. and virus-infected l11itochondrial and cytosolic fractions \\"crc 
isolated each day for 5 days and assayed via inl111unoblot analysis for calpain 10 
expression. Calpain 10 levels in virus-infected cells were decreased belo\\' detectable 
levels in lllitochondrial isolates by day 3 post-infection, while levels in cytosolic fractions 
on day] \verc relatively unchanged and decreased to ~20% of control by day 5 (Fig. ]-
1 A). Calpain 1 () levels in control and scranlble-infecteel cells renlained unchanged (Fig. 
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3-\ Band 3-1 C~). These differences n10st likely reflect differential rates of calpain 10 
turnover bet\veen the two C0l11partn1cnts. Veri fication of calpain 1 O-speci fic knockdo\vn 
was accol11plished via in1111unoblot analysis of the typical cytosolic calpains 1 and 2 (Fig. 
3-1 A,B,C). These data den10nstratc that calpain 1 and 2 expression levels did not change 
bct\vecn controL scran1ble shRNA, and calpain 10 shRNA-infected cells. 
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Figure 3-1. Adenovirus-mediated knockdo\vn of calpain 10. 
Contluent RfYfC \vere infected \vith reconlbinant adenovirus expressing either calpain 10 
shRNA or scranlhlc shRNA. harvested over a 5 dav tinle course~ and suhtl'actionatcd into .; 
cytosolic and crude lnitochondrial fractions. Resultant sanlples were subsequently 
illlll1tlllohlotted for calpain 10 protein expression. Inlnlunoblots for caJpains 1 and :2 
provide evidence for calpain 10-specific protein knockdown. Equal protein loading \vas 
verified by inlnlunoblot analysis using a-GAPDH and a-I--Isp60 antibodies for the 
cytosolic and nlitochondrial fractions. respectively. (A) C~alpain 10 shRNA-infectcd 
RPTC. (B) ('ontrol RPTC (no treatnlent). (C) Scranlble shRNA-infected RPT'C. 
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Calpain Activity is Decreased in Virus-treated RPT(~. 
Mitochondrial calpain activity was evaluated in RPTC 111itochondria isolated ft-onl 
scralllble shRNA and calpain 10 shRNA-treated cells. The results reveal the 111aintenancc 
of III ito chon dria 1 calpain activity in scranlble shRNA-treated cells and a tinlc-dependcnt 
decrease in calpain activity in cells treated with calpain 10 shRNA (Fig. 3-2). These data 
veri fy the loss of calpain 10 seen in the nlitochondria of calpain 10 shRNA-infectcd cells. 
~lit()ch()ndrial Respiration is {inchanged in the Absence of Calpain 10. 
Basal and FCCP-uncoupled Q02 were nleasured in control. scranlble shRNA, and 
calpain lO-treated RPTC over the five day tinle course. The rates of Q02 under basal 
(Fig. 3-3,A) and unCOllp led (Fig. 3-3 B) conditions renlained unchanged bet\vccn each 
trcatnlent group over tinle. We suggest that the loss of calpain 10 docs not nlediate 
1l1itochondrial respiratory dysfunction under basal conditions. 
'Htochondrial l\;lernhrane Potential (A\I'Ill) Remains Unchanged After Calpain 10 
Knockdo·wn. 
As discussed above, reduction of calpain 10 levels had no significant effect on 
basal or uncoupled nlitochondrial Q02. We then nleasured the effects of cal pain 10 
knockdo\vn on nlitochondrial nlenlbrane potential. L1\lfm was assessed qualitatively on 
day 3 post-infection since nlitochondrial calpain 10 levels are undetectable at this til11(, 
point. JC -1 staining denlonstrated no significant differences in L1\lfJll between control, 
scranlblc shRNA, or calpain 10 shRNA-infected RPTC (Fig. 3-4). In contrast. RPTC 
uncoupled by a brief pretreatnlent with FCCP (1 0 ~lM) revealed signi ficant decreases in 
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1l1enlhrane potential. These data suggest that calpain 10-deficient RPTC nlitochondria 
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Figure 3-2. Mitochondrial calpain 10 activity . 
Mitochondrial calpain 10 activity was nleasured in whole RPTC nlitochondria in order to 
verify that decreases in calpain 10 protein levels were correlated with decreases in 
proteo lytic activity. Scranlble shRNA and calpain 10 shRNA-treated RPTC were 
subfractionated into cytosolic and Initochondrial fractions over a 5 day tinle course . 
Mitochondria were subsequently assayed for cal pain activity as described in the text. 
Data are expressed as nleans ± SEM (N=3). Means with different lettered subscript , 
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Figure 3-3. Decreases in calpain 10 expression have no effect on mitochondrial 
respiration. 
(A) ControL scranlble shRNA, and calpain 10 shRNA-treated RPTC were assayed for 
basal 111 itochondrial respiration over a 5 day til11e course. Basal respiration was nleasured 
a. desc ribed in the text in the absence ADP (B) Mitochondrial respiration was 
nleas ll red in the presence of 10 J.lM FCCP in controL scranlble shRNA, and calpain 10 
shRNA-treated RPTC over a 5 day til11e course. Data are expressed as l11eans ± SEM 
(N=4 ). 
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Figure 3-4. Decreases in calpain 1 () do not affect mitochondrial membrane 
potcn tia I. 
Mitochondrial 111CI11brane potential (L\\l/m) was nleasured in control. scranlble shRNA. and 
calpain 10 shRNA-trcated Rlyrc on day 3 post-infection. Day 3 \vas chosen for this tin1e 
point since 111itochondrial calpain 10 expression in virus-infected cells is below detectable 
levels at this tinle. Briefly. RPTC were incubated vvith 200 nM JC-l (a potel1tiol11ctric 
dye) for 20 111il1 prior to ilnaging. To serve as a positive controL one group of contrnl 
RPTC vvere treated with the nlitochondrial uncoupler FCCP (1 a ~LM) for 5 111in prior to 
JC-l loading. (Iells were then in1aged using a 20X objective on a confocal 111icroscopc 
(Zeiss LSM 5) cxciled at 488 nll1 and sct to silllultaneously dctect green cll1isS10ns (510-
525 11111) and l\.'d clllissions (590 nnl) channels using a dual band-pass t~lter. Results arc 















Calpain 10 j\;lcdiates Cellular ATP Levels. 
,As a final 111easure of nlitochondrial physiology, we 111easured cellular ATP levels 
in RPTC lacking calpain 10. Because RPTC are cultured in the presence of glutanline 
and absence of glucose, this culture 1110del enhances aerobic respiration and generates the 
nlajority of cellular A TP through nlitochondrial oxidative phosphorylation, sinlilar to ill 
)'ipo conditions (566). ATP levels \vere 111easured in control, scranlble shRNA., and 
calpain I () shRNA-infected cells over the five day till1e course. Cellular ,ATP levels 
renlained unchanged on days 1-3 following inoculation, but increased 2-fold in calpain 
10 shRNA-infccted RPTC on days 4 and 5 conlpared to control and scran1ble shRNA-
infected ce11s (Fig. 3-5A). 
Because knockdown of calpain 10 increased A TP levels in the absence of changes 
in cellular respiration or ~\IJlll' we exan1ined protein levels of the nlitochondrial ATP 
synthase f3 subunit of the Fl conlplex via in1111unoblot analysis. Our results revealed a 
tinle-dcpendent increase in A TP synthase ~ levels in nlitochondria frOll1 calpain 10 
shRN!\-trcatcd RPTC but not in control or scran1ble shRNA-infected cells (Fig. 3-58), 
suggesting one of 1\vo hypotheses; decreased proteolysis or enhanced synthesis of A TP 
synthase rL 
To evaluate the first hypothesis, RPTC cytosol fron1 each treatnlent group was 
probed for the cellular fuel sensor AMP-regulated kinase (AMPK). AMPK activation is 
known to induce the nuclear transcription factor NRF-l (567) which n1ediatcs 
transcription of respiratory subunits and of conlponents of the F [/Fo ATPase (568). 
shRN/\-inCcctcd cells by day 3 post-infection with no change in AMPK protein 
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expression in control or scran1ble shRNA-infected RPTC under basal conditions (Fig. 3-
6A). 
To address the second hypothesis~ we isolated rabbit RCM and treated theln 'Nith 
1 pM Ca 2-i ror up to 1 hour. [111111unoblot analysis for A TP synthase 0 revealed the Ca 2+-
dcpendcnt cleavage of this protein that was c0111pletely blocked by a 30 111i11 prctreatnlcnt 
with the calpain inhibitor calpeptin (1 0 ~lM) (Fig. 3-68). Our results suggest that calpai11 
10 helps to l11aintain cellular A TP levels under basal conditions and that 111itocho11drial 
calpain 10 111ay nlcdiate A TP dcpletion during conditions of cellular Ca2+ overload as 
obscrved during ischen1ia/reperfusion injury. 
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Figure 3-5. CaJpain 10 protein knockdown induces ATP synthesis. 
C~) Cellular ;\TP levels 'Nere nleasured in control. scralnble~ and virus-infected RPTe 
over a S day tinlC course. Data are expressed as nleans ± SEM (N=J). Means \vith 
di ffcrcnt lettered suhscri pts vvithin each group are significantly different f.'onl each other. 
p<O.OS. (B) Confluent RPTC were infected vvith either scranlhle or calpain 10-specific 
adenoviral shRN.A constructs. harvested over a 5 day tinle course. and subli'actionated 
into cytosolic and crude 111itochondrial fractions. Mitochondrial fractions \VCIT 
subsequcntly inlnlunoblotted for A TP synthase B protein expression. Equal 
nlitochondrial protein loading was verified by ilnnlunoblot analysis using an ex-Hsp60 
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Figure 3-6. Calpain 1 () modulates effectors of A TP synthesis under basal and 
stimulated conditions 
(A) Confluent RPTC were infected \vith either scrall1ble or caJpain 1 O-speci fie 
adenoviral shRNA constructs. harvested over a 5 day tinle course. and subfractionated 
into cytosolic and crude ll1itochondrial fractions. Cytosolic fractions \vere suhsequently 
illl1l1unoblotted for AMPK protein expression. Equal cytosolic protein loading \vas 
veri lied hy inlnlunohlot analysis using an a-GAPDH antibody. Results arc 
representative of three independent experinlents. (8) Isolated rabbit ReM \vere treated 
with I pM Ca2+ in the presence or absence of 1 0 ~lM calpeptin for 30 nlin or I hr. 
Subsequent inlll1unobiotting revealed the Ca2T-dependent and calpain-nlediated cleavage 
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+- A TP synthase ~ 
Degradation 
Products 
Calpain 10 Mediates RPTC Survival. 
Confluent cu1tures ofRPTC were exposed to scranlble shRNA orcalpain 10 
shRNA and cultures followed for five days. Each treatnlent group was evaluated by 
brightfield nlicroscopy for cellular nlorphology, DAPI staining for nuclear nlorphology, 
and caspase 3 activation. 8rightfield nlicroscopy revealed a loss of nlonolayer 
contluency on day 4 that increased on day 5 (Fig. 3-7). Monolayer confluency did not 
decrease in control nor scranlble shRNA-infected RPTC. Exan1ination of RPTC nuclear 
nlorphology revealed condensed nuclei in calpain 10 shRNA-infected cel1s beginning on 
day 1 (Fig. 3-8), renlaining constant on days 2 and 3, increasing on day 4 (25%), and 
decreasing on day 5 to the san1e level as that observed on days 1-3 (Fig. 3-1 OA). 
NUlllerous nuclear aggregates \vere also observed by day 5 in n1any of the calpain 10 
shRNA-infectcd cells (Fig. 3-8). Nuclear condensation was less than 5~/o in control and 
scranlble shRNA-infected cells (Fig. 3-1 OA). Day 5 cell cultures denl0nstrated extensive 
111ernbrane budding \vhich correlated with condensed nuclei inlaged via DAPI staining 
(Fig. 3-9). 
The condensed nuclear n10rphology in calpain 10 shRNA-infectcd cells resulted 
in the further investigation of RPTC calpain 10 deficiency-induced apoptosis. Using 
illllllunohlot analysis, 'we observed the appearance of cleaved procaspase 3 beginning on 
day 1 and rcn1ained present over days 2-5 (Fig. 3-108). No cleaved procaspase 3 was 
observed in control and scranlble shRNA-infected cells over the five day period. We 
suggest that RPTC calpain lOis required for cel1 viability and that the loss of calpain 1 () 
results in RPTC apoptosis. 
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Figure 3-7. Calpain 1 () mediates RPTC survival. 
Control RPTC and those infected with recoll1binant adenovirus expressing either calpain 
10 shRNJ\ or scranlble shRN.A. were inlaged over a 5 day tinle course using a brightfield 
111icroscope and 4X objective. Control and scranlble-infected RPTC denlonstrated 
l1orn1al renal epithelial nlorphology while virus-infected cells denlonstratcd an 
increasingly altered 111orphology by day 3 w'hich nlanifested itself as nlassive cell death 
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Figure J-S. D(Hvnregulation of calpain to induces nuclear condensation. 
Nuclei fro11l control RPTC and those infected \vith recon1binant adenovirus expressing 
either calpain 1 () shRNA or scralllhie shR.NA \vere in1aged via [)j-\PI staining over a 5 
day tinlC course. Visualization of D.API staining \vas perfornled using a Nikon TEJOO 
Eclipse Fluorescence 11licroscope (Nikon. Melville. NY) with excitation and el11issioll 
tilters of 350 a11d 486 11111. respectively. Control and scranlble-infected RPTe 
dCI110nstrated a nor111al nuclear nl0rphology while virus-infected cells denlonstrated 
condensed nuclei by the first day of treatnlent which increased over the 5 day course. 














Figure 3-9. Membrane blebbing correlates to RPTC nuclear condensation in the 
absence of calpain 10. 
Shown above, calpain 10 shRNA-treated cells were imaged by brightfield microscopy 
and subsequently imaged via DAPI staining at a lOX magnification on day 5 post-
infection. As can be seen, numerous RPTC have died and detached from the plate while 
many are in the process of dying. There are numerous plasma membrane 'blebs' which 
seem to be associated with corresponding condensed nuclei in the above DAPI-stained 
section. Results are representative of three independent experiments. 
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Figure 3-10. Calpain 10 knockdo,vn induces caspase-dependent apoptosis in IlP'TC'. 
(A) Nuclei frol11 control H..PTe and those infected \vith recol11binant adcno\'irll~ 
expressing either calpain 10 shRNA or scranlble shRNA were inlaged via I)API staining 
over a 5 cia:' tinle course. Condensed nuclei fronl 10 high powered fields \verc counted 
for each treatnlent group. Data are expressed as nleans ± SEM (N=3). Means \",jtll 
different lettered subscripts \vithin each group are significantly different fronl each other. 
/J<.O.05. (B) Cytoso]ic fractions fronl control. scranlble~ and virus-infected RPTC \\Tre 
probed for total and active caspase 3 to confirnl caspase-dependent apoptosis. Virus-
infected cells denlonstrated the cleavage of procaspase 3 while control and scranlble-
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DISCUSSION 
Calpains are ubiquitously expressed throughout eukaryotic organisn1s fron1 
prin1itive single-celled parasites up through ll1an1n1als and are involved in nUll1erous 
physiological processes (245). Manl111als contain 8 ubiquitously expressed calpains 
(calpains 1, 2, 4, 5, 7, 10, 12, and 13), whereas calpains 3, 6, 8, 9, and 11 have n10re 
tissue-specific distributions (539), suggesting a highly c0111plex and diverse set of roles 
for these cnzynlcs. Unfortunately, the specific physiological and pathological roles for 
calpains and the individual isoforn1s responsible for known calpain functions have not 
been con1pletcly elucidated. While calpains are thought to be cytosolic proteins, 
investigators have reported calpain-like activities in isolated nlitochondria (230,231,233, 
40S, 512,513,527) and in two cases have actually identified specific isoforn1s localized 
to the 1l1itochondria (calpain 1) (232) as well as to Golgi and ER nlenlbranes (calpains 1 
and 2) (52()). Sill1ilarly our laboratory has previously identified an endogenous 
n1itochondrial calpain as calpain 10 and have inlplicated it in Ca2+ -induced 111itochondrial 
dysl'unctioll, In thc present study, we have taken a 11101ecular approach using adenoviral-
nlediatcd shRNA to knock do\t\fn calpain 10 protein expression in a prinlary rabbit renal 
proxil11al tubule ccll1ine in order to elucidate the physiological roles for ll1itochondrial 
calpain 10. 
Using an adenoviral delivery systenl, we were able to introduce calpain 10 
shRNA. into prinlary rabbit RPTC'. Calpain 10 protein expression was decreased belo\v 
detectable levels In 1111tochondria1 fractions 3 days after infection whereas cytosolic 
calpain 10 levels \vere decreased to ~20~/o of control levels by day 5. These results 
suggest di fTcrcntial rates of calpain 10 degradation between the two conlpartn1cnts. The 
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rate eli ffcrcnces seen between n1itochondrial and cytosolic calpain 10 n1ay be due to the 
increased oxidative stress experienced by n1itochondrial proteins in general. For 
exan1ple, it is 'Nell known that oxidized cytosolic proteins are degraded nluch faster than 
their non-ox idized counterparts (569). Also~ since nlitochondria obtain virtually alIa f 
their protein conlponents fronl nuclear encoded genes, it would make sense for this 
organelle to n1aintain a higher protein tun10ver rate. 
Our laboratory has previously identified nlitochondrial calpain 10 as a ('a2'._ 
sensitive n1itochondrial protease which plays a substantial role in Ca~+ -induced 
respiratory dysfunction. However, we also sought to detenlline the basal physiological 
roles for n1itochondrial calpain 10. In the present study, we were able to den10nstratc that 
calpain 1 O-deficient RPTC nlitochondria respire at control levels and are sufficiently 
coupled and energized (Fig. 3-3 and 3-4). Interestingly, however, upon nleasurenlent 0 r 
cellular A,TP levels, we observed a two-fold increase by days 4 and 5 after infection. 'vVe 
latcr detenllined that nlitochondrial ATP synthase ~ levels were increased in calpain 10-
deficient RPTC, indicating a role for calpain lOin the upregulation or degradation A TP 
synthase f). 
Subsequent analysis revealed that calpain 1 O-deficient RPTC delllonstrated 
elevated AMPK levels, a central player in the regulation of cellular ATP levels.AMPK 
acts as a cellular fuel sensor ~rhich n10nitors AMP:ATP ratios (570). During periods ~)f 
energy depletion, AMPK activates nuclear respiratory factors 1 (NRF-1) leading 10 
enhanced transcription of nuclear-encoded respiratory subunits, as well as subunits of the 
Fl/Fo ATPase of the oxidative phosphorylation systenl (567, 568). We believe that 
AMPK n1ay be a proteolytic substrate for calpain 10 whose levels and activity increase in 
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the absence of calpain 10. In facC recent evidence fro111 Otani el al n1ay support this 
clain1, as they found that chronic calpain inhibition increased total and phosphorylated 
AMPK levels in n1urine 111yocytes (506). However, future work is necessary to evaluate 
the activation status of AMPK and its downstrean1 targets. In addition, we also \\lcre able 
to den10nstrate that the A TP synthase r) subunit is a Ca2+ -dependent proteolytic target lor 
Initochondrial calpain 10, suggesting a ll1echanisn1 for the severe ATP depletion seen 
during acute renal failure (571) and ischen1ic dan1age in other organ systen1s (572,573). 
During the course of our studies, \\le noticed a significant decrease in cell survival 
over the 5 day viral treatn1ent which often reduced total cell nU111bers to 60-70% of 
control. Caspase-dependent apoptotic cell death was confirnled by in11l1Unoblot analysis 
and via nuclear Di\PI staining which showed significantly increased levels of highly 
condensed nuclei. \Vhile the n1echanisn1 of calpain 1 O"s involven1ent in caspase-
n1cdiated apoptosis has not been elucidated, it is quite clear that calpain 10 plays a pivotal 
role in 111aintaining RPTC cell survival since infection with scran1ble shRNA adenovirus 
docs not induce apoptosis. 
One attractive n1echanisnl linking calpain 10 to apoptosis could be through 
regulation of the IKB-a/NF-KB pathway. NF-KB is a transcription factor responsible for 
the induction OfnUl11erOUS gene fan1ilies, n10st notably genes involved in the 
inllanllllatory respollse and those regulating cell survival (477). Under nornlal conditio1ls 
IK8-[( is found bound to NF-KB and n1asks the nuclear translocation signal of the p()5 
subunit ofNF-KB. Upon activation, IKB-a is degraded, allowing p65 to translocatc to the 
nucleus and induce gene transcription (574). In fact, both calpains 1 and 3 have 
dClllonstratcd their ability to cleave IkB-a (422,477,574) and thereby regulate cell 
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survival. Calpai11 3 plays such as critical role in this pathway, that 111utations in C'/lPN3 
result in enhanced n1Yocytc apoptosis~ n1uscle degerneration~ and the clinical entity 
kno\vn as lin1h girdle n1uscular dystrophy type 2,t\ (477). It is therefore conceivable that 
calpain 10 n1ay regulate cell survival through the IKB-O,/NF-KB pathway in renal 
proxin1aI tubules. Prelin1inary data fron1 our laboratory has recently shown that total and 
phospho-AId protein levels are decreased in calpain 1 O-deficient RPTC. This n1ay tic in 
to the above-n1cntioned pathway since Akt has been shown to activate the IKB-a/NF-KB 
path\vay and pron10te cell survival (575). An alternative ll1echanisn1 for the apoptosis 
seen in calpain 1 O-deficient RPTC n1ight be through decreased cleavage of a rnell1ber or 
the Bcl-2 fan1ily of proteins such as Bax or Bid, t\VO proapoptotic proteins previoLlsly 
shown to be typical calpain substrates (10, 560). More work is needed to elucidate these 
possible n1cchanisn1s. 
]n SUn1111ary~ \ve have sho\\/n that calpain 10 plays an inlportant role in 
n1aintaining cellular A TP levels under basal conditions and that it nlay serve a 
pathological role by decreasing A TP synthesis under conditions of Ca2+ overload. We 
have also den10nstrated that renal calpain 10 nlay playa significant role in renal cel1 
viability \vhich could have broad in1plications for disease states such as acute renal 
f~lil11re or renal cell carcinOn1'1. To date, the 11101ecular biology of calpain 10 has been 
linked to ryanodine-induced apoptosis~ GLlJT4 vesicle translocation, pancreatic beta-cell 
cxocytosis, cataractogenesis, hypertriglyceridell1ia, and is genetically linked to Type II 
diabetes, a disease associated \vith ll1itochondrial dysfunction (253, 481 ~ 486, 494, 502. 
559). We believe that calpain 10 n1ay also serve to help regulate not only cellular /\ TP 
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levels under basal and injurious cOllditiollS~ but 111ay also playa lTIOre global role as a 
crucial cell survival 111olecule. 
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CHAPTER 4 
DUAL TARGETING OF THE MOLECULAR CHAPERONE OX~'GEN­
REGULATED PROTEIN 150 (ORP150) TO ER AND MITOCHONDRIf\ 
ABSTRACT 
Oxygen-regulated protein 150 (ORP 150) is an inducible endoplaslTlic reticulu1l1 
(ER) chaperone nlolecule that is up-regulated after nUlnerous cellular insults and has a 
cytoprotective role in renal~ neural, and cardiac nlodels of ischenlia/reperfusion inj ury. 
ORP 150 has also been sho\vn to playa role in lnaintaining cellular calciun1 hOll1costasis. 
and in turn, regulating calpain activity. In this study, we identified ORP150 in whole rat 
renal cortical nlitochondria and nlatrix fractions, have denlonstrated the targeting of an 
ORP150-GFP construct to the n1itochondria ofNIH-3T3 cells, and have show'n that the 
N-tcrn1inaJ 13 an11no acids of ORP 150 are sufficient for this translocation. ORP 150 
expression vv'as found to be regulated by the CHOP/GADD 153 transcription factor and 
ORP 150 levels increased in the nlitochondria and ER of COS- 7 cells after diverse 
stresses including hypoxia, serunl starvation, prolyl hydroxylase inhibition 
(din1cthyloxaloylglycine), and exposure to tunicanlycin, ethidiu1l1 bronlidc, and 2-
dcoxyglucose. Induction of the nlitochondrial specific stress response in COS-7 cells 
through expression of an ornithine transcarbanlylase nlutant (~OTC) induced 
n1itochondrial ORP ISO levels and calpain activity. To deternline 'vvhether nlitochondrial 
ORP 150 and calpain 10 interact, rat cortical ll1itochondria exposed to calciul11 resulted in 
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ORP 150 cleavage in a calpain-inhibitor dependent 111anner revealing that calpain 10 
regu lates ORP 150 levels. These data denlonstrate a novel cellular localization for 
ORP 150 and that nlitochondrial ORP 150 is up-regulated by CHOP/GADD 153 in 
response to nlitochondrial and ER stress. Our data also suggest that ORP 150 is a 
substrate for nlitochondrial calpain 10 and that ORP 150 111ay play an inlportant role in 
preserving nlitochondrial function after cell stress. 
INTRODUCTION 
Oxygen-regulated protein 150 (ORP 150) was first identified and described in 
I 99() by Ku\vabara (!f ([/ as a hypoxia-inducible protein expressed in cultured rat 
astrocytes (576). Since then, ORP150 has been reported to be a stress-inducible 
chaperone 1110lecule reported to be localized to the endoplasnlic reticululll in nunlerous 
cell types (576-579). It is a 999 anlino acid protein with both a signal peptide and an ER 
retention-like signal at the N- and C-ternlini, respectively. There are three predicted 
translation products arising fronl three separate transcription start sites defined by the 
presence or absence of stress signals such as hypoxia or ER stress (580), ORP 150 has a 
91 (X) sequence identity to the Chinese hanlster 170 kDa glucose-regulated protein 
(GRP 170) and displays a high degree of sinlilarity to the ATPase donlain of the HSP70 
fanlily of proteins, suggesting the ability to bind ATP (580). Up-regulation of OR PI 50 
has been observed following hypoxia, serunl starvation, ischenlia, in cancer. and 
following treatnlent with tunicanlycin or 2-deoxyglucose (577,578,581-589). 
The functions of ORP 150 have not been fully elucidated, but it appears to playa 
role in apoptosis (577,578,582-585,587,588,590,591), insulin secretion (592, 593), 
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and protein transport as delnonstrated by previous studies in nlacrophages and wound 
healing (594,595), tunlor cells at the nlargin of the vascularized zone (589), and in 
cultured MOCK cells (581). Much of what is known about ORP150 conles fron1 studies 
uti I izing antisense, adenovirus-n1ediated, or whole anin1al knockdown of protein 
expression (577, 582, 584). These studies have shown the in1portance of ORP 150 in 
protecting cells fron1 ischenlia/reperfusion injury in neural, cardiac, and renal in vivo 
1110dels (577, 582, 583). Sin1ilarly, ORP150 has been shown to provide anti-apoptotic 
signals in neuronal cell n10dels (584,587,588,590,591) and in a variety of cancers such 
as prostate (586), breast (589), and bladder cancer (596,597) as well as inlproving the 
l11ctastatic potential of these tunlor lines (598). 
Recently, ORP150 has been shown to be cytoprotective to the renal tubular 
epitheliun1 after ischenlia/reperfusion injury (582). In particular, the authors 
den10nstrated enhanced renal protection in transgenic nllce overexpressing ORP 150 and 
increased renal injury in heterozygous ORP150+i - 111ice (582). The transgenic nlice and 
M DCK cells exposed to hypoxic conditions in this study denlonstrated decreased caspasc 
3 activation. Sinlilarly, the sanle investigators showed a protective role for ORP 150 after 
nlyocardial inf~lrction in the rat heart (577). Rat hearts infected with adenovirus 
expressing ORP 150 exhibited a blunting of calciun1 release, cellular calpain activity, 
cytochronle c release, and caspase 3 activation. The authors suggested that the a11ti-
apoptotic c ffeets of ORP 150 \vere upstrean1 of cytochroll1e c release and caspase 
activation, and that it nlay be tied to the regulation of ER calciull1 stores and the 
subsequent activation of the nlitochondria-nlediated apoptotic pathway. 
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Molecular chaperones are proteins which interact with unfolded or dan1aged 
polypeptides. These interactions serve to stabilize and protect bound proteins fron1 
denaturation and protein aggregation (599). Misfolded and aggregated proteins are often 
signals for dov/nstrcan1 transcriptional events and frequently signal apoptosis through the 
ER-n1ediated unfolded protein response, (UPR) (600). Molecular chaperones, often 
referred to as heat shock proteins, can be found in nUlnerous cellular conlpartnlents 
including the cytosol, ER, and n1itochondria (600). Mitochondrial chaperones can be 
divided into various classes depending on their function and include the Hsp70, 
Cochapcrone (OnaJ type), Cochaperone (GrpE type), Hsp60, Hsp 1 OO/Clp, and 
cyclophilin classes. These 11101ecules participate in pre-protein translocation, protein 
folding, stress protection, protein and protein conlplex assen1bly, FeS cluster biogenesis, 
thern10tolerance, and peptidyl-proline-isonlerization (601). Recently, Zhao et al have 
described what is known as the nlitochondrial stress response (MSR), which is 
responsible for the induction ofnu1l1erous n1itochondrial-specific chaperone 1110lecules 
including HspC10, n1tOna.1, Cpn60, and l~pn 10 folloyving n1itochondrial injury (602). 
Upregulation of n1itochondrial chaperones serves to protect nlitochondrial function by 
facilitating the folding, repair, and proper assenlbly of vital nletabolic enzynlcs critical 
for ATP production and organellar integrity (603). 
In the present study, \ve hypothesized that the localization and chaperoning 
functions ofC)RP150 111ay not be linlited to the endoplas1l1ic reticulunl, but ll1ay also 
reside in the nlitochondria. The nlitochondriallocalization of ORP 150 would provide 
n1Llch needed insight into the anti-apoptotic activities of this n10lecule observed in varioLis 
ill \'ilro and ill ph'o n10dels. The preservation of 111itochondrial energy production due to 
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chaperolle acti vity could also help explain the potent protection observed during vvhole 
organ ischen1ia/reperfusion injury. 
l\lA'TERLL\LS AND lVIETHODS 
Isolation of ER~ l\1itochondria, and Mitochondrial Subfractions. 
Kidney n1itochondria \vere isolated fro111 111ale Sprague Dawley rats (250 g) (162). 
Briefly~ kidney cortex was n1inced and h01110genized in Buffer A (0.27 M sucrosc, 5 n1M 
Tris-HCl, 1 n1M EGTA, pH 7.4). Nuclei a11d cellular debris were pelleted by 
centri fugation at 600 x g for 5 111in. The supell1atant was centri fuged at 7700 x g for 5 
n1in rcsulting in a crude 111itochondrial pellet. The pellet was washed once in 0.27 M 
Sllcrose and resuspended in Buffer B (130 111M KCl, 9 111M Tris-P04, 4 111M Tris-Hel, 1 
n1M EGT A, pH 7.4). Crude 111itochondria were then layered onto a sucrose/Percoll 
gradient and centrifuged at 20,000 x g for 20 n1i11. Endoplas111ic reticulu111 fractions were 
purified by ultracentrifugation ofcytosolic fractions at 54,000 x g for 1 hr. 
Purified 111itochondria were subfractio11ated as described previously (532). Outer 
1l1Clllbrane rupture was achieved by hypotonic lysis in Buffer C (10 111M KH 2P04, pH 
7.4) for 20 111in at 4°C. Mitoplasts were separated fron1 the supernatant by centrifugation 
at 7,700 x g for 5 n1in. The resulting pellet was resuspended in Buffer 0 (300 111M 
sucrose, 1 n1M EGTA, 20 n1M MOPS, pH 7.4) and sonicated five ti111es in 30 s bursts. 
Inner 11len1brane and n1atrix fractions were then separated by centrifugation at 54,000 x g 
for 30 n1in. Matrix fractions were frozen at -70°C for subsequent i111111unoblot analysis. 
Inlillunobiotting. 
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Isolated n1itochondria and subfi~actions were subjected to SDS/PAGE (4-12 (~) 
acrylalllide) and transferred to nitrocellulose nlenlbranes. Melnbranes were incubated 
vvith prilllary antibodies to GRP 1 70 (han1ster glucose regulated protein 1 70, polyclonal 
rabbit anti-hanlster GRP170 -~ 1 :1(000), a generous gift fron1 Dr. John Subjeck 
(Departn1cnt of Medicine, Inlll1unology, Cellular Stress Biology, and Urologic Oncology, 
Ros\vcll Park Cancer Institute, Buffalo, NY). This antibody has been used by other 
investigators to detect ORP150 due to the 91 % protein identity between GRP170 and 
ORP150 (604). The prinlary antibodies used were polyclonal rabbit anti-hanlster 
GRP 170 (1 : 1 00(0) rabbit-anti-calpain 10 (Biogenesis ~ 1 : 1 000), ~-actin (Signla --
1: 1 (00), and n10use nlonoclonal anti-CHOP (Alexis Biochenlicals -- 1: 1 000). Prill1ary 
antibody incubation was followed by a horseradish peroxidase-conjugated goat anti-
rabbit or goat anti-1l10USe secondary antibody (Santa Cruz - 1 : 1 000) incubation. 
Inllllllllorcactive protein was visualized by enhanced chelnilun1inesence (Anlershanl) and 
in1aged using an Alpha Innotech i1l1aging station. 
Plaslnid (:ollstrnctioll. 
eDNA for hU1l1an ORP150 (8C072436) \vas obtained fron1 ATCC in the pCMV-
SPORT6 shuttle vector. Full length ORP150 was anlplified by peR (Sense: 5'-
TGGGAG(~CCGCGGAGCCGAG-3', Antisense: 5'-
TC A TC ACTGCC A TGACGGAGACCTC -3 ') and subcloned into pcDNA3 .1-TOPO-TA-
CT -GFP (pcDNA3.1-0RP 150-GFP) (Invitrogen) producing an ORP150-GFP fusion 
product (C -ternlinal GFP). GFP control plaS1l1ids coding for cytosolic GFP and 
n1itochondrially targeted GFP (cytochrollle oxidase IV signal sequence) \vere generous 
gi fls fro111 Dr. Douglas Sweet (Medical University of South Carolina, Charleston, SC). 
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C0111plcnlentary DNA sequences coding for the N-tenl1inal 13 anlino acids or 
ORP 150 were generated, annealed, and ligated into pcDNA3.1-TOPO-T A-C'T-GFP 
(pcDNA3.l-TS-GFP) to asses N-tenninal sufficiency for nlitochondrial targeting. The 
negative control for this experin1ent was obtained via ligation of the above sequence into 
pcDNA3.1- TOPO-T A-CT -GFP (pcDNA3.1-TSINV -GFP) in the reverse orientation. 
Cell Culture and Transfection. 
NIH-3T3 fibroblasts were 111aintained in Dulbecco's Modified Essential Mediun1 
(DMEM) containing 10% fetal bovine serun1 until confluent. Cells were split and plated 
onto 35-111n1 confocal dishes (MatTek) at a density of 250,000 cells/plate. At 70°/c) 
connucnce~ cclls were transiently transfected with 4 ~lg pcDNA3.1-0RPlSO-GFP. 
pcDNA3.1-TS-GFP, or pcDNA3.1-TSINV -GFP plas111id constructs using Lipofectall1inc 
2000 (Invitrogen). Cells were incubated for 24 hr and, when indicated, exposed to 50 
nfVl M itoTracker Red (Molecular Probes) for 20 n1in prior to confocallnicroscopy 
iIl1aging. Cells \vere inlaged using a Zeiss LSM 5 confocal n1icroscope. 
Induction of lVIitochondrial Stress. 
('OS-7 cells were nlaintained in Dulbecco's Modified Essential MediuIl1 
(L)f\1EI'v1) containing IO°Ic) fetal bovine serun1. At 70% confluence, cells were treated 
\vith various concentrations of ethidiull1 bronlide for 7 days in order to disrupt the 
n1itochondrial genon1e, as previously described (605, 606). ORP150 expression \\'as 
subsequently detcrl11ined by inlnlunoblot analysis. 
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!'vlitochondrial stress was also initiated via induction of the 111itochondrial stress 
response (MSR). COS-7 cells \vere transiently transfected with 4 ~lg pC AGGS-vector 
only control, pC AGGS-OTC, or pCAGGS-~OTC plasnlid constructs using 
Lipofectanline 2000 (plasnlid constructs were a generoLls gift fronl Dr. Nicholas 
Hoogcnraad, La Trobc University, Melbourne, AU). The 11litochondrial expression of the 
aTe and ~-OTC protein products was nlonitored by inl1l1Ulloblot analysis 36 hours a11cr 
transfection. Induction of the (MSR) was validated by i1l1111Unoblot analysis of the 
nlitochondrial chaperone Hsp60 and the stress-induced transcription factor 
CHOP/GADD153. 
COS-7 cells were also challenged with various chel11ical stressors to elucidate the 
inducible nature of ORP150. Cells were treated with tuniCa1l1ycin (1 0 ~lg/nlL), 2-
dcoxyglucose ( 10 nlM), or the prolyl hydroxylase inhibitors dinlethyloxalyl-glycin 
(DMOG) (250 ~lM) or ethyl-3,4-dihydroxybenzoate (EDHB) (500 ~lM) for 24 hours. 
Select cultures were also grown in serulTI-free 111edia or under hypoxia for a period of24 
hours. Expression of ORP150 \vas subsequently evaluated by il11n1unoblot. 
Electrophoretic !\lohility Shift Assays. 
Conlplinlentary oligonucleotides enconlpassing the CHOP binding sequence \vcrc 
synthesized (\\;'i Id type, 5' -CTCGGCTCACTGC AACCTCCCTGCCTGA TT -3', and 
con1pl in1cntary strand~ nlutant, 5' -CTCGGCTCACTGTCGCCTCCCTGCCTGA TT -3', 
and conlplinlentary strand). All duplex oligonucleotides were annealed by con1bining 
then1 in a 1: 1 1110lar ratio in 10 111M Tris-HCI pH 7.5, 1 n1M EDT A, 50 nlM KCL heating 
to 100°C for 5 1111n and cooling to roonl tenlperature. The 5' ends of the annealed 
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oligonucleotides were phosphorylated with [y}2 pJ ATP using polynucleotide kinase and 
purified by passage through NuTrap Probe purification colull1ns (Stratagene). A 20,000 
C.p.lll. aliquot of the probe \\'as incubated for 30 n1i11 at 2SoC with an aliquot ofC()S-7 
nuclear extract containing 1 0 ~lg of protein and 2 ~lg of dI-dC (Pharn1acia) in 40/0 vi\' 
glycerol. :2 111M MgCI~, 0.5 111M EDT A, O.S 111M dithiothreitol, SO 111M NaCI, 10 111M 
Tris-HCI pH 9.0, and 300 ~lg/n11 BSA in a total volun1e of 20 ~L1. The reaction n1ixtures 
\\'cre resolved by electrophoresis on a SOlo polyacrylan1ide gel and dried gels analyzed by 
phosphorin1aging. Antibody con1petition assays used 111011oclona1 antibodies against 
CHOP (Alexis Biochcn1icals) or controln10noclo11a1 anti-~-actin (Sign1a) (2 ~lg) 'Nhich 
\verc incubated for 30 ll11n on icc with the nuclear extracts before the addition of the 
labeled oligonucleotides. 
()RP 150 Degradation. 
The scnsitivity of ORP ISO to calpain 1 0-n1ediated cleavage was detern1ined using 
isolated rat renal cortical ll1itochondria. Briefly, isolated rat re11aln1itochondria \vere 
incubated \vith Ca~-+- (1 ~lM final sustained Ca2-+- concentration) for S ll1in at roon1 
tCl11pcraturc in the presence and absence of 10 pM calpeptin. ORPlS0 degradation \vas 
subsequently evaluatcd by in1n1unoblot analysis. 
Calpain Activity. 
C'alpain activity was assayed spectrophoton1etrically using the calpain-speei fie 
substrate S L LV '( -AM C (Bachen1), as previously described (292). Mitochondrial extracts 
(200 ~lg) \vere diluted in Buffer B and incubated with 10 n1M eaCh (to ensure nlaxill1al 
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calpain activation) in the presence of 50 ~lM SLLVY-AMC. Activity was n1easured 
under linear conditions as a function of AMC hydrolysis using excitation and en1ission 
wavelengths of 355 and 444 nn1, respectively. The fluorescence of n1itochondria 
incubated in the absence of substrate \vas equivalent to Buffer B alone. 
RESULTS 
()RP150 is Dually Targeted to the ER and Mitochondria. 
Evaluation of the N-tern1illus of OR PI 50 revealed an enrichn1ent in positively-
charged residues indicative of classical n1itochondrial targeting signals. The protein 
localization algorithn1 MITOP2 (http://ihg.gsf.de/n1itop2/starLjsp) was used to further 
evaluate the possibility that ORP 150 11lay be a ll1itochondrial protein and returned a 
probability score of 54(/0. Endoplasn1ic reticulu111 and 111itochondrial fractions fro111 rat 
kidney cortex \vere probed for ORP 150 using a prin1ary antibody against the han1ster 
glucose regulated protein 170 (GRP170) (A generous gift fron1 Dr. John Subjeck). This 
antibody has been used by other investigators for in1lTIUnodetection of ORP 150 because 
orthe high degree ofsequellce identity between the two proteins (910/0) (604). 
In1nlunoblot analysis revealed the presence of ORP150 in ER, 11litocho11dria, and the 
n1itochondrial 11latrix fraction (Fig. 4-1 ). 
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Figure 4-1. Localization of ORP150 to the ER and Mitochondria. 
The subcellu lar localization of ORP 150 was assessed by inlll1unoblotting. Tissue fron1 
rat renal cortex was isolated and separated into nlitochondrial and ER fractions by 
differential centrifugation. Equal amounts of protein frol11 ER, whole Initochondri a~ and 
11litochondrial lll atr ix was resolved by SDS-PAGE and probed with antibodies against 
GI~P 170 (ORP 150 honlolog) . Results are representative of three individual experinlents. 
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()I{P150 is Targeted to Mitochondria Via an N-terminal Targeting Peptide. 
Hun1an ORP150 was subcloned into a TOPO-TA-CT-GFP vector (Invitrogen) to 
produce an ()RP ISO-GFP fusion protein containing an intact N-tell11inus and a C-
terJllinal GFP n10iety. This construct was chosen to avoid 1110dification of the N-ternlinus 
vvhich nlay result in the loss of putative n1itochondriallocalization n10tifs. NIH-3T3 cells 
\vcrc transCected vvith the pcDNA3.1-0RP1S0-GFP construct for 24 hr, exposed to 
MitoTracker Red (20 111in), and in1aged via confocal 111icroscopy. Cells also \vere 
translceted using GFP constructs speei fie for cytosol (data not shown) or n1itochondria 
(Fig. 4-2A) to serve as positive GFP controls for these con1partn1ents. The transfection 
expcrinlents revealed that the ORP1S0-GFP construct is localized to n1itoehondria oC 
NIH-3T3 cells (Fig. 4-28). The presence ofORP1S0 in the n1itocho11dria and its relative 
absence in the rest of the eell supports the idea that the GFP 1110iety on the C -tenninlls 
1l1asks the ER retention signal (KNDEL) and distupts the norn1al ER-targeting of this 
protein. 
To test the hypothesis that the N-tell11inus of OR PI SO is responsible for its 
1l1itochondriallocalization, oligonucleotides coding for the first 13 N-ternlinal an1ino acid 
residues \vere annealed a11d ligated into the TOPO-TA-CT-GFP vector. Negative 
controls included the sa111e oligos inserted in the reverse orientation. NIH-3T3 cells 
transfeeted \vith these constructs displayed eytosolic targeting and lnitochondrial 
targeting for the reverse and forward orientations, respectively (Fig. 4-3A). These results 
reveal that the N-tcrnlinal 13 an1i110 acids of ORP 150 are sufficient for n1itocholldrial 
targeting. 'A/e also analyzed the N-tell11inus of ORP ISO using a helical \vheel applet 
OH!.12:/~~y_~~~12igin f'o.on!..cll/lectures/index- 7.htnll) designed to display peptide sequences 
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in an alpha helix representation (Fig. 4-38). The results revealed that the N-tcrnlinus of 




Figure 4-2. ORP150 translocates to the mitochondria .. 
The localization of ORP150 was confirmed by colocalization of ORP150-GFP and the 
mitochondrial-specific dye MitoTracker Red. NIH-3T3 fibroblasts were used for 
localization experiments because of their distinct elongated mitochondrial morphology. 
(A) Cells were transfected with a control mitochondrially targeted green fluorescent 
protein (Mito-GFP) construct and subsequently stained with MitoTracker Red. (B) Cells 
were transfected with pcDNA3.1-0RP150-GFP, and subsequently stained with 
Mito Tracker Red. Results are representative of three independent experiments. 
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Figure 4-3. The N-tcrminus of ORP150 is required for mitochondrial targeting. 
(A) NIH-3T3 fibroblasts \vere transfected with the pcDNA3.1-TS-(}FP and pcDNA3.1-
TSINV -(JFP constructs. pcDNA3.1-TS-GFP-transfected cells were subsequently stained 
\vith Mito·rracker Red. Results are representative of three independent experinlents. (B) 
This hel ical vv:hcel diagranl shows a representation of the ORP 150 N -tern1inus as if it 
\vere a helix. The putative helix is an1phipathic in nature~ containing hydrophobic and 
aliphatic residues on one half and positively-charged residues on the other. Adjacent to 
the helical \vheel diagran1 is a schen1atic representation of the N -terminal 13 an1ino acids 
used to engineer the targeting sequence-GFP construct (asterisks denote positivel) 
charged residues). This helical wheel was generated using an applet found at 
http://\v\v\v.bioinfo.org.cn/lectures/index-7.htn11. 
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()RP150 Expression is Increased After Mitochondrial Stress. 
ORP ISO is a chaperone nl0lecule best kno\\/n for its induction in the ER under 
hypoxic conditions (S76). Given its presence in the nlitochondria, \VC sought to 
deternline if this stress-responsive nl0lecule would also be induced in nlitochondria under 
various cellular insults/stresses. First, we induced cellular stress using ethidiun1 brOlllidc 
treatnlent because this treatn1ent has been shown to disturb nlitochondrial function by 
decreasi ng n1 itochondrial gene transcription (608). COS-7 cells were treated \vith variolls 
concentrations of ethidiu111 bronlide for a period of 7 days. ORP ISO expression \\/as 
found to increase in the presence of ethidiunl bronlide in a dose-dependent nlanner (Fig. 
4-4 ). 
Subsequently, 'Ne chose to induce what is known as the nlitochondrial stress 
response, or MSR, as described by Hoogenraad et al (602). The MSR is induced via 
transfection of cells \\'ith a n1utant fornl of ornithine transcarbanlylase (OTC"), a protein 
norn1ally expressed in liver nlitochondria. The n1utant fonll ofOTe is incapable of 
folding correctly after nlitochondrial in1port and induces the expression of nlitochondria-
speci tic chaperone 1110lecules such as Hsp60, chaperonin 10, chaperonin 60, and n1tDna.l 
(60.2). C'OS-7 cells \vcrc transiently transfected \\'ith wild type OTC, nlutant ~OTC, and 
vector only expression vectors for 36 hr. Protein expression was verified by inl1l1Ul1oblot 
analysis. and dcnlonstrated nlature and processed wild type and nlutant OTC in the 
111itochondria (Fig. 4-5A). Induction of known MSR proteins (Hsp60 and 
('HOP/(JADDlS3) in the flOTC-treated cells was evaluated by inllTIunoblot analysis 
(Fig. 4-58). Finally. the expression of OR PI 50 was evaluated under the sanlC conditions 
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and \vas found to be increased in both the nlitochondrial and ER fractions of L\OTC-
treated cel)s (Fig. 4-5C). 
These results reveal that two different nlitochondrial stresses result in ORP150 
induction. It should also be noted that the L10TC-ll1cdiated increases in ORP 150 
expression \vas not confined to the nlitochondria~ but also increased in the ER. This 
effect is 1110st likely due to conlpeting signals for subcellular localization, whereby 
sinli lar anl011nts of protein are trafficked to both the ll1itochondria and ER. 
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Figure 4-4. Chronic ethidium bromide treatment induces expression of ORPl 50. 
The effect of chronic ethidiunl bronlide treatlnent and ORP 150 expression was evaluated 
in COS-7 cells. COS-7 kidney fibroblasts were treated with increasing concentrations (0. 
0.1. 0.4. and 1.5 ~lghnl) of ethidium bromide for a period of 7 days. Mitochondrial 
fract ions were iso lated and subjected to SDS-PAGE analysis and probed for the 
expression of ORP 150 using pril11ary antibodies against ORP 170. Results are 
representative of three independent experinlents. 
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Figure 4-5. The mitochondrial MSR induces expression of ORP150. 
OTC AOT C 
~OTe 
The n1itochondrial stress response (MSR) can be induced via nlitochondrial expression of 
a nlutated forn1 of ornithine transcarbanlylase (~OTC). ~OTC form s insoluble protein 
aggregates once inside the l11itochondria and induces the expression of nun1erous 
nli tochondrial-spec ific chaperone nlolecules. (A) Diagral11111atic representation of the 
wil d type OTe and deletion nlutant (~OTC) frol11 which the carbamyl phosphate-bindi ng 
donlain (an1ino acids 30-114) have been deleted. (B) Transient expression of wild type 
()TC and ~OTC in n1itochondrial extracts of COS-7 cells. The p- and n1- proteins 
represent precursor and signal peptide-cleaved n1ature forn1s of both OTC and ~OTC. 
(C) Induction of MSR was validated by western blotting. Hsp60 and CHOP protein 
leve ls w"ere increased significantly in ~OTC-transfected COS -7 cell s. (D) Effects of the 
MSR on ORP150 expression was evaluated by western blotting. ORP150 protein level s 
were significantly elevated in ~OTC-transfected COS-7 cells. Results are representati vc 
of three independent experinlents. 
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()RP 150 Expression is Increased AJter Cellular I nsuIts. 
A tter dcn1011strating the induction of ORP 150 expression by nlitochondrial 
strcssors~ \\ie sought to detern1ine if other, nlore broad chen1ical and environn1ental 
stresses could induce ORP150 protein expression. COS-7 cells were treated for 24 hr ill 
the presence of tunicanlycin (1 0 ~lg/n11), 2-deoxyglucose (10 n1M), and the prolyl 
hydroxylase inhibitors DMOG (250 ~lM) and EDHB (500 ~lM). Cells also were grovvn in 
the absence of serun1 or under hypoxic conditions for 24 hr. Each treatnlent induced 
ORP ISO expression above baseline (Fig. 4-()). Also, the addition of tunicanlycin induced 
a splice variant of ORP 150 and showed a preference for the lower 11lolecular \veight 
isofc)rnl (Fig. 4-6). These results reveal that diverse cellular stresses induce ORP 150. 
()RPI50 Expression is Regulated by the Transcription Factor C:HOP/GADD153. 
ORP 150 expression is highly regulated by hypoxia and the unfolded protein 
response (lJPR) via presence of an endoplasn1ic reticulunl stress elen1ent (ERSE) 
spanning intron 1 and exon 2 orthe ORP150 gene (580). The transcription factor CHOP 
is kno\\ln to induce l1UnlerOUS stress response genes including 111itochondrial chaperones 
such as C'pn60/1 0, ('lpP, and n1tOnaJ (602), has been shown to be upregulated through 
the MSR and UPR (602, 609), and has an identifiable binding elell1ent (TGCA.ACC) ill 
the 5' pr01110tcr region (-2645 bp upstreanl of exon 1 A) of the ORP j 50 gene. We 
therefore hypothesized that MSR-ll1ediated ORP150 expression in the ER and 
nlitocholldria is through CHOP induction. To evaluate this hypothesis, we perfornled 
electrophoretic 1110bility shi ft assays in which a 30 bp ORP 150 pron10ter fragnlent 
containing the ('HOP-binding elenlent (wt) and a 111utant probe (nlutant) containing an 
altered CHOP site were incubated with nuclear extracts isolated fron1 cells transfccted 
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vvith various constructs or incubated with tunicall1ycin as indicated in Figure 8 and 
subjectcd to PAGE and Phosphorl1nager analysis. Inln1UnOC0111petition assays were 
pcrforll1cd using nuclear extracts of eOS-7 cells transfected with ~OTC'. As can be seen 
(Fig. 4-7, lanes 6-8)~ an increase in the level of a high 1l10lecular weight con1plex is 
observed vvith incubation of nuclear extracts fron1 the OTe and ~OTe COS-7 cell 
transrection groups, vvith the largest all10unt of binding seen in cells expressing ~OTC. 
As a positive control, extracts fron1 tunical11ycin-treated cells were used, because this 
chcnlical in kno\vn to induce CHOP expression (610) and led to an increase in thc high 
l110lecular v'leight c0l11plex (Fig. 4-7, lane 9). Nuclear extracts froll1 cells treated vvith 
tunicanlycin or cells expressing the various constructs did not produce high nlolecular 
\veight conlplexes \vhen incubated with 111utant probe DNA (Fig. 4-7, lanes 1-4). Wc 
then assessed \vhether the conlplex observed was due to binding of CHOP to this 
pronlotcr region. Nuclear extracts of cells expressing ~OTe were isolated and incubated 
\vith n10110clonal antibodies against CHOP or control (anti-~-actin) prior to conducting 
the EMSA. As shown (Fig. 4-7, lanes 11-12), the cOll1plex was depleted in 
inll11unocon1peted extracts, suggesting that the band shift was dependent on binding of 
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Figure 4-6. Effects of Cellular Stressors on ORP150 Expression. 
The effects of various cellular insults on ORP150 expression were evaluated in COS-7 
ce ll s. Ce ll s \ivere cultured in the presence of each chenlical reagent for a period of 24 
hours (tun icanl ycin - ] 0 J.lg/nll~ 2-deoxyglucose - 10 InM, DMOG - 250 J.lM, EDI-IB -
500 ~lM ). Cells cultured in the absence of fetal bovine serunl or under hypo.' ic 
conditions were also harvested at 24 hr. Sanlples were subsequently prepared fo r 
inll11unoblot analysis and were probed with antibodies against ORP 170. Results arc 
representative of three independent experinlents. 
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Figure 4-7. ()RP1S0 expression is regulated by the transcription factor ("H()P. 
(A) Nucleotide sequence alignnlent of the CHOP consensus elelllent and the putati\"l~ 
Clle)}> binding elcnlent in the ()RP 150 pronloter. Nlllllbers indicate the distance n'onl the 
transcription initiation site and shaded areas the CHOP consensus binding site. (B) 
EMSA of nuclear extracts fronl COS-7 cells transfected with aTe constructs. A probt' 
corresponding to a 30 bp (JRP 150 prollloter fragnlent containing the CH()P-bindint:: 
elenlent (vvild type) and a nlutant probe (nlutant) containing an altered CI--I()P site vvcrc 
incubated \\lith nuclear extracts fronl cells transfected with varioLls constrLlcts or 
incubated \\lith tunicanlycin as indicated and subjected to PAGE and PhosphorInlagcr 
analysis. Inlnlunoconlpetition assays were perforIlled using nuclear extracts of C()S-7 
cells transfected with ~OT(~ and incubated \vith anti-CHOP or anti-~-actin (control) 
antibodies. before adding radiolabelled \vild type probe. Results are representative 01' 
three independent experinlents. 
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()RP150 is a j\;1 itochondrial (~alpain Substrate. 
Recent evidence using cardiac ischenlia as a 1110del systell1 has suggested that the 
ovcrexpression ofORP1S0 negatively regulates cytosolic calpain activity by blocking the 
ischenlia-induced release of ER Ca2+ stores (S77). Given that ORP 150 and calpain 10 
are both localized to the nlitochondrial nlatrix~ we deternlined whether these proteins 
interact \\'ithin isolated nlitochondria. Calpain 10 protein levels and activity were 
dctcrInincd in COS-7 cells after transfection \\lith vector or ~OTC. Calpain 10 activity 
was found to be signi ficantly elevated in i10TC-transfected cells as conlpared to vector 
alone (Fig. 4-8A). Subsequently~ we probed for calpain 10 protein expression in cells 
transfcctcd \\lith the sanlC constructs. Calpain 10 protein levels showed no difference 
bet\vccn vector and ~OTC -transfected cells (Fig. 4-88). 
To further evaluate ORP lS0/calpain 10 interactions, we investigated the 
possibility that ORP150 is a calpain substrate. Using the calpain substrate prediction 
algorithrl1 PEST-FIND (http://srs.nchc.org.tvv/enlboss-
bin/Cfllboss.pl'?_action=input&_app=pestfind), \ve deternlined that ORP1S0 is a candidate 
substrate for calpain-nlcdiatcd proteolysis. Subsequently, degradation experinlents \vcrc 
'"'". })erfOrnlcd in \vhich isolated rat renal ll1itochondria were treated with C~a-' (1 pM 
sllstai ned concentration) in the presence and absence of 1 0 ~lM calpeptin. ORP ISO \\;as 
found to be cleaved in the presence ofCa.2+~ and this degradation was significantly 
inhibited by prctreatnlcnt with calpeptin (Fig. 4-8C). These results suggest that calpain 
1 () activity increases in response to the MSR and that this ll1itochondrial protease cleaves 
ORP ISO in a calciunl-dependent nlanner. 
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Figure 4-8. ()RPt 50 is a substrate for mitochondrial calpain. 
Mitochondrial calpain expression and activity was evaluated under various conditions. 
Mitochondrial calpain's ability to cleave ORP150 was subsequently assessed via d 
calciun1-dependent degradation assay. (A) Mitochondrial fractions fro 111 vector and 
i1()TC-transfected ('OS-7 cells 'vvere assayed for calpain 10-111ediated SLLVY -J\f\1C 
hydrolysis in the presence of 1 ~lM Caeb. (B) Mitochondrial calpain 10 levels in C'()S-7 
cells 'vvere assessed by in1ll1ulloblot analysis following induction of the rvlSR by ~()TC 
expression. «(=) Rat renal cortical nlitochondria were incubated with 1 pM C~aC'12 in the 
presence and absence of 1 0 ~lM calpeptin. ORP 150 degradation 'vvas assessed by 
inlnlunoblot analysis. Data are expressed as nleans ± SEM (N=3). Means \;vith differenl 
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DISC:USSION 
There are two nlajor classes of stress proteins: (1) the GRPs~ which are induced 
by inhibition of glycosylation~ defects in calciunl honleostasis, chronic hypoxia~ glucose 
dcprivation~ and reductive stress~ and (2) the HSPs~ which are induced by heat, oxidative 
stress, and ethanol, anlong varied other environnlental stressors (611). The GRPs are 
1110Stly found as resident ER proteins while the HSPs are generally confined to the 
cytosol, nucleus, and nlitochondria, reflecting the sensitivities of these conlpartnlents to 
various cnvironnlental stresses. Despite their varied localizations, they all act to preserve 
the llornlal integrity and functional viability of daJllaged proteins. Their activities range 
fronl, but arc not linlited to, protein stabilization, protein folding and unfolding, the 
chaperoning ofnloleculcs between cellular conlpartlllents, and protein conlplex assclllhly 
(612). Most of the known chaperone 1l10lecules have expression profiles that are based 
on thc presencc of cellular stresses such as heat, low glucose, and oxidation (612). Under 
such stresses, cells rapidly upregulate the expression of these nlolecules in attenlpts to 
prevent the accunlU 1ation of danlaged proteins and ultilllately cell death. 
Since the discovery of ORP150 in 1996 as a hypoxia-inducible e1enlent in 
cultured astrocytes, nluch has been elucidated about its protective role in cell death. 
f--Iovv'c\'cr, little is known about the actual 1l1echanislll of this protection. Nunlerous 
studies have placed the site of action of ORP 150 at the ER due to its s1n1ilarity to 
GRP 170 and its possession of an N-ternlinal signal peptide and C-ternlinal ER retcntioll-
like signal (KNDEL) (576~ 607). Ho\vever, the possibility ofORP150 localization to the 
n1itochondrial fraction has not been evaluated to date. 
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Nunlcrous studies have inlplicated a role for ORP150 in blocking cell death in 
various tllodels (577,578,582-584,588,590,591). Many of these studies have 
denlonstrated increases in cytosolic calciunl (577, 584), cytochrollle c (577), and active 
caspase,3 (577,582,584) in stressed cells, all of which were found to be decreased \vhcl1 
ORP 150 expression was induced. Even nlore striking were reports of decreased calpain 
activity in ()RP150 transgenic aninlals after induction of cardiac ischenlia/reperfusion 
injury or glutaIllate-nlediated neuronal toxicity (584). Taken together, these observations 
would suggest that although prinlarily found in the ER, the nlitochondriallocalization of 
such a nlolecule could provide a novel nleans of regulating cell death through nlodulatioll 
of the intrinsic apoptotic pathway or through 1l10dulatio11 of cellular calpain activity 
(kno\vn to Illediate apoptosis under various conditions) (574, 613, 614). 
Mitochondrial chaperone nlolecules are unique and varied in their function. Thcy' 
scrve to aid in preprotein translocation, protein folding, protection against cel1ular 
stressors, protein assen1bly, Fe/S cluster biogenesis, prevention of protein aggregation, 
renaturation of heat-stressed proteins, thern10tolerance, peptidyl-prolyine-isonlerisation, 
and can also serve as cochapero11e 1110lecules which help n1aintai11 and stinlulate the 
activity of other chaperone species (613). Mitochondrial proteins encounter extrenlcly 
harsh conditions and are exposed to elevated levels of ROS and RNS~ conditions 'vvhich 
ensure unending n10dificatioll and inactivation ofn1any protein species. Furthernlorc, 
si nec over 9(Y~;) of the III itochondrial proteollle is derived fron1 nuclear gene prodllcts~ the 
presence of nlitochondrial chaperones is essential for regulating protein inlport and 
folding, and in Il1aintaining overall nlitocholldrial viability. 
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In the present study, we hoped to identify the nlitochondrial localization of 
ORP 1 SO and elucidate conditions under which its expression is upregulated. Endogenolls 
ORP 150 expression in rat kidney cOliex was found to be localized to the ER and 
n1itochondria as indicated in Figure 4-1. We also evaluated ORP 150 expression in 
puri fied nlitochondrial nlatrix fractions to elinlinate the possibility of ER contanlinatioll 
in our lllitochondrial isolations, and found conlparable levels as conlpared to the 
organellar fractions alone (Fig. 4-1). Although these data were highly suggestive of the 
Illitochondrial localization of ORP 150~ we endeavored to support these findings llsing 
confocal 11licroscopy as depicted in Figure 4-28. ORP 150 was cloned into the TOPO-
TA-CT -G FP expression vector designed to place a gene of interest in franle \vith a C-
tCrl11inal GFP nloiety. GFP was placed at the C-tern1inus of ORP150 in order to avoid 
blocking any putative N-ternlinal n1itochondrial targeting signals. However~ in doing so. 
it is possible that we nlay have blocked exposure of the C-ten11inal ER retention signal 
(KNDEL) as evidenced by a lack ofGFP not colocalized with MitoTracker Red (Fig. 4-
28). 
1'v1any nlitochondrial n1atrix-targeted proteins contain either an N or C-ternlinal 
signaling nlotif. At the N-tern1inus, this n10tifoften takes the fornl of an an1phipathic 
helix containing positively-charged residues on one half of the helix and hydrophobic 
residues on the other (543). We deternlined the putative existence of such a 1110ti f in 
ORP150 using a helical \vheel applet (http://www.bioinfo.org.cn/lectures/index-7.htnlIL 
designed to display peptide sequences in a helical representation. This applet produces 
the vic\v of a protein helix looking down its axis froll1 the N to C-tern1inus. The results 
revealed that thc N-terll1inus ofORP150 can indeed fon11 such an anlphipathic helix (Fig. 
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4-38}. \Ve tested the hypothesis that the N-tern1inal 13 an1ino acids ofORP150 arc 
responsible for ll1itochondrial local ization, and detern1ined that this signal sequence is 
sufficient for the targeting of ORP 150 to the n1itochondrion (Fig. 4-3A). It is likely that 
the N-tern1inal nlitochondrial targeting signal and the C-tern1inal ER retention signal 
C0l11PCtC \vith each other for the norn1al trafficking of OR PI 50 which nlay be altered 
during stresses felt by various cell ular con1partn1ents. 
The expression of n1itochondria-speci fie chaperone n10lecules can be induced by 
a variety ofstressors including heat shock, oxidation, nlitochondrial inhibition, and via 
accul1lLllatiol1 ofnlitochondrial protein aggregates (603). We utilized two independent 
111cthods ofnlitochondrial stress induction to evaluate their effects on the expression or 
111itochondrialORPl50. Chronic dosing ofCOS-7 cells with ethidiull1 bronlide induced ~) 
dose-dependent increase in nlitochondrial ORP150 expression (Fig. 4-4). Sin1ilarly, the 
induction of the nlitochondrial stress response (MSR) using a truncated deletion 111utant 
of ornithine transcarbanlylase increased ORP150 levels in both the ER and n1itochonciri<11 
fractions (Fig. 4-5). These data suggest that ll1itochondria-speci fie stressors can induce 
ORP 150 and that this ll1ay serve as a protective nlechanislTI to preserve nlitochondrial 
viability. ER-localized ORP 150 expression can be nlodulated by a variety of ehen1ical 
agents and cell treatn1ents including hypoxia, hyperosll10tic culture conditions, and 
culture in the presence oftunican1ycin and 2-deoxyglucose (577,578,581-588). We 
\vcrc able to sho\v that a l1u111ber of these treatnlents as well as SerU111 starvation and 
treatn1cnt with prolyl hydroxylase inhibitors (to ll1in1ic hypoxia) were able to induce 
ORP 150 expression not only in the ER, but in the ll1itochondria as well (Fig. 4-6), 
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suggesting that nunlerous global cellular insults can regulate the pools of ORP 150 in both 
the ER and nlitochondria. 
As nlcntioned above, studies by Aleshin ct 01 and Kitao et al have in1plicatcd a 
role Cor ORP 150 in regulating calciu111 hon1eostasis al1d the subsequent activation of 
calpains (577,584). Recent studies have also begun to place calpains at the site of the 
rnitochondrion (232,526). Therefore, an interaction between 11litochondrial calpain and 
ORP 150 could provide n1uch needed insight into the antiapoptotic etTects seen in cell 
inj ury nlodels \vhen overexpressing ORP 150. Furthern10re, evaluation of the ORP 150 
peptide sequence via the PEST-FIND algorith111 (http://srs.nchc.org.tw/ell1boss-
bin/cnlboss.pl?~~action=input&_app=pestfind) identified it as an extrenlely likely 
candidate Cor calpain-nlediated proteolysis. To detect any possible relationship between 
nlitochondrial calpain and ORP 150, calpain activity and protein levels were exanlined ill 
COS-7 111itochondrial extracts prepared fron1 vector only and ~OTC-transfected cells 
(Fig. 4-8A and 88). These data denlonstrate enhanced calpain activity in the t~lce of 
equal an10unts of protein and seen1 to suggest a role for n1itochondrial ORP 150 in 
nlaintaining calpain function via protein stabilization and/or activation of the n10leculc. 
Conversely, in the setting ofn1itochondrial Ca2+ overload, ORP150 was found to be 
degraded in a Ca2+ and calpain-dependent fashion (Figure 4-8C). We suggest that 
ORP150 n10st likely functions to 111aintain overall protein stability \vithin the nlatrix or 
the n1itochondria. However~ during cellular injury in which calciulTI hon1eostasis is 
disrllpted~ lllitochondrial calpains becon1e activated and negatively regulate ORP 150. 
thereby din1inishing its ability to playa functional role as a chaperone nlolecule. The los:; 
of' a nlitochondrial chaperone would n10st certainly hasten 111itochondrial protein 
184 
dysfunction and degradation and could lead to the enhanced apoptosis seen in cells and 
anin1als deficient in ORP150 (577, 582, 584), however, n1any future studies are needed 1n 
veri fy this hypothesis. 
Finally, \\ie sought to detenl1ine a possible nlechanisn1 of 111itochondrial-strcss 
driven ORP 150 induction. Work by Kaneda et (If have previously den10nstrated the 
production of three n1RNAs driven by alternative pron10ters and have shown the 
preferential induction of one species under stress conditions including hypoxia and 
tunicanlycin treatnlent (580). In this study, pronl0ter analysis revealed the presence of 
three transcription startsites which begin at exons 1 A, 1 B, and exon 2. cDNAs 
containing exons I A and 1 B are translated fron1 a start codon located at the 5' end of 
cxon 2 \vhereas translation of cDNAs beginning at exon 2 is initiated fronl a start codon 
located in exon 3. Interestingly, under norn1al conditions, the nlajority of cDNAs cont<li II 
the 5' end of exon 2 while cells cultured under hypoxia or in the presence oftunical11ycin 
produce n10stly cDNAs containing exon 1 B at their 5' ends. The differential 
transcription of the ORP 150 gene during stress is thought to be controlled by the prCSCl1Cl' 
oran endoplasn1ic reticulunl stress elen1ent (ERSE) located in the pronl0ter region. 
Indeed, upon analysis of the ORP 1 SO pron10ter region, a 19 bp sequence was identi fled as 
being alnlost identical to that of the ERSE (CCAATN{)CCACG) with only 1 bp 
l11is111atch. The authors also showed that this sequence interacts with the transcription 
factor A TF6 and preferentially produces cDNAs containing exon 1 B due to overlap of 
the ERSE sequence with the 5~ end of eXOl1 1 A. Induction of the unfolded protein 
response (UPR) is initiated under periods of ER stress to upregulate cellular chaperones 
required to properly fold and 11laintain danlaged cellular proteins (612). Recent reports 
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have also denlonstrated the uprcgulation of transcription factors such as 
CHOP/GA.DD 153 and XBP-l in response to the UPR (610). 
We vvcre able to denlonstrate the induction of nuclear CHOP/GADDIS3 protein 
levels after the induction of ~OTC-nlediated MSR in COS-7 cells (Fig. 4-5). We \verc 
subsequently able to denlonstrate the binding of CHOP to a putative CHOP binding 
elelnent located 2645 bp upstreanl of exon 1 A via electrophoretic nlobility shi ft assays 
(Fig. 4-7). Taken together, the enhanced expression of ORP150 and CHOP~ and the 
ability ofC'HOP to bind elenlents upstreanl of the ORP150 pronloter under these 
conditions suggest the ability of enhanced CHOP expression to nlodify ORP 150 levels 
during periods ofnlitochondrial stress. These finding are also significant since induction 
orthe UPR also upregulates cellular CHOP levels. 
Our data also suggest the di fferential regu lation of ORP 150 transcripts after 
induction of ER stress 'vvith tunicanlycin. We have denlonstrated the production of a 
Slllallcr lllolecular \veight ORP 150 protein product after tunicanlycin treatlllent which is 
not seen a ftcr treatnlent 'vvi th various other inhibitors (Fig. 4-6). \Ve suggest that stress-
induced expression of CHOP subsequently induces expression of the larger nloJccuJar 
\veight isofonll of ORP150. In turn, tunicanlycin-induced ER stress induces hoth CHC)P-
nlcdiatcd and A TF6-nlediated induction of both nlolecular weight isofornls of ORP ISU. 
In sunlnlary, we conclude that ORP150 is differentially localized to hoth the ER 
and lllitochondria and that this localization is dependent on the presence of a C -ternlinal 
KNDEL and N-tcrnlinal nlitochondrial targeting signal, respectively. We have also 
dC1l10nstratcd that enhanced lllitochondrial expression of ORP 150 increases 
1l1itoc\1ondrial calpain activity under basal conditions and that ORP150 is negatively 
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regulated by the sanle calpain under conditions of Ca2+ overload. Our studies also 
provide evidence lor a novel nlechanislll of transcriptional regulation of ORP 150 by the 
stress-induced transcription factor CHOP which is upregulated by both ER and 
111itochondrial-speci ftc stressors. The localization of ORP 150 to the nlitochondria nlay 
provide an alternative nlechanislll for the anti-apoptotic activity of this chaperone 
nl0lcculc. lA.lternatively, ORP150 nlay produce anti-apoptotic signals specific to both 
cellular conlpartnlents and provide additive cytoprotective effects when induced through 
cell u lar stressors. 
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CHAPTERS 
SUlVIIVIARY, CONTRIBUTIONS, AND FUTURE DIREC1~IONS 
SUMMARY OF THE CURRENT LITERATURE 
Since their discovery in 197(), calpains have been inlplicated in nUlnerous 
physiological and pathological processes. Unfortunately, only isolated infonnation is 
available concerning the cellular and ill vivo functions, activation, and regulation of the 
diffcrcnt calpain isofornls. 
It has beconle clear that pathologies dOlninated by the dysregulation of cellular 
calciunl honleostasis are very often associated with increased cytosolic calciunl 
concentrations and enhanced calpain activity. Sonle of these pathologies include 
ncurodegenerative disorders (Alzheinler's, Parkinson's, Huntington's, anlyotropic late!",l! 
sclerosis, nlultiplc sclerosis), ischenlic injury (stroke, ll1yocardial infarction, acute renal 
!~li1ure), and cataract forn1ation (120,122,447,448,454,457-461,472). These 
pathologies are all associated \vith increased activities of either calpains 1 or 2, both 
typical EF-hand containing calpain isofonl1s. Given that there are 9 typical calpains \\'llh 
varying tissue distributions, it is quite possible that the nlore understudied typical calpail1 
species could be associated \vith nunlerous other disease states. More exacting 11101ccular 
studies '0.:ill be necessary in order to elucidate the functions of the renlaining species or 
typical calpains. 
The 1110st understudied class of calpains ren1ains that of the atypical isoforn1s. 
These species include 5 isoforll1s which retain the conserved active site of the enzyn1c, 
but lack the pcnta-EF hand regulatory calciun1 don1ain at the C-tern1inus. It is currently 
unknovvn hO\\1 these isoforn1s are activated or inhibited for that 111atter. In fact, a potenti~Il 
physiological role for only one of these isoforn1s (calpain 10) has been suggested in 
111an1111als. The con1plex diversity of the atypical calpains at the C-tern1inus suggests a 
\vide array offunctions and possible regulatory don1ains which ren1ain to be evaluated. II 
is unlikely that the atypical calpains are as calciun1-sensitive as their typical counterparts 
due to the absence of calciun1 binding sites at their C-tern1inus. However, recent 
crystallographic studies of calpain 2 have identified potential Ca2+-binding sites in 
dOl11ail1s IIa, IIb~ and don1ain III which 111ay be conserved in n1any of the atypical calpain 
species (263,309-311). If conserved, these novel Ca2+ -binding sites could 111lpart partial 
Ca2 i -sensitivity to these enzyn1es as den10nstrated by calpain activity assays using the 
proteolytic core of calpain 2 in \vhich co-incubation with calciun1 enhanced the cleavage 
of a calpain substrate (310). It is likely, however, that activation of these atypical calpaill 
isofornls involves post-translational 11lodificatlon, translocation to sites of action, or 
regulation through bi nding of allosteric proteins. 
()ver the last 30 years, inforn1ation on the classical calpains has grown to include 
possible ll1cchanisnls of activation and function. Much of the focus has been on the 
identification of calpain substrates under conditions of cellular Ca2+ overload. Until 
recently ho\\!cvcr, a substantial an10unt of work has relied on phan11acological inhibitiOJl 
or calpains using inhibitors that, as described previously, are severely lacking in 
speci ficity for the calpains and in selectivity between calpain isofon11s. Thereforc~ 
dra\ving significant conclusions fron1 ll1allY of these studies beconles difficult and brings 
nlany of these findings into question. For exanlple, nlany cOlnnlercially available calpain 
inhibitors such as calpain inhibitors 1 and 2 are quite potent inhibitors of the cathepsin 
f~lnlily of cysteine proteases, Iysosonlal enzynles inlplicated in various 1110dels of cell 
death. Sin1ilarly, nunlerous studies utilizing pan-caspase inhibitors such as ZVAO-FMK 
to inhibit caspase-nlediated apoptosis should also be re-evaluated since concentrations 
llsed to inhibit cell death in these nl0dels is sufficiently high to inhibit cytosolic calpains 
as \vell. Hovvever. advances in nlolecular biology over the last decade have provided us 
\vith the tools to ask better questions and the ability to answer then1 with nlore robust 
technical 111ethods thereby circUll1venting the problenl of inhibitor proll1iscuity. 
Significant interest in n1itochondrial proteolytic systell1s over the past 20 years 
has provided great insight into the nlechanisnls controlling nlitochondrial protein inlport. 
processing, turnover, and signal peptide processing. There are nunlerous proteolytic 
nlcchanisnls present in various lnitochondrial conlpartn1ents whose representative 
nlenlbers include serine, cysteine, and A TP-dependent proteases. The Lon protease, 
present in the n1itochondrial n1atrix, is an A TP-dependent serine protease involved in the 
proteo lytic processi ng of nlitochondrial proteins as well as proteins n10di tied hy 
oxidation (() 15). Another class of ATP-dependent n1itochondrial proteases includes the 
/\AA. proteases (171-AAA and i-Ai\A). These n1etalloproteases have been inlplicated ill 
the degradation of inner nlenlbrane respiratory c01l1plexes fron1 the n1atrix and 
intcnllcnlbranc space sides of the inner nlenlbrane (615). A third group of A TP-
dependent nlitochondrial proteases include the ClpP-ClpA/X cOll1plex. This proteolytic 
conlplcx functions as a serine protease and has been in1plicated in general protein 
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degradation (615). A final A TP-dependent protease, MISP I, discovered in the 
internlenlbrane space is a cysteine protease containing degradative properties sin1i1ar to 
the cellular proteasonle. The processing of inlported nlitochondrial proteins is OftCIl a 
neccssary step in producing nlature and functional nlitochondrial proteins. These 
functions are carried out by a group of proteins found in the nlatrix and intern1elllbranc 
space. The tirst of these proteins is MPP, or nlitochondrial processing peptidase~ \vhich 
recogni/es the N-ternlinal targeting signal on nlitochondrial preproteins. The MPP 
behaves as a Zn~t--nletallopeptidase and is inhibited by nletal chelators (615). Further 
cleavage of the N-tcrnlinus of MPP-processed proteins occurs via cleavage by the 
1l1itochondrial nlatrix internlcdiate peptidase (MIP), a 111etalloprotease inhibited by thiol-
blocking reagents such as n-nlethylnlaleanlide (615). Studies perfornled in ycast 
Initochondria have identi tied yet another processing peptidase nanled inner nlenlbranc 
protease I. This peptidase is thought to be localized to the 1l1itochondrial inner 111enlbral1c 
and controls the release of processed preproteins into the 1l1itochondrial internlen1branc 
space (() 1 5 ). 
While kno\vn 111itochondrial proteases play clear roles in regulating nlitochondrial 
protein processing and inlport, little work has been conlpleted on those proteases 
involved in cell signaling or cell death. For instance, llUnlerOUS procaspase isofonlls as 
\vcll as the serine proteases 01l1i/Htra have been localized to the nlitochondrial 
intCrll1Clllbranc space and are prcsu1l1ably released to the cytosol subsequent to apoptotic 
stinluli (() 16). Sinlilarly, llU1l1CrOUS reports over the last two decades have suggested the 
presence ofnlitochondrial calpains (231-233,527). The "calpain-like" activities 
ident i fled in variolls species and tissues have been inlplicated in the cleavage of variolls 
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1l1olcculcs including aspartate anlinotransferase, the RXRa protein, inner nlenlbranc 
bound .A.IF and ornithine transcarban1ylase, and has been denl0nstrated to be involved in 
forlllation of the M PT pore (408, 510-512, 527). Recent work has even placed calpai 11 1 
at the site of the nlitochondrion in rat cerebral cortex (232). 
Much of the work accon1plished on the atypical calpains has focused on calpaill 
10, a Type II diabetes susceptibility gene. Until recently, n10st investigators have i'OClISC(1 
on the role of cal pain 10 polyn10rphisn1s on the clinical endpoints of diabetes. For 
exanlple, nunlcrOLlS studics have denlonstrated a role for calpain 10 nlutations in 
producing elevated free fatty acids, triglycerides, increased body nlass indexes (BMl) 
(493), elevated \vaist-hip ratios (WH R) (494), decreased sleeping nletabolic rates in SOlllC 
populations (479), and decreased sensitivity to insulin stinll11ation (479) .. Analysis of 
these data have provided clear evidence that, in son1e populations, calpain 10 nlutatiollS 
play critical roles in the regulation of nunlerous diabetogenic phenotypes. HowevcL 
functional data linking calpain 10 to these phenotypes is lacking. 
Follo\ving the nunlcrous epidelniological studies conducted on diabctic cohorts, 
attention shifted towards identifying the 11101ecular 111echanisnls of how calpain 10 nlight 
increase diabetic susceptibilities. Insulin resistance in peripheral tissues is one of the 
nLln1crOllS h£1lln1arks of Type 2 diabetes. In fact, one of the 111any rate-lill1iting stcps fc)r 
insulin action is that ofGLlJT4-111ediated glucose transport (501), a process inlpaircd in 
Type:2 diabetes. It was SOOI1 discovered that chronic calpain inhibition (505) and the llSl' 
of calpain 1 () antisense n1ethodologies (502) resulted in blockage of insulin-Illcdiatcd 
(1 LtJT4 vesicle translocation to the plasllla ll1en1brane. HoweveL this effect \vas not 
lllcdiated by PI3-kinase signaling through the insulin receptor substrate pathway, but \VClS 
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instead found to be 111ediated by regulation of cortical actin network reorganization 
required for GLlJT4 vesicle translocatio11 (502). 
In addition, calpain 10 has also been shown to regulate insulin secretion in 
pancreatic r~ cells (480). The insulin secretion pathway in pacncreatic ~ cells involves a 
host ofsequcntial events including dynanlic changes in plasn1a nlen1brane potential, 
glycolysis, and Ca2+-dependent regulatory processes which culn1inate in the relocation or 
secrctory granules to the plasn1a ll1en1brane. Recent studies have been able to link 
calpain 10 vvith deficits in this path\vay. For exanlple, long-tern1 inhibition of calpain in 
pancreatic ~ cclls has been shown to depress glucose nletabollsnl with additional 
suppression of do\vnstrean1 Ca2+ -n1ediated responses and insulin secretion (480). 
Additionally, t\VO n1en1bers of the n1en1brane fusion fa111ily of proteins called SNAREs 
(syntaxin 1 and SNAP-25) have been identified as calpain 10 binding partners, 
Interestingly, the calpain 10 isofor111 responsible for this association was identi fled as a 
54 kDa protcin and sho\ved an ability to partially cleave the SNAP-25 con1ponent of the 
ll1cnlbrane fusion nlachinery, thereby inhibiting vesicle fusion and insulin secretion 
(486). ('onversely, calpain 10 overexpression increased insulin secretion in this nlodel. 
An alternative path\vay inlplicated in insulin secretion has recently been descrihed 
and involves the Ca2+ -independent secretion of insulin n1ediated by the ryanodinc 
receptor, and investigators speculate that deficits in ryanodine receptor protein levels or 
acti\'ity (exhibited in diabetes) can lead to hyperinsulinenlia. Very recent evidence has 
also denlonstrated that inhibition of type 2 ryanodine receptor-n1ediated Ca2-+ influx in 
pancreatic ~) cells results in cellular apoptosis that is inhibited by calpain inhibitors (4S I\. 
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It is clear that calpain 10 plays a critical role in glucose hOlneostasis and insulin 
secretion. The ovenvhelnling epidenliological data and forthconling 1l101ecular findings 
arc 110\\/ placing calpain 10 at the top of the list as a key target for therapeutic interventio11 
in Type II diabetes. It will be interesting to deternline the conlplete repertoire ofcalpaill 
10 functions and whether or not the proteolytic functions of each isoforn1 are redundant 
for one another. 
Fe\v other functions are ascribed to calpain 10 and nl0stly involve its contribution 
to the apoptotic process. T\vo independent studies have provided cOITelative evidence 
that calpain 1 () can function in a proapoptotic n1a11ner (403, 509). The first of these 
studies dcnlonstrated that trcatnlent of PC 12 cells with par-4 (a tun10r suppressor gene) 
antisense reduced glutan1ate-1l1ediated apoptosis with conconlitant decreases in 
intracellular Ca2+ and calpain 10 nlRNA (403). Subsequent studies perfornled by Wu and 
colleagues \vere able to show that treatn1ent of rat renal interstitial fibroblasts vv'ith the 
toxin lipoxin A4 induced calpain 10 protein expression and caspase 3 activity leading to 
increased levels of apoptosis (509). These data suggest a novel role for calpain 10 ill 
initiating or regulating the apoptotic cascade. However, these studies provide 1110Stly 
correlative data and 111ust be validated with 1110re rigorous techniques. 
[ntercst in calpain 10 physiology has grown rapidly over the last 5 years. The 
apparent association between calpain 10 dysfunction and Type 2 diabetes has generated 
an increased desire to elucidate the nl01ecular 111echanisnls linking calpain 10 to glucose 
llletabolisrll and insulin handling. Given that Type II diabetes is a disease affecting 20.S 
ll1illioll Anlcricans and costing over $130 billion dollars in direct and indirect costs each 
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year (http://\v\v\v.diabetes.org/about-diabetes.jsp), it is likely that the interest in calpaill 
10 biology \\'i II continue unabated for years to conle. 
CONTRIBUTIONS TO THE FIELD 
As described above, ll1itocholldrial proteases play key roles in nlaintaining viable 
and healthy ll1itochondria .. A.ny disturbances in the regulation of these nlolecules can 
severely perturb 111itochondrial functions including nletabolisnl and oxidative 
phosphorylation. NUIllerous pathologies are also associated \vith Illitochondrial 
dysfunction including ischenlia/reperfusion injury, neurodegenerative disorders 
(AlzhciIller's, Parkinson's), and Type II diabetes to nanle a few. With the recent 
discovery associating calpain 10 dysfunction with Type II diabetes, it is beconling clear 
that the activation/inactivation of nlitochondrial proteases n1ay be a final endpoint in 
lllllllerOllS disease states. 
Mitochondrial respiratory dysfunction is one of the 111any hall111arks of acutc rCll;.\l 
I~li lure and has been denlonstrated in nun1erous ill vivo 1110dels (171-173, 198, 218, 221, 
222). It has been hypothesized by nUll1erous investigators that these respiratory deficits 
arc a result of1l1itochondrial ('a.2+ overload subsequent to ischell1ia/reperfusion injury 
(172, 218). Our laboratory had previously de1110nstrated that isolated renal nlitochondri;: 
exhibited severe deficits in state 3 respiration which could be protected by pretreatnlcnt 
\\ith various calpain inhibitors. 
The research presented in this dissertation was undertaken to elucidate the icictllil\ 
and nature of the lllitochondrial calpain responsible for the ll1ediation ofCa2-
i
-induced 
lllitochondrial dysfunction. Previous work on nlitochondrial calpain activity focused 011 
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the ability of this enzyn1e to cleave typical calpain substrates, but did not endeavor to 
identify the actual calpain isoforn1 involved. We identified a Ca~+-inducible calpain 
activity in isolated renal n1itochondr1a that was inhibited by the Ca2+ chelator EGTA, 
calpain inhibitors, and rutheniunl red. In fact, subfractionation ofRCM preparations 
dClllonstrated (~a~f sensitive activities in each fraction. It is conceivable that these 
activities resulted fron1 partial in1purity of the n1itochondrial fractions. We also 
den10nstratcd that the nlitochondrial calpain activity was sensitive to both calpeptin and 
E-()4, but not to the 00n1ain IV specific inhibitor PO 150606. Since the atypical calpains 
lack this donlain, we found it unlikely that the ReM calpain could be a n1en1ber of the 
typical t~nni Iy of calpains. 
For J11any years, calpain activity has been routinely assayed via FITe-casein 
zyn10graphy, an assay in which proteins are separated via non-denaturing PAGE and 
assayed for the cleavage of the co-polynlcrized casein substrate within the gel. To furthlT 
characterize our ReM calpain, \ve en1ployed this technique as well as a n10dified vcrsi(1) 
oCthe assay in \vhich the peptidic fluorophore SLLVY-AMC~ (a substrate proteolyzcd by 
the ReM calpain) \vas used as the substrate. The RCM calpain was unable to cleave the 
typical calpain substrate FITC-casein, but effectively cleaved SLLVY -AMC in this aSS(l~'. 
In addition, RC~rvl subfractionation den10nstrated that viliually all of the Ca2-+-induced 
activity in this assay was lin1ited to the 111itochondrial n1atrix fraction and did not co-
111igrate vvith purified porcine kidney calpains 1 and 2. These data suggested to us that 
the ReM calpain was not calpain 1 or 2 and that it denl0nstrated a different substrate 
speci flcity than the typical calpains. 
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The identity of the RCM-specific calpain isoforn1 was subsequently detern1ined 
via three independent techniques. Firstly, each calpain isoforn1 \vas analyzed by the 
ll1itochondrial protein prediction algorithn1 MITOP2. This algorithn1 produced a positi\'i..' 
hit for calpain 10, but not for the ren1aining 13 large subunit calpain isoforn1s. Secondly, 
calpain 10 \vas identified in RCM subfi·actions via in1n1unoblotting using three dissinliLlr 
calpain 10 antibodies. In addition, calpain 10 was identified by in1n1unoblotting protein 
species eluted fron1 bands ofn1atrix fraction zyn10gran1 activity. Finally, calpain lO-(JFP 
constructs \vere found to be colocalized with the nlitochondrial-specific dye ivlitoTrdckcr 
Red in transfected NIH-3T3 cells. Interestingly we also detell11ined that the N-tern1inal 
IS an1ino acids of calpain 10 are sufficient for n1itochondrial targeting. 
[)uring our initial transfection experin1ents with calpain 1 O-GFP, we noticed t\\ 0 
distinct populations of cells expressing GFP. The first of these populations exhihited 
large globular patches of GFP staining which colocalized with the lysosonle-specific dye 
LysoTrackcr Red. These cells also dell1011strated an altered cellular 1110rphology and 
decreased plate adhesion. The second population of cel1s observed in these studies 
exhibited a norn1al cellular n10rphology and punctuate GFP staining which colocalizcd 
\vith MitoTracker Red. Interestingly, the n1itochondria observed in this population or 
cells appeared fragn1ented and swollen in conlparison to the norn1al branched reticular 
pattern of 11litochondria seen in these cel1s. Mitochondrial swel1ing and fragn1cntation 
are con1n10n to a nun1ber of insults including fOll11atio11 of the MPT, 111assive 
depolarization, electron transport chain (ETC) dysfullction, and perturbation of the 
n1itochondrial fusion and fission proteins. We chose to evaluate the possible forn1atiol1 (,,-
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MPT in order to explain the altered n1itochondrial n1orphology observed in our confocal 
expcrin1cnts. 
()ur initial studies using calpain 1 O-GFP and LysoTracker Red suggested the 
for111ation oCautophagocytic vesicles, a process suggested to be induced by the forn1atiol~ 
of MPT (174,546). Sin1ilarly, the conversion ofnorn1al branched l1litochondria to thOSl' 
with a fragn1ented and swollen n10111hology also suggested the possible illvolven1ent or 
calpail1 1 () in the [orn1ation of MPT (Fig. 5-1). To exanline this hypothesis, NIH-3T3 
cells vverc treated \\/ith the MPT inhibitors cyclosporine A and 3-n1ethyladenine prior to 
transfcction \vith calpain 10-GFP. Subsequent confocal analysis den10nstrated 
preservation of the norn1al nlitochondrialtTIorphology. Experil11ents using isolated RC\ r 
also del110nstratcd a role for calpain lOin the [orn1at1011 of MPT by inhibiting Ca=:+-
induced n1itochondrial swelling by ~30%. However, it is difficult to nlake broad 
generalizations concerning calpain 10 and MPT since classical endpoints such as 
cytochr0l11c c release \vere not n1easured. Future experinlcnts nlust be conducted to 
conlplctcly validate these data. 
Jt\s nlcntioned earlier. ETC dysfunction is conl1110nly associated vvith 
111itochondrial Ca2-'- overload. Since previous experinlents in our laboratory had 
den10nstrated Ca=:+ -induced decreases in RCM state 3 respiration, \ve decided to cvahl~lll' 
allY possible calpain 10 involvenlent in Ca2+-nlediated ETC dysfunction. Our initial 
investigations dcn10nstrated the ability of calpain inhibitors to protect against Ca2t _ 
induced state 3 dysfunction and that this dysfunction was confined to C0l11plex lofthe 
respiratory chain. Subsequent analysis revealed that, in our systell1, Conlplcx I 
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dysfunction 'vvas due, in part, to the Ca2+-dependent calpain 1 O-nlediated degradation or 
the NDlJFV2 and ND6 subunits of Conlplex I (Fig. 5-1 ). 
To further explore the nlitochondrial effects of calpain 10 action. \ve constructed 
an adenoviral cassette containing an shRNA sequence specific for calpain 10 to block 
calpain 10 synthesis. Infection ofprinlary rabbit RPTC induced conlpartnlent specific 
knockdo'vvn of calpain 10 expression. Cytosolic calpain 10 expression decreased to less 
than 20(~~) of control over a 5 day tinle course, while that in isolated nlitochondria 
decreased bclo\v levels of detection by day 3. These data suggested significant 
di fferences between the rates of calpain 10 degradation between the two cOlllpartnlCl1ts. 
Dccreased calpail1 10 expression was also verified by calpain activity analysis that 
sho\ved slistained activity in scranlble-infected cells and decreased activity in virlls-
infected cells over a 5 day tinle course. Mitochondrial paranleters including respiration, 
ATP generation. and nlenlbrane potential (~\Iflll) were evaluated and conlpared to control 
and scralllblc-infccted cells. Basal and FCCP-uncoupled nlitochondrial respiration 'vverc 
unchanged between all treatnlent groups. ATP levels renlained unchanged in the control 
and scralllble treated cells, while ATP production increased two tinles control levels in 
the virus-infected cells. Interestingly, qualitative assessnlent ofnlitochondrial nlcnlbratlC 
potential sho\ved no difference between all treatnlent groups. 
The above data presented an interesting question; how is the absence of calpaill 
10 increasing cellular ATP in the absence of a glycolytic substrate and unchanging 
respiratory rates and nlcnlbrane potential? To answer this question, we initially probed 
nlitochondrial sanlples fron1 calpain 10 shRNA-infected cells for protein species foulld ill 
Conlplex I orthe ETC and for the ATP synthase ~ subunit of the Fl/Fo conlplex. We 
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found that the expression of ATP synthase ~) increased significantly over the 5 day ti1l1C 
course. This increase in protein levels could be explained by two hypotheses~ 1) 
decreased proteolysis, or 2) increased expression. Decreased proteolysis of A TP 
synthase f) \vas denlonstrated by incubating RCM with Ca2+ in the presence or absence (!~' 
the calpain inhibitor calpeptin. In addition, cytosolic extracts fronl virus-infected cell~ 
vvcrc probed for AMPK, a nlolecule sensitive to AMP:ATP levels (570). AMPK levels 
\;\Y!CI"C increased~40(Yc) by day 5 of the treatnlent suggesting regulation of A TP levels 
through this path\vay (Fig. 5-1). Recent studies by Otani et af also have sho\vn increased 
AM PK levels after chronic calpain inhibition in nlyocytes, suggesting that AMPK is 
indeed a calpaill substrate (506). Taken together, we believe that these data reveal that 
cellular ATP levels are regulated in our 1110del at the level of ATP synthase B in Conlplc\ 
\1 of the electron transport chain. Under basal conditions, it appears as if calpain 10 acts 
to lllaintain steady state levels of ATP production through regulation of .AMPK and its 
do\vnstreanl target A TP synthase r), whi Ie under conditions of nlitochondrial Cal, 
oYcrlo(1cL calpain 10 can act as a negative regulator of oxidative phorphorylation through 
cleavage of .ATP synthase r) (Fig. 5-1). Ho\vever, future experill1ents validating the 
phosphorylation status of AMPK and the activation of its downstreall1 targets 111Ust be 
perCorn1cd. Sin1i larly, ill vitro experinlcnts dell10nstrating Ca2+ -induced cleavage of ATP 
synthase r) nlllst be perfornled to fully validate calpain 1 O's role in this process. These 
results are quite significant in light of the fact that Ca2+-induced cellular danlage, as seen 
in IlUll1CrOUS nl0dels of ischell1ia/reperfusion injury, is known to produced severe deficits 
in cellular ATP often leading to necrotic cell death (218). 
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During the 5 day course of our experin1ents involving viral1y-n1ediated calpain 10 
knockdown, we noticed significant changes in RPTC survival rates between control, 
scranlblc, and calpain 1 O-shRNA-treated cells. Control and scranlble-treated cells 
renlained conflucnt and retained their n01111a1 cellular 1110rphology over the tinle course 
\vhile cell survival in the virus-treated group decreased to ~40-50% by day 5. Cell death 
was analyzed by nuclearDAPI staining and via inlll1unoblotting for activated caspase 3. 
Virus-infected cells den10nstrated significant an10unts of condensed nuclei over the tilllC 
coursc and increased levels of active caspase 3, indicating apoptotic cell death. These 
results indicate a pro-survival role for calpain 10 and n1ay Inediated by the cytosolic 
isofc)rnl since gross cell death in culture is not evident until day 4 of the viral treatnlcnt. 
We propose the above hypothesis because nlitochondrial calpain 10 is conlpletely absent 
by \vcstern blot on day 3 while it takes considerably longer to knock down calpain 10 
levels in the cytosol (the days on which we see n10st cell death). Future experinlcnts arc 
planned to detennine the Inechanisnl of this cell death. 
As discussed above, the significance of calpain lOin the pathobiology of Type I I 
diabetes has placed this protease at the forefront of calpain research. The known 
1110lecular ll1echanisnls for calpain 10 and those elucidated by Ollr work suggest that 
calpain lOis involved in the regulation of insulin secretion, glucose ll1etabolisnl, and 
regulation of A TP levels and nlitochondrial viability. These data link calpain 10 to 
diabetes at IlUll1erOUS entry points and suggest to us that a nunlber of other diabctes-
associated gene products n1ight also be potential calpain 10 substrates. Upon an 
extensive literature search~ we identified a nun1ber of potential protein targets that \\;'el'C 
both inlplicated in the pathogenesis of Type II diabetes and identified as possible calpaill 
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substrates as detern1ined by the PEST-FIND algorithn1. We chose to evaluate the 
llloiccular chaperone nlolecule ORP150 (oxygen regulated protein 150). 
ORP150 has been shown to nlediate insulin secretion (592, 593), to be 
downregulated in diabetic cohorts (617), and contains nlultiple PEST n10tifs in its 
prilnary anlino acid sequence. Upon further evaluation of the ORP150 an1ino acid 
sequence, we identified a putative n1itochondrial targeting signal. This observation led us 
to the hypothesis that ORP150 nlay be localized to the nlitochondria \vhere it would be III 
a position to be regulated by calpain 10 action. Indeed, we identified the nlitochondrial 
localization of ORP 150 by illlnlunoblot analysis and inlnlunolocalization bet\veen 
.~litoTracker Red dye and a transfected ORP150-GFP construct. We also deternlined th~lt 
the N-tern1inal 13 a111ino acids of ORP 150 are sufficient for nlitochondrial targeting. 
Subsequent analysis of the ORP150 gene product revealed that its expression ill 
both the ER and n1itochondria is induced by nlitochondrial specific stressors (ethidiulll 
bronlicic, ~OTC transfection) and nl0re global cellular insults including serunl starvation. 
hypoxia, and treatnlcnt \vith tunicanlycin, 2-dcoxyglucose, and the prolyl hydroxylase 
inhibitors DMOG and EDHB. In fact, while sonle of this induction is controlled by the 
cndoplaslllic reticulunl stress elenlent (ERSE) in the 5' pronloter region of OR PI 50 
(580), \ve also detern1ined that the induction of the transcription factor CHOP can 
uprcgulate ORP 150 expression in the ER and 111itochondria by binding to a CHOP 
consensus sequence farther upstreanl of the ERSE. 
Investigation of the interaction between calpain 10 and ORP 150 provided 
evidence that overexpression of ORP 150 is correlated with increases in 111itochondria I 
calpai11 activity \vhich are 110t related to increased calpain 10 protein levels after 
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transfection \vith the MSR-inducing construct ~OTC. We also were able to den10nstratc 
that ORP 150 is indeed a substrate for calpain 10 (Fig. 5-1), and lTIay be negatively 
regulated during periods ofn1itochondrial Ca2+ overload as seen during 
ischen1ia/reperfusion inj ury. In addition, the san1e insults which increased ORP 150 
expression did not produce a conco111itant increase in calpai11 10 levels across all 
treatn1cnts (data not shown), suggesting that increases in tTIitochondrial calpain activity 
after induction of ORP 150 expression is n10st likely due to stabilization of calpain 10 
through the chaperoning activity of ORP 150. 
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Figure 5-1. Calpain 10 Substrates 
The schematic above depicts the mechanisms of action for calpain 10 elucidated in this 
dissertation. Mitochondrial calpain lOis responsible for the Ca2+ -induced cleavage of 
ATP synthase B, ORP150, and the electron transport chain subunits NDUFV2 and ND6 
(* and #, respectively in the figure). Cytosolic calpain 10 was also found to regulate 
expression of AMPK, and is important in RPTC survival. 
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FUTURE DIRECTIONS 
Our overall goals for future studies are 1) to identify the anti-apoptotic role ft.)!" 
::alpain lOin cultured RPTC and to exanline the effects of nephrotoxic ants in calpain I () 
deficient RPTC, 2) to elucidate a potential rolc for calpain lOin caspase-indcpendent 
apoptosis, and 3) to evaluate the effects of calpain lOon renal recovery after 
ischell1ia/reperfusion injury. 
A.s shown in Chapter 4, reduction of calpain 10 expression in RPTC leads to 
subsequent apoptotic cell death which correlates \\/ith the loss of cytocolic calpain 10. 
Previous literature has delll0nstrated a pro-apoptotic role for calpain lOin IlUnlCrOUS cell 
types including pancreatic ~ cells, PC 12 cells, and rat renal interstitial fibroblasts (403, 
48 L 5(9). Evidence fron1 t\VO of these studies has provided only con-elative evidence or 
calpain 10 involvenlent in apoptosis, ho\vever the third study conducted in pancreatic I) 
cells benefited 1'ron1 the usc of a calpain 10 knockout n10use n10del (481). In this study. 
the authors \verc able to den10nstrate the inhibit10i11 of ryanodine-induccd apoptosis, alld 
rcnlains the only direct evidence placing calpain lOin the apoptotic cascade. Our data 
arc not consistent with the findings n1entioned above, and this n1ay be due to difTercnc(:~ 
in cell types. 
Nurncrolls ll1cchanisll1s exist to either inhibit apoptosis or to proillote cell 
survival. Son1e of these n1echanisll1s involve expression of anti-a pop to tic 11101ccules slIel] 
as Bc1-2 or inhibitor ofapoptosis protein (lAP) \vhile others function via induction of 
pro-survival cellular pathways often linked to activation of growth factor receptors. ()I1C 
C01l11l10n do\\'nstrcan1 111echanisI11 pron10ting cell survival is that orthe NF-KB path\V~I~ 
The NF-kB patll\vay functions in conjunction \Nith its n101ecular binding partner IKH-u. 
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Under norn1al unstinlulated conditions~ IKB-a is found in a heterodinler conlplex \vith 
NF-KB and shields its nuclear localization signa1. During periods of cellular stress~ IKB-
Ct. is phosphorylated and cleaved thereby releasing NF-KB to the nucleus (574). There <Ire 
Illll11erous signals which induce phosphorylation of IKB-a~ however, these events 
cul!llinate in the calpain-nlcdiated cleavage of IKB-a and the translocation of NF-KB to 
the nucleus which then transcriptionally induces pro-survival and cel1ular defense gcnes 
(574). In fact~ llunlcrous studies have den10nstrated the ability of cal pains to cleave the 
IKB-(1 suppressor (422,477,574) thereby, proll10ting cell survival during stress. Rccellt 
results have even shown that defects in calpain 3 (responsible for linlb girdle nlllscular 
dystrophy) induce n1yocyte apoptosis via inhibition ofNF-KB translocation (477). 
Ho\vevcr, while both calpains 1 and 3 have been shown to cleave IKB-a, it is not clear ,IS 
to vvhcther or not these are the only cal pain isoforn1s that can perforn1 this function or if 
different isofonl1s are responsible are necessary for this function in different tissues. 
We have pcrfornled prelinlinary experinlents to evaluate \vhether or not calpain 
10 plays a role in th~ IKB/NF-KB pathway in RPTC. The signaling kinase Akt has been 
inlplicated as an upstrean1 regulator of IKB-a phosphorylation (575). As such~ we 
evaluated total Akt and phosph-/\kt levels in control, scranlble-infected, and virus-
infected RPTC. We detected decreases in total Akt and phospho-Akt levels in virus-
infected cells (Fig. 5-1). These data suggest that calpa1n 10 rnay regulate Akt levels 
and/or activation \vhich n1ay trans1ate to decreased IKB-a phosphorlyation and decreased 
translocation ofNF-KB to the nucleus. We suggest an alternative hypothesis in vvhich 
IKB-u is actually a calpain 10 substrate in RPTC, thereby inhibiting a pro-survival 
pathway in the absence of calpain 10. Future experinlents will be necessary to dctcrlllil1l' 
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ifcalpain 10 plays a role in regulating the NF-KB pathway. However~ elucidation ofa 
role for calpain 1 O-nlediated cell survival would significantly add to our understanding (\ r 
calpain I (fs association to Type II diabetes. 
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Day 1 2 3 4 5 
Control ~-- "",J 4W - ' S · S ~ Total Akt 
____ r .-__ ____ ..... _ GAPDH 
.,..---.. .-, ...... _ ........ ., --- GAPDH 
Virus Total Akt 
p-Akt 
~-~~7 ...  _. -_lit __ _ GAPDH 
Figure 5-2. Akt and phospho-Akt levels are decreased in response to calpain 10 
knockdown. 
onfluent RPTC were infected with either scramble shRNA or calpain 10-specific 
adenoviral shRNA constructs, harvested over a five day time course, and subfractionatcc.! 
into cytosolic and crude n1itochondrial fractions. Mitochondrial fractions were 
subs quently in1111ul1oblotted for total and phospho-Akt protein expression. Equal 
Co' 1os01ic protein loading was verified by ilumunoblot analysis using an a-GAPDH 
antih )dy. Re ult are representative of three independent experill1ents. 
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Recent work in our laboratory has focused on the role of calpain 10 as it relates tn 
apoptosis. Our initial findings den10nstrated that the absence of calpain 10 was 
dctrinlcntal to cell viability. Subsequent studies using RPTC treated with 1l10del 
toxicants such as the ionophore A23187 (1 0 ~lM) and nephrotoxicant cisplatin (50 pM) 
have dell10nstrated that our RPTC are significantly 1l10re sensitive to these toxicants in 
the absence calpain 10 expression (Fig. 5-2). Elucidation of the ll1echanisnl of this 
sensitivity \vould provide nluch needed insight into calpaill 10 biology. These 
prelilllinary data are also exciting due to their inlplications for cancer research. For 
exanlple, chell10therapeutic regill1ens nlight benefit fron1 a calpain 10 inhibitor that could 
hclp sensitizc cancerous cells to nlore standard therapeutic agents. 
Progranlnlcd cell death is a conlplex process that proceeds via caspase-dependcllt 
or independent nlechanisnls. Caspase-dependent apoptosis is a well-understood process. 
However. the nlolecular events leading to caspase-independent apoptosis are less \\lcll 
knovvn. One underlying event in this process is the release of apoptosis-inducing t~lctor 
(AIF) frolll the nlitochondria after an apoptotic stinlulus. The nlechanisl11 controlling lhi~ 
release has been ascribed to proteolytic cleavage of AIF froll1 the inner ll1enlbranc and 
release of the nlolecule to the cytosol and nucleus where it behaves as a nuclease. 
Calpain-nlcdiated release of AIF has been docull1ented by two separate investigators \\hl'l 
propose that calpain 1 is responsible for this proteolysis. Interestingly. Polster ct (// havl' 
suggested this nlcchanisnl using isolated 111itochondria and purified calpain 1, although 
they do concede that an endogenous 111itochondrial calpain could also be responsible 
(408). Recent reports have used C APN4-'- nlouse ell1bryonic fibroblasts (MEFs) to 
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investigate the role of the typical calpain species in AIF release, and concluded that the 
calpains arc responsible for this proteolysis. 
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Figur'c 5-3. C:alpain 10-deficient RPTC are more susceptible to toxic agents. 
Confluent RPlC' \vere infected \\lith calpain 10 shRNA or diluent and lllaintained for 
three days in culture. Subsequently. RP1'C were treated with either 1 0 ~lM A23187 
(ionophore) or 50 ~lM cisplatin (nephrotoxicant) in1aged via brightfield nlicroscopy at 4. 
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The nlolecular studies presented above provide a sonlewhat clear picture of the 
nlcchanisnls involving AIF release. However, we find it difficult to believe that a protei 11 
species as large as calpain 1 (~~80 kDa) can gain entrance into the nlitochondria given ib 
lack of any identi fiable 111itochondrial targeting signal. It 111ay, however. be able to signal 
events at the 111itochondrial outer 111elllbrane which translate to the internlelllbrane space 
and induce AIF cleavage there. We suggest the altenlative hypothesis that an 
endogenous rnitochondrial internlen1brane space calpain nlediates this cleavage. The 
calpain 1 0 f~lnlily is conlposed of 8 splice variants, al1 of which contain a nlitochondrial 
targeting signal at the N-ternlinus. Seven of these splice variants retain an intact protease 
dOl11ain and, in theory, could serve as functional enzyn1es. In our experinlents, \ve have 
characterized calpain activity in each of the fOllr 11litochondrial subfractions and have 
dcternlined that the nlajority of this activity is found in the intern1en1brane space (Fig. 5-
3), a finding observed by Gores ef 01 in lever nlitochondria. Interestingly, in rat 
internlell1brane space fractions, we have observed a calpain activity that is Ca2'-
independent and can recognize FITC-casein as protein substrate (Fig. 5-4) (527). 
In1nlunoblot analysis of protein eluted fr0111 bands of activity in these FITC-casein 
/Ylllogranls revealed a calpain 10 isoforn1 ~58 kDa in size which could represent calpail1 
10 isoforn1s c or d (Fig. 5-4). Future studies will be en1ployed to deternline the effects oj" 
ca1pain 10 knockout on AIF translocation after caspase-independent specific stinluli. 
This endeavor n1ay prove difficult, however, as knockout of individual calpain 10 splice 
variants would be nearly inlpossible. This problen1 will no doubtedly plague future 
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Figure 5-4. Ca lpain activity in rat mitochondrial subfractions. 
I urified 111itochondrial fractio n (Mat - 111atrix, OM - outer ll1ell1brane, IS -
internlenlbran , pace. 1M - inner 111el11brane) were assayed fo r SLLVY-AMC hydr lvsis 








... Calpain 10 
Splice Variant 
Figure 5-5. Rat intermembrane space contains a calpain 10 splice variant. 
Following calpain zymography, protein from the active enzymatic band indicated above 
was extracted and subjected to SDS/P AGE and immunoblotted with the anti-calpain 10 
(dIIB) antibody. Results are representative of three independent experiments. 
(Abbreviations: IS-intermembrane space) 
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Fil1ally, \ve would like to explore the effects ofcalpail1 10 on renal recovery alter 
ischen1ia/reperfusion injury. To accon1plish this, we have obtained calpain 1 () knockollt 
1l1icc (Dr. Polollsky, Washington lJniversity, St. Louis, MO) and are currently 
characterizing their basic nletabolic profiles. Little is currently known about the renal 
status of these al1il11als. Ho\vever, qualitative aSSeSS1l1ent of these ani111als has 
dcn10llstrated polyuria which n1ay or 1l1ay not be indicative of depressed renal function. 
This \vould, however, be a very interesting finding since our ill vitro studies have alrcad~: 
revealed decreased cell survival in the absence of calpain 10. Our calpain 10 knockout 
Inice and agc-n1atchcd controls \vill be challenged with 30 n1in of bilateral renal artery 
occlusion. The anin1als will be nlonitored for 48 hours, at which point blood and tissuc 
sdlllples \vll1 be obtained for purposes ofn1easuring serun1 creatinine and the extent oj' 
tubular injury, respectively. Based on our prelin1inary ill vitro expcrin1ents \ve expect to 
sec higher serunl creatinine levels and increased epithelial cell danlage in the knockouts 
as cOll1parcd to controln1ice. 
In conclusion, we have revealed the identity of a nlitochondrial calpain as calpain 
10 and have den10nstrated its role in Ca2+ -induced n1itochondrial dysfunction. Calpaill 
lOis increasingly gaining attention as a central player in glucose n1etabolisrn and, in pur 
hands, has been shown to n1ediate electron transport chain dysfunction~ apoptosis. and 
regulation or A.TP synthesis. ,Also, our findings involving the negative regulation of 
nlitochondrial ()RP150 indicates to us that calpain 10 and its splice variants nlay 1l1cdiatl 
illllllcrOllS other n1itochondrial and cytosolic pathways. The link betvveen calpain 10 and 
Type II diabetes \vill also be an area of furtive investigation in the future, especially i r 
calpain 10 can be placed in a signaling cascade relevant to this disease process. The 
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1dcnti fication of calpa1n 10 as a Ca~~-induc1ble lllitochondrial protease and regulator or 
apoptosis, as well as its role in glucose and illsulin l11etabolislll lllake th1s nlolecule and 
the pathways it regulates wonderful targets for therapeutic intervention in llUl11CrOUS 
d1sease states including Type II diabetes, cancer, and pathologies nlediated by the 
dysregulation of Ca2 + honleostasis. 
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